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ABSTRACT OF THESIS 
The application of Molecular Biochemistry for transfection studies 
in eukaryotic systems is well documented. Of the numerous methods 
employed for the introduction of foreign DNA into eukaryotic cells, 
the use of low density lipoproteins (LDL) as carriers of DNA into 
cells has not been reported. 
LDL was isolated, characterized with respect to its protein and 
lipid components, and then variously modified in an attempt to 
enhance its affinity for DNA. It was found that both unmodified 
and modified LDL could interact with DNA, at physiological pH. 
The carbodiimide modified LDL (ECDI - LDL) showed the greatest 
affinity for DNA. 
LDL and ECDI - LDL were used to study LDL receptor binding in 
skin fibroblasts. This was followed by a study of receptor 
binding activities of both uhmodified LDL ~nd ECDI - LDL compl~xed 
to DNA (pBR322). Although the extent of binding of ECDI - LDL 
and ECDI - LDL - DNA complexes to plasma membranes was greater, 
the internalization and degradation of both modified and unmodified 
LDL complexes were equivalent. This additional binding was 
attributed to non - receptor - specific affinity of the carbodiimide 
modified complexes for the plasma membrane. 
The transfection of foreign DNA into eukaryotic cells in culture 
was monitored by assaying for the expression of the cloning vector, 
pSV2cat, complexed to LDL or ECDI - LDL and introduced into the 
i i i 
cells by LDL receptor - mediated endocytosis. Of the cell lines 
in which the expression of the pSV2cat recombinant DNA was monitored, 
the human lung fibroblasts showed the greatest activity of the 
expressed chloramphenicol acetyl transferase enzyme. Although 
transfection efficiency was lower than that of the calcium 
phosphate - DNA coprecipitation procedure, the LDL receptor -
mediated transfection of eukaryotic cells was carried out under 
physiological conditions and may be applicable in vivo . 
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C H APT E R ONE 
1.1 Introduction 
Research carried out by Baker and Carrell, as early as 1926, 
attributed certain adverse effects of aging to serum components which 
were possibly lipoproteins. The nature of lipoproteins and the 
solubility of serum lipids were poorly understood until methodologies 
for electrophoresis and ultracentrifugation were improved and 
utilized for separating molecules according to their size and 
density. Hitherto, it was believed that cholesterol was associated 
with serum globulins (Homburger and Bernfeld, 1958). 
Machebauf (1929) was the first to isolate plasma proteins 
containing a high concentration of lipids, and thereby laid the 
foundation for research on the transport systems of lipids. Two 
distinct lipoproteins, namely the d- and p - lipoproteins, were 
isolated and characterized by Cohn and coworkers in 1946. The 
r - lipoprotein was found to contain about 75% of the serum 
lipids (Homburger and Bernfeld, 1958). A quantitative analysis 
of p - lipoproteins was made by isolating the low density component 
by preparative ultracentrifugation. The sedimentation coefficient 
(S) was then modified to Sf (Svedberg unit of floatation) in 
order to identify the lipoproteins separated by ultracentrifugation 
(Mann, 1958). By 1956 serum lipoproteins could also be separated 
successfully by electrophoresis and determined quantitatively. 
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However, the variation in lipoprotein levels in humans, from one 
individual to another, had hampered the use of lipoprotein profi l es 
for diagnostic purposes, e.g., lipoprotein patterns in plasma were 
found to increase with age, diet, pregnancy as well as in disease 
conditions such as xanthomatosis, nephrosis, billiary cirrhosis and 
diabetic acidosis. In the case of idiopath ic hypercho~ esterolemia, 
however, serum lipoprotein levels were greatly increased and could 
be detected by measuring serum cholesterol levels. 
In the next three decades new methods for isolatinglipoproteins were 
developed and existing methods were improved. The lipoproteins were 
also classified with a greater degree of accuracy. For ultra -
centrifugation methods, density adjustments were made with NaCl, KBr, 
NaN03, glycine and heavy water. Electrophoresis was carried out 
on paper, starch and agar. Lipoproteins, especially r - lipoproteins, 
were isolated by precipitation methods such as high molecular weight 
dextrans, ethanol or zinc reagent (Oncley, 1958; Bragdon et al ., 1956; 
Edelstein, 1979; Burnstein and Scholnick, 1974; Lee and Alaupovic, 
1974; Albers and Cheung, 1979). In addition to the existing methods, 
chromatographic and immunochemical methods were also developed for 
r 
the isolation and characterization of serum lipoproteins (Fellini et 
al ., 1974; Seidel, 1979; Mahley et al ., 1979; Lee, 1976; Laggner, 
1976; Carrol and Rudel, 1983; Kostner and Laggner, 1979). 
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1.2 The plasma lipoproteins 
The circulatory systems of higher animals transport various 
components such as oc - and P - globulins, albumin, glucose and 
other carbohydrates and ionic and hydrophobic components in 
solubilized form. The hydrophobic components are carried in plasma 
in the form of lipoproteins. These lipoproteins are required for 
both structural and functional aspects of the living cell's 
metabolism. The lipoproteins are lipid - associated proteins which 
transport various components throughout the body. 
The lipoproteins are classified on the basis of their densities, 
floatation coefficients and electrophoretic mobilities (Cawley and 
Minard, 1969; Brown and Goldstein, 1974). They are conveniently 
separated by ultracentrifugation techniques using density gradients. 
Thus chylomicrons, very low density lipoproteins (VLDL), low 
density lipoproteins (LDL) and high density lipoproteins (HDL) are 
found to have the following densities: < 0,940, 1,006 to 1,019, 
1,019 to 1,063 and 1,063 to 1,21 9 / ml respectively. The ultra -
centrifugation floatation coefficient (Sf) values ascribed to the 
lipoproteins are as follows: Sf 0 - 12 for LDL, Sf 12 - 20 for VLDL 
and Sf 20 - 4 000 for chylomicrons, where Sf is the Svedberg unit of 
floatation (Bernfeld, 1958; Gofman, 1958; Cornwell and Kruger, 
1961; Hatch and Lees, 1968; Cawley and Minard, 1969; Chiat et aZ ., 
1974; Laggner, 1976). HDL have been isolated at Sf 0 - 9 (Lindgren 
et aZ ., 1972). 
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Since lipoproteins are charged molecules, they also behave like 
proteins, in electric fields, and can be classified according to 
electrophoretic mobilities. The HDL have been designated (£- lipo -
proteins as they migrate close to the a1 - globulins, just 
behind albumin. The LDL have been designated P - lipoproteins as 
their electrophoretic mobility is that of ~ - globulin. VLDL 
move ahead of the LDL and are known as pre - p - lipoproteins, 
while chylomicrons do not migrate in the electric field (Bernfeld, 
1958; Lees and Hatch, 1963; Noble, 1968; Cawleyand Minard, 1969). 
The existence of a- and ~ - polypeptides in the lipoproteins h?s 
been confirmed immunologically. Although this classification of 
the 1 i poproteins hi stori ca lly preceded that by ultracentri fugati on, 
the latter has become more popular because, from a practical point 
of view, it is easier to isolate and separate lipoproteins by 
the ultracentrifugation methods (Havel et al., 1955; Bragdon et al. , 
1956; Hinton et al., 1973; Rudel et al., 1974; Redgrave et al., 
1975; Foreman et al. 1977; Chung et al., 1980; Zechner et al., 
1984; Roberts et al., 1985). 
The general functions of plasma lipoproteins have been ascertained 
from studies in vitro. Chylomicrons transport dietary cholesterol, 
triglycerides and other lipids from the intestines to adipose 
tissue and liver. Chylomicrons are the largest of the lipoproteins 
and are rich in triglycerides. Thus they have very low density 
« 0,94 9 / ml) and a protein content of .( 2%. The triglycerides 
of chylomicrons are hydrolysed within a short time by serum 
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lipases in capillaries of adipose tissues and other peripheral 
tissues. The resultant remnant particles are taken up by the live r , 
where VLDL are synthesized. The VLDL particles transport 
endogenously synthesized triglycerides to adipose tissues. The 
removal of triglycerides from VLDL results in the formation of 
LDL particles, which are rich in cholesterol. Most of the 
cholesterol in LDL are esterified to cholesteryl linoleate . The 
LDL transport cholesterol to peripheral tissues and also 
regulate the synthesis of cholesterol in these cells by the enzyme 
3-hydroxy-3-methylglutaryl Co A reductase (Section 1.5). HDL are 
synthesized in the liver, and ~are rich in phospholipids and 
cholesterol. The HDL transport cholesterol from peripheral tissues 
to the liver. 
Chromatographic, electrophoretic and other separation methods have 
sh?wn that lipoproteins are heterogeneous, and contain more than 
one type of protein, e.g., HDL contain mainly apoprotein A (apo A) 
but also apoprote in C (apo C). LDL contain apoprotein B (apo B 
or apo B - 100) as the major protein component and apoprotein C 
(apo C) as the minor component. VLDL contain ape Band apo C. 
The apoproteins isolated to date, from the lipoproteins, are 
apoproteins A I, A 11, B - 100, C I, C 11, C Ill, apo D, apo E, 
apo F and ape G (Alaupovic et aZ ., 1972; Nystrom and Sjoval, 1975; 
Merrisett et aZ ., 1975; Lee, 1976; Gidez et ale , 1979; Alaupovic, 
1981; Cardin et ale , 1984; Galton et ale , 1985). Some apoproteins 
play a structural role in the formation and stabilization of 
6 
lipoproteins, while others, e.g., A I, B - 100, C 11 and E have 
functional roles in the catabolic pathways of lipoproteins in 
non - hepatic tissue. The major enzymes responsible for lipoprotein 
breakdown are ' lipoprotein lipases (and hepatic lipases) which 
hydrolyse neutral lipids in the lipoproteins. The enzymes are 
found most abundantly in adipose tissue and heart muscle. They catalyse 
the hydrolysis of triglycerides to provide fatty acids to the 
cells (Korn, 1955; Goldstein et al., 1975; Speake et al., 1985). 
Lipoprotein lipase is sometimes present in the blood, 
where it hydrolyses lipoprotein - and chylomicron - associated 
triglycerides. In hyperlipemic patients levels of this enzyme 
may be increased by administering heparin thereby reducing plasma 
triglyceride levels (Bragdon, 1958; Jansen and Hulsman, 1985). 
The serum enzyme lecithin: cholesterol acyl transferase (LCAT) 
is responsible for the esterification of plasma cholesterol. 
It is an enzyme of hepatic origin, which transfers a long fatty 
acyl group from the 2 - position of lecithin to the 3 - P - hydroxy -
group of cholesterol. The cholesterol esters formed are then 
transferred to LDL and VLDL (Assman and Jabs, 1985; Owen et al., 
1985). The major receptor proteins found in peripheral cells 
are the LDL receptors. These bind apo B - and apo E - containing 
lipoproteins (Vogel et al., 1985). Receptor binding studies of 
lipoproteins have been carried out in a number of cell lines, 
including monocytes, fibroblasts, adipocytes, adrenal cells and 
rat aortic smooth muscle cells (Galton et al., 1985; Fong et al., 
1984; Hui et al., 1984; Mazzone and Chiat, 1982; Pitas et al., 
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1983; Chiat et al., 1979; Bierman et a l ., 1974; Kovanen et al. , 
1979). 
A considerable number of disorders have been associated with 
lipoprotein metabolism and function, and characterized by the 
excess, deficiency or absence of specific lipoproteins, e.g., 
the absence of the ~ - polypeptides (apo B) results in the disorder 
abetalipoproteinemia, while the absence of a - polypeptide 
causes Tangier disease (HDL is absent). The HDL deficiency is 
due to an autosomal recessive inheritance (Fredrickson ,et al ., 1967e). 
Lipoprotein disorders may be detected from abnormal electrophoretic 
patterns, which have proved invaluable in diagnoses. Pre - r -
lipids (i.e. VLDL) aye increased in patients with coronary heart 
disease and diabetes. Alpha - and beta - lipoproteins increase 
in nephrotic syndrome; ~ - lipoproteins are elevated in patients 
with hypothyroidism (Papadopoulos, 1978). 
Abetalipoproteinemia is characterized by the congenital absence 
of LDL (Fredrickson et al ., 1967c). This causes serious disorders 
in various organs, e.g., severe malabsorption in the intestine, 
neuromuscular disorders, mental retardation and retinitis 
pigmentosa. There is also a marked decrease in cholesterol levels 
in plasma. Since abetalipoproteinemia is coupled with a lack 
of chylomicrons and VLDL, and an accumulation of triglycerides in 
intestinal mucosa and liver, it is believed that the LDL is 
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essential for the transport of triglycerides, in addition to 
cholesterol, in plasma and lymph (Hatch and Lees, 1968; Shore and 
Shore, 1972). In abetalipoproteihemia the ~ - polypeptide 
synthesis is defective but serum HDL levels are normal (Cawley 
and Minard, 1969). 
Also associated with genetic abnormalities of f - lipoprotein are 
the type 11 and type III hyperlipoproteinemias (Fredrickson et al ., 
1967b, d; Wieland and Seidel, 1973; Brown and Goldstein, 1974; 
Papadopoulos, 1978). The type III hyperlipoproteinemia is 
characterized by subcutaneous lipid deposits and increased serum 
VLDL levels and reduced LDL levels. The type 11 hyperlipoprotein -
emia (familial hypercholesterolemia) is associated with a decreased 
catabolism of LDL. The metabolic error is the result of LDL 
receptor deficiency (Brown and Goldstein, 1984). 
1.3 Low density lipoprotein: structure 
It was previously thought that LDL was a large globular molecule 
containing core lipids and peripherally arranged proteins, 
containing hydrophilic exteriors which accounted for its solubility 
and protein - like chemical behaviour (Mann, 1958). Subsequently 
it was proposed that the LDL component (apoprotein B) consisted of 
several sUbunits which formed globules and were embedded in the 
phospholipid coat of the LDL. Part of these globules were buried in 
the lipid and part were exposed to the aqueous medium. The basis 
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for this proposal was that upon delipidation the apoprotein B 
(apo B) was found to disaggregate into a number of subunits 
ranging from 8 000 to 25 000 daltons (Goldstein and Brown, 1977). 
A more recent hypothesis for the structure of p - or low density 
lipoproteins is the location of a single large globular protein 
(~po B, molecular weight approximately 500 000 daltons) embedded 
in an array of lipid molecules. The protein presents a hydrophilic 
exterior while the hydrophobic parts are embedded in the lipids. 
The lipids, on the other hand, are arranged such that the non -polar 
or neutral lipids are located in the core of the particle, while 
the phospholipids and unesterified cholesterol are arranged on the 
periphery of the spherical macromolecule (Figure 1.1). The 
orientation of the peripheral components is such that their 
hydrophobic ends (fatty acyl chains and steroid groups) face 
towards the core, while , their hydrophilic head groups face outwards 
(the aqueous medium)(Brown and Goldstein, 1976; Brown and Goldstein, 
1977; Brown and Goldstein, 1984). It is the hydrophilic exterior 
of the LDL particle that confers solubility to the LDL particle 
in aqueous media such as blood, extracellular fluid and buffers. 
The phosphorylcholine groups of LDL are accessible to the surround -
ing medium and display a high degree of motional freedom. The 
phospholipid polar head groups protrude slightly higher than the 
protein component of LDL (Laggner, 1976). The core lipids of LDL 
have weak lipid - lipid hydrophobic interactions and are surrounded 
by the partly hydrophilic protein, phospholipids and cholesterol. 
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Figure 1.1 :Structure of a low density lipoprotein particle in 
cross - section. 
1 1 
The LDL particle allows an exchange of lipids (cholesteryl esters 
and triglycerides) from its core and surrounding medium (Zilversmit 
and Johnson, 1975; Zilversmit et aZ ., 1975; Roberts et aZ ., 1985). 
There is also an exchange of cholesterol between different lipo -
protein classes. LDL reacts with a large number of substances 
such as cations (e.g., Ca++), polyanions (dextran sulfate, heparin) 
and other macromolecules (e.g., mucopolysaccharides, proteoglycans) 
(Bernfeld et aL , 1957; Ghosh, 1976; Margolis and Capuzzi, 1976). 
LDL is isolated from human plasma by ultracentrifugation, within 
the density range 1,019 - 1,063 g / ml. The molecular weight of 
LDL has been determined to be between 2 x 106 and 3,5 x 106 daltons 
(Shore and Shore, 1972; Goldstein and Brown, 1977). Its diameter 
o 0 varies between 193 A and 250 A. The size and molecular weight 
variations have been attributed to variation of lipids in the core 
and not the protein component. The average level of LDL in normal 
human plasma is 400 mg / 100 ml and 340 mg / 100 ml for males and 
females respectively. 
The LDL lipids comprise about 75% of the LDL particle , while the 
proteins comprise 22% of LDL. About 5 - 9% of the protein 
component consists of carbohydrates (galactose, mannose, glucosamine 
and sialic acid residues). Cholesterol constitutes 40 - 60% of 
the total lipid of LDL, 80% of which is esterified and located in 
the apolar core (Skipski, 1972). The major fatty acid component of 
the cholesteryl esters is linoleate. This constitutes 50% of the 
1 2 
total fatty acids. Other fatty acids found in the LOL are oleate 
(20%), palmitate (15%) and small amounts of stearate, palmitoleate 
and arachidonate (Brown and Goldstein, 1976a; Goldstein and Brown, 
1977). The phospholipids comprise 30% of total LOL lipids. The 
major phospholipids are phosphatidylcholine (65%) and sphingomyelin 
(25%). LOL also contains about five different glycosphingolipids. 
The triglycerides constitute 7 - 11 % of LOL lipids (Shore and Shore, 
1972; Goldstein and Brown, 1977: Skipski, 1972). 
A LOL variant, designated Lp (a) has also been isolated from the 
plasma of normolipemic donors and found to band at densities 1,019 -
1,21 g / ml and comprise three species. The Lp (a) lipoproteins 
contain additional disulfide - linked, carbohydrate - rich 
components which vary from the apo B component of LOL (Fless et al. , 
1984). The protein of Lp (a) is designated apoprotein (a). The 
origin and metabolism of Lp (a) has yet to be determined. 
In addition to the preparative ultracentrifugation methods used 
for the isolation of LOL (and other lipoproteins; Section 1.2), 
selective methods such as immunoprecipitation and heparin - Mn++ 
precipitation methods have also been developed for isolation and 
purification of low density lipoproteins (Burnstein et al., 1970; 
Burnstein and Scholnick, 1974). Affinity chromatography on 
Sepharose gels containing coupled cholesterol and cholic acid 
have also been used in the isolation and purification of LOL 
(Carroll and Rudel, 1983). 
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1.4 Apoprotein B 
The apoprotein B of human plasma LDL has been designated apo B - 100 
and has a molecular weight of between 5 x 105 and 5.5 x 10
5 
daltons 
(Brown and ,Goldstein, 1976; Cardin et aZ., 1984). It is partly 
embedded in the hydrophilic coat of LDL lipids and is recognized 
by receptors located on the plasma membrane of cells. Minor 
quantities of apo B - 74 (Mr 410 000) and apo B - 26 (Mr 145 000) 
have been detected in LDL preparations and are believed to be due 
to the proteolytic degradation of apo B - 100 (Cardin et aZ ., 1984) 
during exsanguination. LDL apo B - 100 contains a highly specific 
cleavage site which is recognized by both plasma and tissue 
kallikreins(Cardin et al. , 1984). 
The extraction of lipids from LDL renders the apoprotein B i nsoluble 
in aqueous medium. LDL contain a total of 22% protein. A portion 
of this is hydrophobic in nature and embedded in the lipid core 
of LDL. The hydrophobic portion is insoluble in aqueous medium 
and in the absence of lipids. The solubility of apo B is increased 
by chemical modifications such as succinylation and maleylation. 
Due to the difficulty in solubilizing the apo B without the use 
of denaturing solvents, the amino acid sequence of the apoprotein 
has not been determined. However, chemical studies have thrown 
light on ~arious aspects of the apoprotein structure. Infra red 
and circular dichroism spectra have shown that apo B contains a 
large amount of anti - parallel, ~ - chain structure (Shore and 
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Shore~ 1972). Apo B also contains single amino - terminal 
glutamic acid and carboxy - terminal serine residues. Thus Brown 
and Goldstein (1984) have recently proposed a structure for the 
LDL particle which contains a single apoprotein. Apo B contains 
5 - 9% carbohydrates, however~ their exact role and significance 
is not known. 
The extraction of lipids from LDL results in the formation of 
intermrnecular disulfide bonds in apo B. It is this disulfide 
bridge formation that results in aggregates of the apoprotein. The 
cross - linking reaction occurs by a sulfhydryl - disulfide exchange 
between free sulfhydryl groups present in the original apo B of LDL 
(Cardin et al. ~ 1982). Disulfide bond formation occurs in the 
absence of lipids and renders the apo B insoluble. 
Attempts to isolate apo B by delipidation of LDL affords unstable 
and aggregated forms of the apoprotein . Solubilization is 
achieved by various denaturation techniques. Gustafson (1965) 
extracted LDL lipids with heptane and used soluble starch to stabilize 
the apoprotein. Sodium dodecylsulfate, sodium deoxycholate, Nonidet 
P 40, cetyltrimethylammonium bromide~ guanidine hydrochloride and 
other solvents have been used to solubilize the delipidated apoproteins 
(Gotto et al ., 1969; Helenius and Simons~ 1971; Cardin et al ., 1982; 
Shore and Shore ~ 1972; Kri eger et al. , 1978a ~ b; Kane ~ 1973; Lee 
and Alaupovic, 1974a). The removal of LDL lipids with ether and 
ethanol at high salt concentration and subsequent dialysis at lowered 
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salt concentrations has also been carried out in an attempt to 
isolate soluble, non - denatured apo B (Lee and Alaupovic, 1974b) 
LDL is generally isolated in the density range 1,019 - 1,063 g / ml, 
and is regarded as being homogeneous. Lee and Alaupovic (1974b) 
have separated LDL into si x subfractions, all of which contained 
apo B as the major protein component and apo A and apo C as the 
minor components. Of these LDL I, 11 and III have apo A and apo C 
in an associated form while LDL IV, V and VI contain apo A and apo C 
in the free form. 
Stoichiometric binding studies using Fab fragments of 8 monoclonal 
antibodies were carried out to determine the number of epitopes 
present per molecule of LDL. Wickland and co - workers (1985) 
found that one antibody bound per LDL for each of the 8 different 
molecular loci in apo B. Thus immunologic data also point to the 
presence of a single large protein monomer of apo B per LDL particle. 
Young and co - workers (1986) prepared a monoclonal antibody 
(MB 47) directed against an epitope in the LDL receptor - binding 
domain of human apo B. The Fab fragments of the purified 
antibody were prepared by papain digestion, and could react with 
LDL from human and various animal species (lion, bear, shark, seal, 
whale and tuna). This cross - reactivity shows a possible common 
ancestral origin of apoprotein B. 
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1.5 LDL metabolism and function 
Although LDL is the major cholesterol - carrying lipoprotein in 
human plasma, it is not secreted as such in the blood. The protein 
component of LDL, apoprotein B, is synthesized in the intestine and 
liver. It is secreted by the liver as part of the triglyceride -
rich lipoprotein, VLDL. which also contains other proteins. VLDL 
is transported to adipose tissue where a large amount of triglycerides 
and proteins, except apo B, are removed from the particles. 
In addition, the cholesterol content is increased to yield the LDL 
particle (Margolis and Capuzzi, 1972; Coleman, 1973; Goldstein 
and Brown, 1977). 
Turnover studies with [1251 ] LDL show that about 700 mg LDL appears 
in human plasma per day. This comprises about 40% of the plasma 
pool~ Unused LDL is believed to be degraded in the liver as well 
as in other tissue. A number of non - hepatic cells in culture 
have been used to study the LDL metabolic pathway. Cell types 
utilized are skin fibroblasts, arterial smooth muscle cells, 
lymphoid cells and endothelial cells. These have helped in further 
elucidating LDL metabolism, function and associated abnormalities, 
and in understanding the significance and importance of low 
density lipoproteins. 
Mammalian cells in culture preferentially utilize exogenous 
cholesterol, contained in LDL, obtained from serum added to the 
culture medium. The fate of LDL in normal skin fibroblasts, as 
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outlined by Goldstein and Brown (1977) begins with the binding of 
LDL to high affinity receptors on the cell surface. The receptor -
bound LDL are then internalized by a process called receptor -
mediated endocytosis (discussed in Section 1.7). The LDL particles 
are then delivered to the lysosomes, where the LDL components are 
broken down and made available to the cells (Figure 1.2). 
LDL - derived cholesterol is essential for plasma membrane and 
steroid hormone synthesis. The accumulation of free intracellulari 
cholesterol regulates the activities of two microsomal enzymes, 
namely, 3 - hydroxy - 3 - methylglutaryl Co A reductase (HMG Co A 
reductase) and acyl Co A : cholesteryl acyl transferase (ACAT). The 
presence of free cholesterol in the cell suppresses the HMG Co A 
reductase (thereby supressing endogenous chol~sterol biosyn -
thesis) and activates ACAT (which esterifies cholesterol). 
Cellular esterified cholesterol contains mainly oleate and 
palmitate. The cholesteryl esters of plasma LDL contain mainly 
the linoleoyl fatty acyl group. Thus the overall function of LD L 
is to transport cholesterol from the plasma to the cell (extra -
hepatic) where part of it is utilized for synthesis of cell 
membrane and the remainder is re - esterified and stored in a 
liquid crystalline state. 
More than 90% of the cholesterol produced in the body is synthesized 
in the liver and intestine. Although most cells require cholesterol, 
its synthesis is suppressed in non - hepatic cells, in favour of 
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exogenous cholesterol (Brown and Goldstein. 1976a), which is 
obtained from plasma LDL taken up by LDL receptor - mediated 
endocytosis (Section 1.7). However, the cholesterol synthesis in 
the liver is controlled by dietary cholesterol (which is taken to 
the liver in chylomicrons remnants) and not by LDL - associated 
cholesterol. 
I n vitro studies have shown that when adequate amounts of 
cholesterol are accumulated by the cell, the LDL binding activity 
is reduced. This constitutes a feedback mechanism for the 
regulation of cholesterol levels in the cell. The accumulation 
of cholesterol in the cell suppresses de novo synthesis of the LDL 
receptors, thus reducing, and finally blocking, further transport of 
cholesterol (LDL) into the ce l l. This protects the cell against 
the abnormal accumulation of cholesterol. Cholesterol synthesis, 
in the absence of exogenous cholesterol, is regulated by HMG Co A 
reductase. When cholesterol is available from an exogenous source, 
the enzyme activity is suppressed. Esterification of cholesterol, 
catalysed by ACAT, is stimulated, thus preventing excess accumula -
tion of free cholesterol in the cell (Brown and Goldstein, 1976 a; 
Dempsey, 1974; Goldstein and Brown, 1977; Brown and Goldstein, 
1984). 
1.6 Abnormalities associated with low density lipoproteins 
Familial hyperlipoproteinemias are disorders associated with 
lipoprotein metabolism. Clinically significant hyperlipoproteinemia 
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can be classified into 3 major types: hypercholesterolemia, 
hypertriglyceridemia and the combined hyperlipemia (hypercholestero-
lemia and hypertriglyceridemia). Of these hypercholesterolemia is 
due to increased concentration of LDL in serum. The classical 
disorder of familial hypercholesterolemia is due to a genetic 
defect in the LDL receptor - mediated uptake of LDL by the cells. 
Manifestations of the heterozygous form are xanthomas of the tendons 
(hand and Achilles), xanthelasma arid corneal arcus. The homozygous 
form is characterized by the same manifestations as for the 
heterozygous form, but also by premature ischaemic heart disease. 
It has long been suggested that the accumulation of cholesteryl 
esters, from LDL, on the walls of arteries lead to the formation 
of atherosclerotic plaques. This predisposition to atherosclerosis 
is also due to increased plasma levels of LDL. Atherosclerotic 
plaques may inhibit blood flow and eventually lead to thrombosis, 
which may finally block arteries and lead to heart attack or 
stroke (Hanig, 1958; Goldstein and Brown t 1977; Brown and Goldstein. 
1984). Thus. the removal of LDL, from serum, by the LDL receptor, 
maintains normal levels of LDL and reduces the risk of atherosclerosis. 
Plasma LDL levels also increase in women with breast carcinoma 
(Petermann e t al ., 1958) and bil atera 1 oophorectomy. Estrogens 
maintain normal levels of LDL, and this is disrupted when ovaries 
are removed. The turnover of LDL is increased in patients 
suffering from rheumatoid arthritis, cancer, leukemia and hyper -
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thyroidism (Margolis and Capuzzi, 1972). Elevated plasma LDL 
in hypothyroidic patients can be corrected by administration of 
thyroid hormone. 
Serum LDL levels in hypercholesterolemic individuals may be 
reduced by both dietary and pharmaceutical approaches. Thus it is 
known that the presence of unsaturated fats in the diet leads to 
decreased LDL levels. It has been shown that administration of 
thyroid hormone also normalizes serum LDL levels albeit temporar i ly 
(Gofman, 1958). More recently, familial hypercholesterolemias 
have been treated with cholestyramine, a resin which sequesters bile 
acids in the gut, thereby stimulating bile acid synthesis from 
cholesterol. Inhibitors of the enzyme HMG Co A reductase have al so 
proved to be useful therapeutic agents. 
1.7 LDL receptors and endocytosis 
LDL receptors were discovered in 1973 during LDL binding studies 
carried out on human skin fibroblasts in culture (Brown et aZ., 1973). 
The finding that fibroblasts utilized cholesterol only from LDL 
gave the first indication that cells utilized specific receptor -
mediated mechanisms for internalizing the cholesterol - containing 
LDL (Brown et al., 1974; Goldstein and Brown, 1974). 
In order to study the cell surface receptors which carried LDL 
into the cells, LDL was labelled with iodine. Goldstein and co -
workers (1979a) found that [1251 ] - labelled LDL bound to the 
21 
receptors of normal skin fibroblasts at 4°C but were not internalized. 
Internalization and degradation were facilitated at 37 °C. 
Fibroblasts produce between 20 000 and 50 000 receptorsper cell 
d . th f d· 1 t t· (Ca++ or Mn++) to an requlre e presence 0 lva en ca lons 
bind LOL. The receptors are sensitive to proteases (Pronase, 
trypsin and chymotrypsin) but resistant to glycosidases. 
The LOL receptor recognizes and binds the apoprotein B component of 
LDL and VLDL. It also binds apoprotein E of HOLc ' which shows some 
sequence homology to apo B. Apoproteins A I and A 11 of HDL 
do not bind to the receptors. 
The LDL receptor is a glycoprotein which is embedded in the plasma 
membrane. It has a recognition site for apo B - 100, and due to 
its high affinity for the LDL particle, the receptor can bind to 
LOL at a concentration of less than 10-9 M (Brown and Goldstein, 
1984 ). 
The LOL receptors are located in specialized indented regions of the 
cell membrane called coated pits, the interior surfaces of which 
are coated with the protein called clathrin. The coated pi ts 
invaginate and 'pinch off' from the membrane to form coated vesicles. 
LDL bound to the receptors is thus carried into the cell inside 
the clathrin - coated vesicles. The entry of LDL particles into 
the cell by this method is known as receptor - mediated endocytosis 
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Synthesis of LDL receptors and the internalization of LDL 
by receptor-mediated endocytosis. The LDL receptor is synthe-
sized on polyribosomes bound to endoplasmic reticulum (ER), 
glycosylated in the Golgi apparatus (G) and inserted i nto 
the plasma membrane (PM) at random sites. The LDL receptors 
gather at clathrin coated pits (CCP) and internalize LDL 
into clathrin coated vesicles (CCV) by receptor - mediated 
endocytosis (Section 1.7). The LDL is delivered via the 
endosomes (E) to lysosomes (L) where they are degraded. The 
LDL receptors are returned to the cell surface in recycling 
vesicles (RV). 
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The LDL receptor is synthesized on membrane - bound polyribbsomes 
and glycosylated in the Golgi apparatus. The receptor is initial ly 
inserted into the plasma membrane at random sites. Experimental 
data suggest that the LDL receptor has two recognition sites : one 
for binding LDL (LDL binding site) and the other for binding to 
coated pits (internalization site). The LDL binding site is 
located on the extracellular surface whilst the internalization 
site is positioned on the cytoplasmic side. Receptors with 
normal internalization sites gather at coated pits (Figure 1.2). 
Receptor - bound ligands are first internalized into coated 
vesicles which contain a polyhedral protein of molecular weight 
180 000 daltons, originally designated clathrin (Pearse, 1975; 
Brown and Goldstein, 1979). The coat can be dissociated into 
hexameric protein complexes that consist of three heavy chains 
(112000 - 125 000 daltons) and three light chains (30 000 - 36 000 
daltons). Electron microscopy studies have revealed that each 
hexameric molecule is organized into a three legged structure 
termed clathrin triskelion (Ungewickell and Branton, 1981). 
Purified triskelions reassemble into cage - like structures in 
which the arrangement is similar to the original coat. The 
clathrin heavy chains exhibit substantial a - helical conformation 
and are stabilized by the trypsin - labile monomeric light chains 
(Ungewickell, 1984). Clathrin cages also bind to 100 000 dalton 
and 50 000 dalton polypeptides which connect clathrin to the 
membrane of coated vesicles. 
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The liver has by far the largest concentration of LDL receptors and 
degrades a large amount of cholesterol. LDL receptors have been 
purified from bovine adrenal cortex membranes, cultured human 
fibroblasts and cultured human epithelioid carcinoma A -431 cells 
(Schneider et al., 1979; Schneider et al., 1982). The receptors 
have been solubilized in a non - ionic detergent, octyl - r -0 -
glucoside, followed by affinity chromatography on LDL - coupled 
Sepharose 48. The receptor was eluted with suramin. The LDL 
receptor was found to be a single glycoprotein (molecular weight 
164 000 daltons) which displayed the binding properties of intact 
LDL receptors. 
The coated pits on the plasma membranes are areas which contain 
LDL receptor protein and other migrant proteins. The reason for 
gathering of LDL receptors in coated pits is possibly to isolate 
them from other membrane proteins, which are permanent constituents 
of the plasma membrane and must not be carried, in the endosomes, 
to the lysosomes. Other receptors found in coated pits include 
those for transferrin (Omary and Trowbridge, 1981), insulin (Kasuga 
et al., 1982), epidermal growth factor (Ushiro and Co hen , 1980) 
and asialoglycoprotein (Drikamer, 1981; Drikamer and Mamon, 1982; 
Steer et al., 1981). Unlike the transferrin receptor which is a 
160 kilodalton dimer, the mature LDL receptor is a single glyco -
protein chain of 164 kilodaltons, bearing 0 - linked as well as 
N - linked carbohydrate chains which have been added post -
translationally (Schneider et al., 1982). 
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Receptor - bound LDL particles are internalized as a complex, 
with their receptors, in small coated vesicles. The small vesicles 
lose their clathrin and fuse together to form large vesicles 
called endosomes or receptosomes. In the receptosomes, the LDL 
particles are released from their receptors which return to the 
cell surface. The LDL particles are carried to the lysosomes where 
the lipid and protein components are degraded. The internalization 
of LDL by receptor - mediated endocytosis is illustrated in Figure 
1.2. The LDL receptors are migrant glycoproteins which complete 
a single cycle of internalizing LDL every 12 minutes (Brown et al., 
1983). 
It has been found that cells can internalize receptor - bound 
macromolecules or ligands at a steady state without the depletion 
of cell surface receptors. Even when cycloheximide was used to 
block the synthesis of new receptors, the cells continued to 
internalize macromolecules by receptor - mediated endocytosis. 
(Goldstein and Brown, 1974). This could only have been possible 
if the receptors were recycled. The occurrence of the recycling 
phenomenon is supported by the use of chloroquine, which raises 
the pH of intracellular compartments, including lysosomes. Under 
these conditions, the receptors, once internalized, cannot return 
to the cell surface. LDL receptors trapped intracellularly can 
be detected by suitable tagging (with ligand or antibodies) 
and electron microscopy. 
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Endocytosis has been defined as the process by which internalization 
of extracellular molecules occurs by invagination of the plasma 
membrane, giving rise to a vesicl~. Depending on the type of cell 
in which endocytosis occurs (and the type of internalization), the 
vesicle formed may be a phagosome (phagocytosis), pinosome (pino -
cytosis) or coated vesicle (receptor - mediated endocytosis) 
(Besterman and Low, 1983). 
Endocytosis has been classified into two types : phagocytosis 
(or eating) and pinocytosis (drinking). The former defines 
internalization by the cell of particles larger than a few fm 
in diameter. Pinocytosis has been further subdivided into fluid-
phase pinocytosis (smaller substances enter cells in the fluid) or 
adsorptive pinocytosis (bound to vesicle membranes). Adsorptive 
pinocytosis includes the endocytosis of ligands by specific ce l l 
membrane receptors (receptor - mediated endocytos i s) . Molecu les 
taken up by receptor - mediated endocytosis include polypeptide 
hormones (epidermal growth factor. insulin, thyroid hormone), 
plasma transport proteins (LDL, transferrin, asialoglycoproteins) 
and a2- macroglobulins (Cuatrecasas, 1974; Silverstein et al ., 
1977; Besterman and Low, 1983; Brown et aZ ., 1983; Dean et aZ ., 
1984). 
Electron microscopic studies indicate that receptor - ligand 
complexes are located in endosomes for up to 20 minute s before 
the ligands are delivered to the lysosomes. The endosomes are 
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heterogeneous (round, cup - shaped or tubular) when viewed under the 
electron microscope. Biochemical analysis has shown that the 
endosomes do not exhibit acid phosphatase and arylsulfatase activity 
(lysosomal marker enzymes). It has been found that at 20°C fusion 
of endosomes is inhibited (Dunn et al ., 1980). This also 
illustrates that the endosomal and lysosomal compartments are 
functionally different. 
The pH within the endosomal compartment has been found to be acidic. 
It has been demonstrated that isolated endosomes become acidified 
in v itro in the presence of ATP. An ATP - driven proton pump, 
resembling that of lysosomes (Schneider et al., 1981) may also 
exist in the endosomes. At pHs below 6 receptor - ligand 
dissociation has been shown to occur with LDL, lysosomal enzymes, 
epidermal growth factor, asialoglycoproteins and a2 - macroglobulin. 
The dissociated receptor is then returned to the cell surface to 
bind another ligand (i.e., the receptor is re - used or recycled). 
Some bacterial toxins such as di phtheria and tetanus toxin have 
been called 'opportunistic ligands' as they bind to cell surface 
receptors and enter the endosome, where the acidic pH induces a 
conformational change in the toxins, thus allowing them to cross 
the endosomal membrane and enter the cytoplasm (Donovan et al . , 
1981). 
The receptor - ligand dissociation phenomenon accounts for the 
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rapid return (3 minutes) of the LDL to the cell surface. It also 
explains how the LDL receptor can make up to 150 rounds into the 
cell and back without undergoing proteolysis. The proteolytic 
enzymes are contained in the lysosomes. Only 10% of the interna l ized 
LDL is regurgitated intact. Thus 90% of the endosomes must pass 
on their contents to the lysosomes. 
Genetic defects in LDL receptor function produce familial hyper -
cholesterolemia. Because LDL is inefficiently internalized, or not 
internalized by defective receptors, an accumulation of LDL occurs 
in the plasma, eventually leading to atherosclerosis (Section 1.6). 
Receptor deficiency is inherited and can lead to homozygous or 
heterozygous familial hypercholesterolemia (FH). Patients 
diagnosed as FH homozygotes show abnormality in both alleles of 
the gene for the LDL receptor. Three classes of mutant alleles 
have been identified by Brown and Goldstein : Rbo, which specifies 
a receptor that has no binding ability, Rb-, which specifies 
a receptor that has reduced binding ability and Rb+/ i o, which 
specifies a receptor capable of binding LDL normally but incapable 
of internalizing the LDL (Brown and Goldstein, 1979). In the 
heterozygous form of FH, patients have one normal allele and one 
(of the three above) mutant allele at the receptor locus. Since 
binding and internalization are mediated by a single protein, 
the two alleles, whether normal or mutant, must reside in a single 
locus. The heterozygous form of FH is more common (1 in 500) than 
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the homozygous form (1 in 106). Both forms of FH are characterized 
by elevated plasma LDL levels. 
11251 ] labelled monoclonal antibodies (IgG - C7), raised in mice, 
against LDL receptors of bovine adrenal cortex, have been shown to 
bind to receptors of abnormal human fibroblasts in molar amounts 
equivalent to that of human [1251 ] LDL. However, fibroblasts from 
FH homozygotes showed a tendency to bind negligible amounts of 
[1251 ] LDL and r 1251 ] 19G - C7, thus illustrating that the 
receptors were defective (Beisiegel et al. , 1982). 
Mazzone and Chiat (1982) have described two types of receptor -
mediated systems in monocyte - derived macrophages. One type 
recognizes native LDL and internalizes the LDL by the receptor -
mediated pathway described (Goldstein and Brown, 1977). The 
second is a unique pathway which contains receptors which 
recognize chemically modified LDL (acetyl - or malondialdehyde 
treated LDL) and degrade them at a more rapid rate than native 
LDL. Thus a study of the literature shows that the LDL receptor 
serves two major functions : it provides cholesterol for plasma 
membrane synthesis and maintains normal LDL levels in plasma 
by continuously binding and internalizing plasma LDL. 
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1.8 Interaction of LDL with mammalian cells 
The number of receptors on the surface of the cell is under 
feedback control (Brown and Goldstein, 1975). This control is 
exerted on the synthesis of LDL receptors. The LDL internalized 
by receptor - mediated endocytosis provide cholesterol for plasma 
membrane synthesis. As a feedback control the cholesterol not 
utilized for plasma membrane synthesis is esterified and 
cholesterol synthesis is suppressed by ACAT and HMG Co A reductase 
respectively (Section 1.5). This system is dependent on 
exogenous cholesterol brought to the cell by LDL. The entry of 
cholesterol (from LDL) is controlled by the synthesis of LDL via 
a feedback loop. The LDL receptors are essential in the control of 
cholesterol synthesis by the cell, however, the receptors can be 
by - passed in culture by free cholesterol or oxygenated 
analogues (15 - hydroxycholesterol, 7 - ketocholesterol) added to 
the culture medium (Brown and Goldstein, 1974b). 
Basu and co - workers (1976) have reported that LDL, cationized 
by reaction with N,N - dimethyl - 1,3 - propanediamine, increased 
LDL degradation in homozygous FH fibroblasts in vitro 100 - fold. 
This degradation was inhibited by chloroquine, suggesting that 
the degradation occurred in the lysosomes. The cationized LDL 
was shown to regulate cholesterol metabolism in the cells. The 
authors have suggested that an alternate method of internalization 
o cc u r s. which is charge - related. However, LDL which is not 
modified will also bind to negatively charged material, such as 
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glass beads (Dana et al ., 1977) and sulfated glycosaminoglycans and 
polyphosphates (Burnstein and Scholnick, 1974; Burnstein et al . , 
1970). 
Of interest is the finding that ascorbate increases the receptor -
mediated internalization and degradation of LDL in cultured bovine 
smooth muscle cells (Aulinskas et al ., 1983). This is inhibited by 
cycloheximide, suggesting that ascorbate stimulates de novo 
synthesis of LDL receptors. Although maximum receptor activity 
occurs about 12 - 24 hours after treatment, and is transient, 
ascorbic acid therapy is being considered in patients with familial 
hypercholesterolemi a or those pred i sposed to atherosclerosis. 
LDL particles have been modified and reconstituted in order to 
probe in vitro metabolism of LDL. Thus, Krieger and co - workers (1978) 
have removed cholesteryl esters from the LDL core and replaced 
them with labelled cholesteryl linoleate. The reconstituted LDL 
exhibited the same biological activity as native LDL, in cultured 
human fibroblasts. It was also able to regulate the activities 
of HMG Co A reductase and ACAT. 
Cholesterol analogues, 7 - ketocholesterol and 25 - hydroxycholesterol 
(Figure 1.3a) have been utilized to study receptor - mediated 
endocytosis in vi t r o . The oxygenated sterols have been found to 
enter the cell, replace the cholesterol of plasma membranes and 
suppress the activity of the LDL receptor (Brown and Goldstein, 1974b). 
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7 - ketocholesterol 5«- cholest - 8 (14) en - 3p - 01 - 15 one 
Figure 1.3a Structures of cholesterol and its analogues used 
in vitro to study LDL receptor activity and LDL 
receptor - medi ated regul ati on of HMG Co A reductase and 
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Figure 1.3b: Cholesterol derivatives (I, Ill) and fluorescein 
probe (11) incorporated in LDL and used in the study 
of LDL receptor function discussed in Section 1.8. 
R = (Gal - OCH3); Gal = galactose. 
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Another cholesterol analogue, 5«- cholest - 8 (14) - en - 3, 01 - 15 one, 
also reduced plasma cholesterol leve l s, in cholesterol fed Rhesus 
monkeys. This was coupled with the decrease in LDL and VLDL levels 
(Schroepfer et al . ,1984). 
Fluorescent probes, 3 - pyrene methyl - 23,24 - dinar - 5 cholen - 22 -
oate - 3 - f - yl oleate (PMCA oleate) and dioleoyl fluorescein 
(Figure 3b) were incorporated into LDL ~nd added to cultured human 
fibroblasts to visualize receptor - mediated endocytosis (Krieger 
et al., 1979). These reconstituted LDL probes were used to show 
that cells from homozygous FH patients lacked LDL receptors. 
A derivatized cholesterol, N - (tris - ~ - 0 - galactopyranosylmethyl) 
methyl) - N« - 4 - (5 - cholesten - 3f3 - yloxy) succinyl glycinamide 
(abbrevi ated Tris - Gal - Chol; Figure 3b) was introduced into LDL 
and liposomes. These were injected into rats and found to be 
incorporated into the liver parenchymal cells 10 minutes after 
injection (van Berkel et al ., 1985) . The cholesterol derivative 
was rapidly catabolized by the hepatic cells. The authors proposed 
this as a method for targeting drugs, hormones and other substances 
into specific cells. However, since the liver is a Idetoxifyingl 
organ, substances intended for targeting may be broken down before 
reaching the target organs. 
It has been reported that a maximum of 250 000 molecules of [1251 ] LDL 
can be bound per cell in normal skin fibroblasts with high affinity 
and specificity (Brown and Goldstein, 1974). Fibroblasts from 
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patients with abetalipoproteinemia, on the other hand, do not bind 
[1251 ] LDL. This indicates a complete absence of LDL receptors. 
In the normal cells HMG Co A reductase activity is regulated by 
the LDL in the culture medium. HMG Co A reductase is the rate -
controlling enzyme in cholesterol biosynthesis. The enzyme activity 
is not regulated or suppressed in FH homozygous cells in vitro, 
by exogenous LDL. Consequently, these cells are resistant to LDL -
mediated suppression of HMG Co A reductase activity and continue 
to carry out cholesterol synthesis. 
Scavenger receptors of human monocytes and macrophages recognize 
human LDL containing derivatized lysine residues and take up the 
acetylated, succinylated or malonylated LDL particles if the 
modified components comprise more than 16%. The recognition of the 
modified LDL was shown to be due to the presence of positive 
charges on the lysine residues (Davis and Malone - McNeal, 1985). 
1.9 Lysosomes 
In 1955 de Duve discovered a distinct type of subcellular organelle 
which he called the lysosome. He conducted latency studies and 
found that the lysosomes carried out the digestion of intracellular 
and extracellular macromolecules. Since then more research 
has been carried out to elucidate the functions of the lysosomes. 
It has been found that vesicles containing various endocytosed 
macromolecules fuse with primary lysosomes to form secondary 
lysosomes. The hydrolytic enzymes are contained in the primary 
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lysosomes after being synthesized in the endoplasmic reticulum 
(Reijngoud and Tager, 1977). The lysosome functions as an intra -
cellular digestive system, and in it the hydrolytic enzymes have a 
working optimum pH which is acidic (pH 6). 
All lysosomal enzymes are synthesized as inactive precursors 
which contain oligosaccharides and are activated by cleavage of 
the precursors at specific sites (Tager et al., 1984). It has 
been found that a transmembrane pH gradient is generated by a 
proton - translocating ATPase of intracellular organelles such as 
lysosomes, endosomes, storage granules and Golgi apparatus. This 
proton gradient maintains a more acidic pH in the interior of t he 
organelles (Harikumar and Reeves, 1984). The acidic pH is required 
for the optimal functioning of the lysosomal enzymes, which 
degrade macromolecules. The efflux of degradation products has 
also been shown to be dependent on ATP (Schneider et al., 1984). 
A specific Mg++ - dependent ATPase is an integral component of 
lysosomal membranes (Schneider, 1981). 
In the lysosomes, components internalized by receptor - mediation 
are selectively broken down by processes which complement cellular 
biosynthesis. About 50 lysosomal enzymes have been detected in 
the lysosomes (Neufeld et al., 1975; Dobrota and Hinton, 1984; 
Barrett, 1984; Tager et al., 1984). Lysosomal metabolism, 
involving these enzymes, has been divided into the proteolytic, 
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glycanolytic, nuclease and lipolytic pathways. 
DNA and RNA entering the lysosome by the process of autophagy or 
endocytosis are broken down via the nuclease pathway (Barrett, 1984; 
Dean, 1984; Duncan et al ., 1984). Lysosomal ribonuclease and 
deoxyribonuclease have an acid pH optimum. The lysosomes also 
contain acid phosphatase, phosphodiesterase and phosphatase 
activities to complete the hydrolysis of DNA and RNA (Dobrota and 
Hinton, 1984). 
The lysosomes also contain various lipolytic enzymes, e.g., tri -
acylglycerol lipase (which cleaves fatty acids from triglycerides 
and cholesteryl esters), phospholipase A1 and A2, phosphatidate 
phosphatidase (degrade phospholipids), sphingomyelin phosphodiesterase 
and acylsphingosine deacylase (hydrolyse sphingolipids). 
Lysosomal enzyme deficiencies with respect to the lipolytic and 
nuclease pathways manifest serious inherited diseases such as 
Gaucher, Tay Sachs (sphingolipidosis) and Wolman's disease 
(cholesteryl ester and triglyceride accumulation). The lysosomal 
proteolytic pathway has, to date, shown no hereditary deficiencies. 
Proteolytic activity of the lysosome makes it the largest source 
of amino acids for new protein synthesis. The proteolytic enzymes 
also have a reaction maximum at acid pH. Lysosomal preparations 
are characterized by acid phosphatase and arylsulfatase activities. 
These are the lysosomal marker enzymes. 
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1.10 Clontngvehicles 
Recombinant DNA techniques have been useful- for the structural 
analysis of the chromosome. Specific segments of the chromosome, 
bearing genes of interest, can be isolated, inserted into cloning 
vehicles and propagated in suitable hosts. 
The most commonly used cloning vehicles or vectors are plasmids 
and bacteriophages (Glass, 1982). The plasmids are double - stranded 
circular DNA molecules which can replicate in the host (usually 
specific strains of E. coli ). Plasmid vectors have been derived 
from naturally occurring plasmids such as pSC101 and ColE1. 
Depending on the size of foreign DNA inserts, these plasmids can 
vary in size from 3 000 to 30 000 base pairs. The plasmids, 
carrying specific genes of interest, have been used to transform 
selected strains of E. coli (C600, HB101, h303, RR1) by 
adsorption of the plasmid to the host in the presence of calcium 
ions at reduced temperature, followed by temperature elevation 
to 42°C (Sinsheimer, 1977; Wilson and Goulding, 1986). 
The plasmids may be Istringent l or Irelaxedl with respect to DNA 
replication. The former type produces 6 - 8 plasmid molecules per 
chromosome in exponentially growing cells and requires new 
protein synthesis. Plasmid pSC101 and its derivatives fall into 
this category. The ColE1 and its derivatives are relaxed plasmids 
which produce 20 - 30 plasmid molecules per chromosome and do not 
require new protein synthesis for their replication. Neither type 
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of plasmid requires an active DNA polymerase I for replication. 
Plasmids used as vectors for recombinant DNA carry genes for 
antibiotic resistance, e.g., pBR322 plasmid carries genes for 
resistance against the antibiotics ampicillin and tetracycline, 
denoted by ampR and tetR respectively (Sutcliffe, 1978; Watson 
et al ., 1983; Maniatis et al ., 1982). A distinct advantage is 
the presence of restriction sites (Section 1.11) in the antibioti c 
resistance genes. The insertion of a foreign gene into such a 
restriction site destroys the antibiot ic resistance gene. However, 
the loss of resistance can be detected easily, as a check for the 
successful insertion of the foreign gene. When the recombinant 
plasmid is then i ntroduced into a host bacterium, it confers 
resistance to the host by virtue of the second resistance gene 
(Bolivar et al ., 1977). A scheme for the insertion of a foreign 
gene into the Pst1 restricted site of the ampR gene of pBR322 plasmid 
is presented in Figure 1.4. 
In the presence of an inhibitor of protein synthesis, e.g., 
chloramphenicol, which blocks host DNA replication as well, the 
plasmid can continue replication until the plasmid DNA constitutes 
40 - 50% of the cellular DNA. Thus plasmid DNA molecules can be 
increased from 20 copies per cell to 1 000 copies per cell (Potter 
and Dressler, 1979). 
The viral cloning vector most commonly used for gene transfer is 
bacteriophage A (Philipsen et al ., 1978; Maniatis et al ., 1982). 
Fi gure 1.4 
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bacteria is by tetracycline resistance. 
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Since the phage A DNA cannot be encapsulated unless at least 75% of 
its total genome is present, the ADNA is excised and non - essential 
genome is replaced with the specified (foreign) gene under study. 
Large inserts in plasmids lead to large molecular weight plasmids 
which decrease the efficiency of transformation of host cells. 
Hence the use of bacteriophages (such as phage A) as alternate 
vectors has become useful. Foreign DNA of up to 17 000 kilobases 
in length can be inserted into such a recombinant. The recombinant 
DNA molecules are then packaged into viral envelopes and allowed to 
infect bacterial cells on agar plates. The viral DNA, together 
with the insert, is injected into the bacterial cells, therefore 
the efficiency of transformation is very high and is detectable as 
viral plaques (Wilson and Goulding, 1986). 
A cloning vehicle used for transforming eukaryotic cells is the 
derivative of the oncogenic virus SV 40 (Simian virus 40), which 
contains a 5 kilobase double stranded circular DNA. SV 40 mutants 
with intact origin of replication (ORI) region have had their 
deleted genome (late genes) replaced by foreign genes. However, 
such recombinant DNA can only be propagated with the aid of a 
helper SV 40 virus (Sinsheimer, 1977; De Pamphilis and Wasserman, 
1980). 
Very long DNA fragments have been inserted in viral vectors at the 
cos sites and given rise to recombinants known as cosmids. Since 
the only requirement for a DNA molecule to be packaged into a 
viral head is the presence of cohesive (cos) sites (12 bases in 
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length) spaced about 37 - 52 kilobases apart, long pieces of DNA 
located between cos sites and with plasmid origin of replication 
and unique restriction sites, for the insertion of foreign DNA, 
can be used as recombinants. The method of transformation by viral 
vectors is illustrated in Figure 1.5. 
Plasmids have also been used as vehicles for transferring DNA into 
eukaryotic cells. These require a eukaryotic origin of replication 
gene (ORI) and a marker gene which, when expressed, i s detecteble 
in eukaryotic cells. A useful cloning vehicle is the naturally 
occurring plasmid 2fcircZe , which is found in yeasts. Its orig i n 
of replication can be utilized, with further genetic manipulation, 
to produce a smaller plasmid containing a foreign insert. 
A plant bacterium Agrobacterium tumefaciens contains a plasmid 
called Ti plasmid, which transfers part of its genetic material 
into the plant when the bacterium infects the plant. This plasmid 
has been used to introduce foreign genes into plants and forms 
the basis of genetic engineering in plants. 
1.11 Methods of preparing recombinant DNA 
With the advent of sequencing procedures as a means of studying 
DNA and RNA function, ideas for the production of recombinant 
genomes ' also arose. The first nucleic acid to be sequenced was yeast 
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and RNA molecules were sequenced (Sanger and Coulson, 1978; Fiers 
et a I. , 1976; Sanger et aI., 1977; Maxam and Gilbert, 1977; 
Sutcliffe, 1978; Winter and Brownlee, 1978). Unlike the DNases 
and RNases which cleave DNA and RNA at random sites, other enzy~es, 
which cleaved at sites of specific nucleotide sequences, were 
discovered. These were called restriction enzymes. 
A restriction enzyme from the bacterium Haemophi lus inf luenzae was 
found to cleave foreign DNA at the sequence 
5' 3' - G T Py Pu A C -
3' - C A Pu Py T G - 3' 
(arrows indicate exact site of cleavage). The restriction enzyme 
was later called HindIII (Smith and Wilcox, 1970; Salser,1974). 
Restriction enzymes that cut at other specific sequences have been 
isolated from different bacteria (Kessler et a l ., 1985; Roberts, 
1983; Kelley and Smith, 1970; Sharp et aI. , 1973) . 
The discovery of restriction enzymes permitted reproducible 
restriction maps to be obtained for specific DNA fragments, using any 
chosen restriction enzyme. Restriction analysis was utilized in 
the determination of the sequence of small fragments of DNA 
such as pBR322 (which contains 4362 bases) and of 0 X174 DNA 
(Sutcliffe, 1979; Sanger et al ., 1977). 
Restriction enzymes recognize specific sequences in DNA and cleave 
at these sites to produce restriction fragments which contain 
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either blunt ends or cohesive ends . For example, an enzyme like 
Eco R1 makes staggered cuts to produce short 4 - base single -
stranded cohesive ends - T T A A 51 (Figure 1.6) at the ends of 
each fragment (Dugiackzyk et al ., 1975). The cohesive or Istickyl 
ends can reanneal with each other or with other DNA fragments that 
have been similarly restricted. After complementary base - pairing, 
the nicks on the DNA strand can be resealed by a ligase (Gefter, 1975
) 
as shown in Figure 1.6. An example of a restriction enzyme producing
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Since no sticky ends are produced, no re - annealing will occur. 
However, the blunt ends can be joined together by DNA or RNA 
ligases (Lobban and Kaiser, 1973; Hinton et al ., 1978; Hinton et al .
, 
1982). The ligases will also join any other DNA fragments with 
blunt ends. 
A more useful feature can be endowed to blunt ended DNA fragments, 
such as poly dA homopolymeric extension of the 3
1 
- end of each 
blunt ended fragment, using the enzyme terminal transferase (poly A 
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or "sticky" ends. The sticky ends produced in one DNA 
fragment can anneal with those produced in the second 
fragment because they have been produced by the same 
restriction enzyme. 
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tailing). Other DNA fragments can be poly dT tailed. The A - T 
complementary base pairing and DNA ligase can thus be used to 
join the two types of DNA together. These restriction and recombina 
tion methods were employed in the synthesis of recombinant DNA 
molecules (Mertz and Davis, 1972; Lobban and Kaiser, 1973). 
The first practical method for preparing recombinant DNA was used 
by Cohen and co - workers (1973), who restricted the E. coli plasmid 
pSC101 with EcoR1 and converted the double - stranded circular 
plasmid to a linear molecule containing cohesive ends. They then 
, 
added foreign DNA which had been subjected to EcoR1 cleavage and 
contained coheslve ends. The nicks were ligated with DNA ligase. 
Thus a recombinant DNA was created, the plasmid pSC101 being the 
cloning vector which now carried one or more pieces of foreign DNA. 
Since pSC101 carried its own origin of replication it could be 
used to transform E. coli. This was followed by a vast amount of 
research into recombinant DNA construction methods (Section 1.12) 
and gene transfer methods (Section 1.13). In order to transform 
prokaryotic and eukaryotic cells the correct origin of replication 
and promoters had to be inserted, in addition to the gene under 
study. 
A further method for preparing recombinant DNA was also developed. 
Most eukaryotic mRNA molecules have a number of adenine nucleotides 
at their 3' - ends (poly A tails). The addition of a short oligo dT 
chain results in complementary hybridization with the poly A. thus 
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the poly dT acts as a primer for the enzyme reverse transcriptase, 
which utilizes the mRNA as a template to synthesize a complementary 
DNA strand (cDNA). This results in the formation of an RNA - DNA 
hybrid. The newly synthesized cDNA ends in a hairpin loop which 
DNA polymerase I utilizes as a primer to copy the newly - synthesized 
cDNA (Efstratiadis et al., 1976).The result is a double - stranded 
cDNA molecule with a single - stranded hairpin loop which is 
subsequently removed by the single - strand specific S1 nuclease 
(Young and Anderson, 1985; Brown and Stern, 1974). A scheme for 
the preparation of cDNA is presented in Figure 1.7. The double -
stranded cDNA obtained by this method is blunt-ended. The 
blunt ends can be either tailed (using terminal transferase) or 
made cohesive by attaching chemically synthesized linkers (using 
DNA ligase) which have the same single - stranded end sequences 
as the restricted cloning vector into which the cDNA is to be 
inserted. The recombinant DNA thus formed can be introduced 
into a suitable host, such as E. coli, and propagated. 
The cDNA methods have been used in the cloning of eukaryotic genes 
such as the globin gene (Efstratiadis et al., 1976), fatty acid 
binding protein gene (Chan et al., 1985), the ovalbumin gene 
(Monahan et al., 1976) and growth hormone gene (Goedel et al., 
1979). Mammalian genes, inserted into plasmid or phage cloning 
vectors, cannot be expressed unless the correct initiation 
signals, recognized by E. coli ribosomes, are also inserted. 
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Synthesis of cDNA from mRNA. 




Jay and co - workers (1982) chemically synthesized initiation 
signals, which, when inserted upstream of SV 40 t antigen gene 
prior to its cloning in the plasmid pBR322, were able to promote 
the synthesis of the SV 40 t antigen gene. The gene was identical 
to the gene produced in vivo,as determined by immunologic, 
electrophgretic and proteolytic digestion assays. Since recombinants 
retain their restricrion sites, their amplified clones can be 
assayed by restriction analysis. 
Recombinant DNA techniques have also been employed to prepare a 
cDNA clone for bovine adrenal LDL receptor (Russell et al., 1983). 
Immunoselected poly A - containing RNA were used to construct 
a cDNA library containing more than 5 x 105 recombinants. One cDNA 
clone, pLDL R- 1, for bovine LDL receptor, was isolated. The 
nucleotide sequence of a region of the cDNA insert encoded a 
protein sequence identical to that of the original bovine LDL 
receptor, except for one amino acid. The authors attributed 
this discrepency to technical error or polymorphism in the LDL 
receptor gene of different animals. 
The ability to express eukaryotic proteins in E. coli has 
proved useful in identification and isolation of eukaryotic cDNA 
clones. An expression vector containing a reconstructed apoprotein E 
cDNA, a APL promoter (regulated by the thermolabile cl repressor) 
and a ribosomal binding site derived from AcII or E. coli 
~ lactamase gene, inserted in the PstI site of pBR322, has been 
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used to transform E. coli . Humanapoprotein Ehas thus been 
produced successfully in the transformed E. coli (Vogel et al ., 
1985). 
Plasmids pBR322 and pDY160 have been utilized in the preparation 
of recombinants containing human papovavirus (BKV), which have 
subsequently been amplified in E. coli strains HB101 and C600 
(Arkigg et al ., 1981; Harley et al., 1982). Although the BK virus 
is not associated with clinical diseases in man, it has been 
shown to have oncogenic potential in some animal cells (Seif et al . , 
1979). Passage of the virus in human cell lines has resulted in 
genomic changes, hence amplification of the virus in E. coli 
has also been attempted. 
1.12 Recombinant DNA with selectable markers 
A number of well defined selectable marker genes have been used 
in genetic studies in eukaryotic cells. The best characterized 
and possibly the most widely used is the gene for thymidine kinase 
(tk), an enzyme used in the salvage pathway of pyrimidine bio -
synthesis. During the degradation of DNA, the thymidine released 
is salvaged and converted to dTMP and then to dTTP which is 
eventually re - incorporated into DNA. The normal pathway for dTTP 
synthesis is via dCDP. Thus tk is not an essential component 
for survival of eukaryotic cells. 
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Cells lacking the thymidine kinase enzyme are designated tk-, and 
can be easily isolated by feeding cells with bromodeoxyuridine 
(Br dU). Br dU can be phosphorylated by thymidine kinase and 
incorporated into DNA with lethal effect. The tk cells survive 
as Br dU does not become phosphorylated and hence it cannot be 
incorporated into host DNA. However, tk- cells will not survive 
in HAT medium, which contains hypoxanthine, aminopterin and 
thymidine, because aminopterin inhibits the normal biosynthetic 
step: dCDP ~ dCTP ~ dTTP (Szybalski et al . , 1962). In such 
a case the only source of dTTP is via the thymidine kinase pathway. 
Hence only tk+ cells are likely to survive in HAT medium. 
It was found that the tk gene from Herpes simplex virus (HSV) could 
be incorporated into tk mouse cells (by the Ca++ - precipitated 
DNA transfection method described in Section 1.13) to confer 
resistance to these cells in HAT medium (Wigler et al ., 1977; 
Littlefield, 1974; Munyon et al ., 1971). This has meant that 
the HSV tk gene can be used as a selectable marker for the 
integration of other genes linked to it and can be detected in 
culture as surviving colonies. 
Mutant tk deficient mouse cells (Ltk-) have been treated with 
BamH1 restriction endonuclease - cleaved HSV 1 DNA (Pellicer et al ., 
1978; Perucho et al ., 1980). The resultant surviving colonies were 
+ shown to stably express the tk phenotype. The tk gene incorporated 
into the tk- mouse genome was found to be a 3,4 kilobase DNA 
fragment. The gene was stably inherited with a frequency of one 
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copy per chromosome complement; however, the integration was not 
site - specific. 
Enquistand co - workers (1979) constructed a hybrid plasmid by 
insertion of the tk gene of HSV type I into the BamH I site of 
the plasmid pBR322 which is found in E. coli (Figure 1.8). A 
restriction map was subsequently prepared for 10 nucleases to 
confirm its stable insertion in mammalian cells. 
Another example of the use of thymidine kinase as a selectable 
marker for a recombinant DNA was the linking of the HSV type I 
tk gene to the aminoglycoside 3' - phosphotransferase gene (coded 
for by the Tn 5 transposon). The Tn5 transposon also codes for 
the kanamycin - neomycin resistance gene . This makes mammalian cells 
(murine, human, simian) resistant to the neomycin analogue, G418, 
which is otherwise toxic to these cells. Both selectable markers 
were inserted into the plasmid pAGO. The hybrid was stably 
expressed in mammalian cells which showed resistance to G418 and 
could be grown selectively in HAT medium (Colbere - Garapin et al ., 
1981). 
The use of tk gene as a vector for gene transfer into eukaryotic 
cells has necessitated the conversion of the recipient cells to 
the tk- mutant form . The process involved was laborious (Figure 1.9). 
Therefore a search was made for dominant - acting vectors which 
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Figure 1.8 Insertion of thymidine kinase (tk) gene into the 
Barn HI site of pBR322. 
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SVgpt vector, which codes for the enzyme xanthine - guanine 
phosphoribosyltransferase (XGPT) and allows bacteria to use 
xanthine as a precursor of purine nucleotides. The corresponding 
mammalian enzyme hypoxanthine - guanine phosphoribosyltransferase 
(HGPT) utilizes hypoxanthine as precursor. The SV gpt vector was 
therefore made by inserting the XGPT coding gene between the 
promoter and poly A addition sites of the large T antigen gene 
(Figure 1.10). The SV gpt vector has an efficient SV 40 promoter 
(Laimins et al ., 1982), and can transform HGPT mammalian cells 
to the HGPT+ form . Selection for transformants was carried out 
in medium containing xanthine and mycophenolic acid. Since 
mycophenolic acid blocks the HGPT enzyme, only those cells which 
have taken up the SV gpt vector wi th the bacterial gene will 
survive by using xanthine in the medium as a precursor of purine 
nucleotides (Mulligan and Berg, 1981). 
Another dominant- acting vector constructed (SV neo) consists 
of the prokaryotic neomycin - resistance gene (neoR gene) inserted 
into the SV 40 early region. The neoR gene inactivates neomycin and 
its analogue, G418, by phosphorylating them. Thus SV neo -
transformed cells are resistant to these antibiotics. 
Plasmids (especially pBR322) have been widely used as cloning 
vectors for genes from various sources. The successful insertion 
of the DNA fragments can be confirmed, usually, by the loss of 
expression of one of its antibiotic resistance genes. For example, 
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synthesized and inserted into the plasmid pBR322, restricted with 
Pst I, by means of the poly dA - poly dT tailing procedure (Devos 
et al., 1979). Since the PstI restriction site is located in the 
ampR site of pBR322, successful insertion of the MS2 DNA is 
confirmed by loss of ampicillin resistance. 
The plasmid pBR322 has also been used as a cloning vector for the 
Hind III restricted APRT gene. The gene coding for the enzyme 
adenine phosphoribosyl transferase (APRT) has been isolated from 
hampster and restricted with Hind Ill. The APRT gene was ligated 
- + to pBR322 and used to transform mouse APRT cells to the APRT 
phenotype (Lowy et al ., 1980). Since plasmid sequences served as 
biological markers the isolation of the APRT gene from the 
transformants was possible. 
Recombinant genomes which direct the expression of the enzyme 
chloramphenicol acetyl transferase (obtained from S . aureus or 
E. coli episomal factors; Shaw, 1967; Shaw and Brodsky, 1967) 
confer chloramphenicol resistance to transformed cells, and have 
been used as selectable markers . The resistance phenotype results 
from the inactivation of chloramphenicol by acetylation (Shaw, 1975; 
Goldfarb et al., 1982). Thus the chloramphenicol resistance gene 
has been used in the preparation and study of recombinants of 
pBR322 cloning vectors containing SV 40 early region or Adenovirus 
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Gorman et al., 1982a, b; Gorman et al., 1983; Kruckzek and 
Doerfler, 1983; Burke and Mogg, 1985; Darnell and Boime, 1985). 
The construction of the pSV2cat and pRSVcat recombinants, 
containing the chloramphenicol resistance gene, are presented in 
Figure 5.1 and 1.11 respectively. Both expression vectors 
function well in mammalian cells. The RSV LTR has been utilized 
as promoter in non - mammalian cells as well (Gorman, 1986). 
1.13 Methods for introducing recombinant DNA into eukaryotic cells 
Cloning vectors used in gene transfer in eukaryotic systems have 
several important features. The vectors contain prokaryotic origin 
of replication and antibiotic resistance sequences which allow for the 
amplification and selection of the clones in bacterial hosts. They 
also contain eukaryotic promoter sequences (and regulator) which 
control initiation of transcription in eukaryotic cells. 
Polyadenylation sequences are also incorporated in the cloning 
vectors for efficient expression in mammalian cells. Lastly, the 
cloning vector contains the test gene or the gene under study. 
A number of methods have been employed for the introduction of 
recombinant DNA into eukaryotic cells. The most widely used method 
is the calcium phosphate- DNA coprecipitation technique, which 
was first used to study the infectivity and transforming activity 
of viral DNA (Graham and van der Eb ,1973; Graham et al., 1980; 
Strain and Wyllie, 1984). The DNA under study is coprecipitated 
with calcium phosphate at room temperature before being applied 
61 
to eukaryotic monolayers in culture. Adsorption of the calcium 
phosphate - DNA is allowed to occur for 3 - 4 hours at 37 °C before 
replacing the medium. The cells are believed to take up the 
foreign DNA by a calcium - mediated endocytic process. The 
foreign DNA molecules have been shown to be incorporated into 
phagocytic vacuoles (Loyter et al ., 1983), but their mechanism 
of incorporation into the host genome is unknown. This method of 
gene transfer has been utilized in the introduction of eukaryotic 
DNA into cultured cells (Pellicer et al ., 1980; Gasser and 
Schimke, 1986). Thymidine kinase has been incorporated into tk 
cells by this method (Pellicer et al ., 1978; Colbere - Garapin et 
al ., 1981; Scangos and Ruddle, 1981) and other recombinants into 
cultured somatic cells (Gorman et al ., 1982a, b; Gorman et al ., 
1983; Kruckzek and Doerfler, 1983; McLauchlan et aI. , 1985; 
Burke and Mogg, 1985; Gorman. 1986). Stably inherited clones are 
visualized as antibiotic resistant colonies within 7 - 14 days 
while transiently expressed genes are assayed within 48 hours. 
The efficiency of transformation by the calcium phosphate - DNA 
coprecipitation method has been enhanced by treatment of transfected 
cells with glycerol or butyrate (Gorman et al ., 1982a, b; Gorman e t 
a l., 1983; Burke and Mogg, 1985). 
In addition to calcium phosphate, other facilitators have been 
used for the introduction of foreign DNA into cells. These include 
the polycation DEAE dextran (Vaheri and Pagano, 1965) and poly -
ethylene glycol (Chu and Sharpe, 1981). However, the efficiency of 
transfection with these facilitators is much lower than with the 
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calcium phosphate method. The calcium phosphate - DNA coprecipita -
tion method is regarded as the classical method of gene transfer 
and has been used for various cell lines such as L cells, NIH 3T3 
cells, HeLa cells, CV - 1 cells and fibroblasts. However, this 
method is not practicable in vivo. 
Another method for the transfer of foreign DNA into cells is the 
direct microinjection method. This method makes use of micro-
pipettes for the mechanical transfer of macromolecules into somatic 
cell monolayers and is not restricted to specific cell types (Gt.'aessmann 
and Graessmann,1976; Diacumakos, 1980; Graessmann etaL,1980). 
Capecchi (1980) has successfully monitored the transfer of the HSV 
tk gene into LM tk mouse nuclei by microinjection with glass 
micropipettes. The p - globin gene has also been successfully 
introduced into mutant cells by microinjection and was found to 
be functional (Anderson et . a~., 1980). 
DNA can be introduced directly into the cell nucleus or cytoplasm 
without the use of facilitators. The size of the macromolecules 
introduced into the cells does not have to be limited. Even single 
gene copies may be introduced. However, the number of cells 
transfected becomes a limiting factor and possible cell damage 
cannot be overlooked. Although transformed cells can be cloned; 
cell division of injected cells is reduced by 10% (Stacey, 1980). 
Another disadvantage is that this technique cannot be applied in vivo. 
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Erythrocyte ghost mediation is another technique employed in the 
transfer of genetic material into eukaryotic cells. The erythrocyte 
ghosts are loaded with the material under study under hypo - osmotic 
haemolytic conditions and then fused to somatic cells (Loyter et al ., 
1975; Schlegel and Mercer, 1980). Methods are also being developed 
for antibody - directed interaction of erythrocyte ghosts with 
cell surface antigens. Avidin - coupled erythrocytes have been 
fused with biotin - labelled cells (Godfrey et al ., 1983). However, 
the introduction of DNA by this method requires the use of EDTA 
and repeated freeze - thawing to trap DNA in the erythrocyte ghosts 
(Wiberg et al ., 1983). Another disadvantage is that additional 
unnecessary material is also loaded into the ghosts and introduced 
into the cells. Moreover, transformation efficiency is lower than 
that for calcium phosphate - DNA coprecipitation method. 
Liposomes have also been used as mediators in transforming cells 
with foreign DNA. The DNA is trapped in the phospholipid vesicles 
(liposomes) /which then deliver the genetic material (and possibly 
other substances) to recipient cells (Papahadjopoulus et al ., 1974). 
The mechanism of transfer is still uncertain. However, liposomes 
tagged with colloidal gold have been shown to bind at coated pits, 
endosomes and secondary lysosomes (Straubinger et al ., 1983; Hardy, 
1986). This points to an endocytic transfer rather than by fusion 
of liposomes with plasma membranes. The efficiency of transformation 
is lower than methods already described. Liposome - mediated drug 
targeting has the potential of being more successful than liposome -
mediated gene targeting. 
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DNA may also be trapped i n Sendai viral envelopes during reconstitu -
tion and subsequently fused to cultured cells by means of the viral 
F protein (Fusion factor; Vainstein et al ., 1983). However, this 
technique is restricted to specific cell types. This method of gene 
transfer affords protection against nucleases, thus improving chances 
of transforming recipient cells. Packaging of concatenated DNA 
into viral heads (discussed in Section 1.10) may also be employed 
for the transfer of genes into recipient cells. 
The electroporation technique used for gene transfer is a new method 
of gene transfer. It involves the application of a high voltage 
to the recipient cells. This induces the formation of pores which 
allow the entry of foreign DNA into electrically shocked cells 
(Potter et al ., 1984). This technique may be applied to all cell 
types in vitro , but is undesireable as a method of in vivo gene 
transfer. 
Protoplast fusion method has also been used to introduce foreign 
DNA into eukaryotic cells. This technique allows for the transfer 
of cloned DNA from bacteria to eukaryotes. The DNA is first 
introduced into bacteria which are subjected to lysozyme digestion 
of the cell wall to yield bacterial protoplasts (Schaffner, 1980). 
The fusion of protoplasts with eukaryotic cells is then induced 
with polyethylene glycol. Although prior purification of the DNA 
is not essential, the technique is suitable for in vitr o studies 
only. 
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1.14 Assays for the expression of foreign DNA 
If recipient cells become transformed by foreign genes, one should 
be able to detect or assay for the expression of the transferred 
genes. This can be accomplished by gene screening techniques for 
stably transformed cells and enzymic assays (usually) for transiently 
expressed genes. 
To screen for foreign DNA in recipient cells, a suitably labelled 
probe is first prepared by nick translation (Maniatis et al., 1982; 
Rigby et al., 1977; Hutchison et al., 1982; Manuelidis et al., 1982; 
Arrand, 1985). The nick translation procedure makes use of DNase I 
to create single - stranded nicks in double - stranded DNA. E. coli 
DNA polymerase is then utilized to carry out 51~ 31 exonuclease 
and polymerase reactions. This results in the removal of fragments 
of single - stranded DNA, starting at the nicks, and replacement 
with new strands synthesized by the incorporation of labelled 
deoxyribonucleotides. The nick in each strand therefore moves 
in a 51 -43 1 direction as the strand is being repaired. A 
diagrammatic representation of the process is given in Figure 1.12. 
Nick - translation, using a [32 p ] - labelled deoxynucleotide is 
most often used in the preparation of the probe. [125 r ] -, [3H] -
I 
labelled and non - radioactive biotinylated nucleosides may also 
be used (Arrand, 1985). In an alternative and increasingly 
popular procedure, a restricted probe may be labelled using the 
Klenow enzyme (Feinberg and Vogelstein, 1983). Probe fragments 
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Figure 1.12 Preparation of DNA probe by nick translation. 
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using random primers, [ « 32p] - radiolabelled deoxynucleotide 
triphosphates and the 51 ~ 31 polymerase activity of the Klenow 
fragment of DNA polymerase I. 
Cellular DNA is isolated, restricted with an appropriate restriction 
enzyme, fragments are separated electrophoretically and then 
hybridized to the labelled probe which has been similarly restricted. 
Various hybridization strategies may be employed. Cellular DNA 
may be denatured and transferred onto nitrocellulose filter 
supports before applying the labelled probe. The techniques are known 
as Southern blot or dot blot analyses (Southern, 1975; Dubensky et 
a I. , 1984; Anderson and Young, 1985; Mackett et aI. , 1986). Radio-
labelled probes hybridized successfully to transformed cellular DNA 
can be detected by autoradiography (Mason and Williams, 1985). 
Hybridization with biotin - labelled probes may be detected with 
avidin - enzyme or streptavidin - enzyme complexes which elicit a 
colour reaction and can be assayed colorimetrically (Arrand, 1985) 
or by electron mocroscopy if in s i tu hybridization techniques are 
employed (Hutchison e t aI., 1982; Manuel idis e t aI., 1982). 
Transcription of inserted genes may be established by Northern 
blotting (Alwine et al., 1977). Here total mRNA is separated on 
agarose gels in the presence of denaturing agents (methylmercury 
or formaldehyde) and transferred to chemically treated paper or 
nitrocellulose (if formaldehyde is used as denaturing agent). 
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Hybridization of mRNA to labelled probe is detected by autoradiography. 
Northern blotting is a suitable screening method for transformation 
of recipient cells with cDNA clones, as this method will reveal 
whether the cDNAs are full - length or not. 
Transiently expressed genes are usually assayed by enzymic methods 
e.g., the chloramphenicol acetyl transferase (CAT) enzyme produced 
in mammalian cells transfected with pSV2cat (Gorman et al ., 1982; 
Gorman, 1986) or the dihydrofolate reductase (DHFR) enzyme produced 
in plants transfected with cauliflower mosaic virus (CaMV) which 
has the R67 plasmid encoded DHFR gene (Lichtenstein and Draper. 1986). 
1.15 LDL receptor - mediation as a possible method of gene transfer 
in eukaryotic cells and its impact on gene therapy 
LDL particles are internalized by the method of receptor - mediated 
endocytosis (Sections 1.7 and 1.8). It is therefore theoretically 
possible that LDL complexed with DNA may also be internalized by 
this method provided that complex formation does not interfere 
with receptor recognition. This may form the basis for a novel 
method for introducing foreign DNA into mammalian cells. Moreover, 
the technique may be assessed using cloning vectors (Sections 1.10 
and 1.11) containing selectable markers (Section 1.12). Expression 
of DNA introduced into the recipient cells may therefore be 
monitored. 
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LDL - DNA complexes internalized by receptor - mediated endocytosis 
would presumably be delivered, via the endosome, to the lysosomes 
where they would be exposed to a series of hydrolytic enzymes 
including nucleases (Section 1.9). LDL is degraded largely through 
the action of proteases and lipases and the DNA could also undergo 
some degradation. The ultimate success of this method for 
introducing DNA into mammalian cells would rely on that portion 
of the DNA which escapes the action of lysosomal nucleases. 
The successful transformation of cells in culture by LDL receptor 
, 
mediation could have a significant impact on gene manipulation 
in vitro and may find application in whole organisms in the field 
of gene therapy. Abnormal (mutant) genes may be supplemented by 
stable transformation with normal counterparts. Insertion of 
normal genes into defective recipient cells may thus correct 
genetic abnormalities. 
Of the various methods of transfection (Section 1.13) of foreign 
genes into eukaryotic cells, in vitro, the use of inactivated 
Retrovirus (segments coding for viral protein removed) is, at 
present, being considered as the most favourable vector for the 
introduction of corrective genes into humans. Enzyme deficiencies 
such as hypoxanthine phosphoribosyl transferase (HGPT), purine 
nucleoside phosphorylase (PNP) and adenosine deaminase (ADA) 
afflict infants. The first of these causes delayed motor develo p -
ment (Lesch - Nyhan disease), while the latter two cause severe 
immune deficiency (Kolata, 1984; Miller et al., 1984). 
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Correction of these genetic diseases is envisaged by removal of the 
patient1s bone marrow (Stem) cells, transfection of the cells by 
the corrective gene i nserted into inactivated Retrovirus, in vitro , 
and subsequent return of the transfected cells into the patient1s 
bone marrow for reproduction. The inactivated Retrovirus, however, 
can become infective if the patient becomes infected by another 
(helper) virus. Since Retroviruses have been associated with 
diseases such as cancer and AIDS (acquired immune deficiency syndrome), 
the use of the virus in humans would not be entirely safe. Thus, 
the use of LDL - DNA complexes for the introduction of corrective 
genes -into bone marrow cells, as above, may prove to be a far 
safer technique in gene therapy, as such procedures can be carried 
out under physiological conditions, without the risk of viral 
infection or the use of chemical or mechanical methods of cell 
transfection. As yet gene expression in transfected cells cannot 
be controlled. However, it is believed that overproduction of 
enzymes such as HGPT, PNP and ADA will not be detrimental to 
the patient. 
1.16 Formulation of present work 
LDL are composed of protein anJ several lipid classes and are 
therefore readily modified (Glomset, 1969; Roberts et aZ ., 1985; 
Zilversmit et al ., 1975; Haberland et al ., 1984); moreover, 
LDL particles may be reconstituted (Krieger et al ., 1978; Krieger 
et al., 1979) to include unnatural or chemically altered components. 
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The binding, internalization and degradation of such particles 
has yielded much information with respect to LDL catabolism and 
the control of LDL anabolism (Brown and Goldstein, 1976; Brown 
et al ., 1976; Goldstein et al ., 1976; Brown and Goldstein, 1975; 
Goldstein and Brown, 1974; Brown et al ., 1975a, b, c; van der 
Westhuyzen et al ., 1984). 
The introduction of DNAs into viable mammalian cells has been 
induced by methods such as microinjection (Celis et al ., 1980; 
Capecci , 1981; Celis, 1984; Diacumakos, 1980), calcium phosphate -
DNA coprecipitation methods (Graham and van der Ebb, 1973; Graham 
et aL, 1979; Wigler et aL, 1978; Gorman et aL , 1982a, b; Gorman, 
1986) and other methods (Section 1.13) for the purpose of using 
such manipulations to study gene expression in higher eukaryotes. 
However, the use of low density lipoproteins as carriers of DNA 
into cells has not been cited in the literature. 
Most mammalian cells, normal and transformed, have, on their cell 
surfaces, receptors for binding low density lipoproteins (Goldstein 
and Brown, 1977; Brown and Goldstein, 1976; Roensch and Blohm, 1976). 
This makes the mammalian system an attractive one for the introduction 
of DNA into cells, i n vitro , by LDL receptor - mediation. With a 
view to introducing DNA into eukaryotic cells, LDL was isolated, 
characterized and then variously modified. The modification of LDL 
was carried out to enhance its binding to DNA. 
72 
One method of modification utilizes the watersoluble carbodiimide, 
N - ethyl - NI - (3 - trimethylaminopropylammonium) carbodiimide 
(or ECD1). The carbonyl groups of glutamic and aspartic acid 
residues of apoprotein B of LDL were modified as shown in Figure 1. 13, 
and resulted in the formation of N - acylureas, under the reaction 
conditions employed. 
The LDL particle was also modified by acetylation (Figure 1.14). 
Both the protein and lipid portions of LDL undergo acetylation. 
The major N ~ acetylations occur at lysine residues and to a lesser 
extent at asparagine and glutamine residues of apoprotein B. In 
addition, of the peripheral lipids of LDL, phosphatidylserine and 
phosphatidylethanolamine are probably also N - acetylated, while 
cholesterol may be 0 - acetylated. Thus acetylation of LDL 
extensively modifies both the lipid and protein components. 
Another modification of LDL involved its conjugation to ethidium 
bromide. The ethidium bromide possibly interacts with the lipid 
and protein components of LDL (Figure 1.15) to yield the ethidium 
bromide - LDL conjugate. 
The LDL was also labelled by cholesteryl ester exchange as 
illustrated in Figure 1.16. Two types of reaction were carried 
out. One required the use of DMSO for the exchange of unlabelled 
3 core cholesteryl esters for [ HJ - labelled cholesteryl esters. 
The second method used the enzymatic e~change of cholesteryl esters in 
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Figure 1. 14: Acetylation of lysine residues of apoprotein B (i) and 
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Figure 1. 15 Ethidium bromide - LDL conjugation in the presence 
of carbodiimide occurs via the phospholipid portion 
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Modification of LDL by the cholesteryl ester exchange 
method. The labelled cholesteryl esters enter the 
core of the LDL particle and probably also adhere to 
the external surface. 
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All the modified LDL were characterized and analysed before 
attempting to bind them to DNA. The native and modified LDL were 
complexed to pBR322 DNA or calf thumus DNA. The interaction 
between native LDL and DNA was found to be mainly electrostatic 
and a possible mechanism for this interaction is presented in Figure 
1.17. Of the modified LDL, the carbodiimide - modified LDL had 
the highest affinity for DNA. Interaction with the DNA was 
probably due to both lipid and protein components as illustrated 
in Figure 1. 18. 
The interaction of modified LDL - and native LDL - DNA complexes 
with cells in culture, was investigated. Since the final aim of 
the project was to ascertain whether the DNA internalized by 
LDL receptor mediation could be expressed i n vitro , both normal 
and transformed cells were used to carry out studies on the 
expression of chloramphenicol acetyl transferase (CAT) enzyme. 
The gene for the CAT enzyme is present in the recombinant pSV2cat. 
Its expression has been reported in various cell lines, by 
introducing the DNA by the calcium phosphate - DNA coprecipitation 
method only. The expression of any gene by LDL receptor ~ mediated 
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Possible mechanism of interaction of phosphatidylcholine 
quaternary trimethylammonium group with the negatively 
charged phosphate groups in DNA. Sphingomyelin and 
apoprotein B, modified with the carbodiimide also 
contain t he quaternary ni trogen and will therefore 
react in a similar manner to the above. This is 
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Figure 1.18 Partial CPK model of part of a carbodiimde-modified LDL 
particle interacting with fragments of DN.f!:. 
PC = p~osphatidylcholine~ S = sphingomyelin. X = glutamic 
and aspartic acid residues of apo B modified with 
carbodi imide to form N - acyl ureas . 
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C H APT E R TWO 
ISOLATION, MODFICATIONAND CHARACTERIZATION OF HUMAN SERUM LOW 
DENSITY LIPOPROTEINS 
2.1 Introduction 
In order to study the interaction of LDL with DNA and subsequent 
interaction of LDL - DNA complexes with eukaryotic cells, the LDL 
had to be isolated first and characterized to confirm that it was 
biologcally active. The most frequently used methods, cited in the 
literature, for the isolation of LDL are the repetitive ultracentri -
fugation methods, which employed different types of rotors, speeds 
and times (Havel et al., 1955; Bragdon et e l ., 1956; Zechner et al ., 
1984; Wiklund et al . , 1985). 
However, all LDL isolations employing sequential ultracentrifugations 
are time - consuming, although the final product may be fairly pure 
and concentrated. Isolation of LDL by ultracentrifugation, followed 
by the separation of the lipoproteins by column chomatography (Rudel 
et al., 1974) was also time - consuming and the LDL obtained was very 
dilute and necessitated concentration. The discontinuous ultra -
centrifugation method proved to be the most convenient. This method 
involved a single ultracentrifugation step to separate serum lipo -
proteins successfully. 
The LDL isolated was also modified to enhance its interaction with 
DNA. This chapter deals only with the modifications and characteriza -
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tion of the LDL particles. The various modifications involved 
modification of LDL by a water - soluble carbodiimide, conjugation 
of LDL to ethidium bromide and the acetylation of LDL. The labelling 
of LDL with (3H ] cholesteryl linoleate was also attempted. Two 
methods for the labelling were employed. The first involved the 
exchange of cho 1 esteryl esters in the presence of DMSO (Faust et al. , 
1977; Brown et al. ,1975; Goldstein et al ., 1975; Krieger et al., 1978). 
The second method used involved an enzymatic cholesteryl ester 
exchange. A cholesteryl ester exchange enzyme is present in the 
serum. This enzyme is utilized to carry out the exchange of r3H 
cholesteryl esters for the non - labelled core cholesteryl esters 
present in the LDLs (Glomset, 1959; Zilversmit and Johnson, 1975; 
Zilversmit et al ., 1975; Roberts et al., 1985). 
The chemical analysis of native and modified LDLs were done by 
standardized procedures. The protein content of all preparations was 
determined by the method of Markwell et al. (1981), using bovine 
serum albumin as standard. This is a modification of the Folin -
Lowry method (Lowry et al., 1951) but more specific for lipoproteins. 
The cholesterol (Zak, 1957; Zlatkis and Za k , 1969), 
inorganic phosphate (Bartlett, 1959; Fiske and SubbaRow, 1925) 
and triglyceride content were determined for native as well as the 
modified LDLs. The methods were adapted from those found in the 
literature, to suit the LDL preparations. The LDL preparations 
were also subjected to agarose gel electrophresis and immunoassays, 
as well as to gel exclusion and thin layer chromatography, in an 
attempt to further characterize them. 
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2.2 Methods 
2.2.1 Isolation of LOL from human serum 
Fresh blood was collected from normal, healthy donors who had fasted 
for twelve hours. The blood was allowed to coagulate and the 
coagulum was then cut into small pieces with a pair of scissors. 
Serum was collected from the coagulated blood by centrifugation 
at low speed (400 x g) for 5 - 10 minutes, at 4°C. The plasma was 
adjusted to a density of 1,3 g/ ml with solid KBr. The density -
adjusted plasma was dispensed into 38,5 ml cellulose nitrate tubes 
(10 ml ! tube) and overlaid with 0,15 M NaCl - 0,27 mM EOTA, pH 7,0 
solutions which had been adjusted, with solid KBr, to densities of 
1,2 g / ml (5 ml), 1,063 g / ml (10 ml), 1,019 g / ml (8 ml) and 
1,006 g / ml ( 1 - 2 ml) respectively. Ultracentrifugation was 
carried out in a Beckman ultracentrifuge (Model L5 - 65) for 24 hours 
at 15°C, using an SW28 rotor, at a speed of 120 000 x g. The 
separated lipoprotein bands were collected by density gradient 
fractionation, with optical monitoring at a wavelength of 280 nm. 
The peak fractions were pooled, dialysed against 0,15 M NaCl - 0,27 
mM EOTA (pH 7,0) at 4°C,over a period of 24 hours, with several 
changes of dialysis buffer,and stored at 4°C. The lipoproteins 
-
were analysed by gel exclusion chromatography (Section 2.2.1.5), 
immunoelectrophoresis (Section 2.2.1.7) and immunodiffusion (Section 
2.2.1.6) once the protein content (Section 2.2.1.1) of each 
lipoprotein had been determined. Once the purity of the LOL 
preparation had been confirmed, the cholesterol (Section 2.2.1.2), 
inorganic phosphate (Section 2.2.1.3) and triglyceride content 
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(Section 2.2.1.4) of each LDL sample was determined. 
2.2.1.1 Protein determination 
Protein determinations of all lipoprotein samples were carried out 
by the method of Markwell et a l. (1981). This is a modification 
of the Lowry method and more specific for lipoproteins. The prote i n 
content of the LDL was used as a measure of LDL concentration in al l 
subsequent experiments, using bovine serum albumin as standard. 
2.2.1.2 Cholesterol determination 
Cholesterol content of LDL was determined spectrophotometrically 
using the 0 - phthalaldehyde colour reagent (Zlatkis and Zak, 1969), 
and recrystallized cholesterol as standard. 
2.2.1.3 Phosphate determination 
LDL samples were concentrated to 100?1 (under a stream of N2 gas) 
. and contained 150 - 300?g LDL (protein). To each tube was added 
100 fl of 10 N H2S04 (final concentration 5,0 N). The LDL samples 
were incubated at 150 - 160°C in an oil bath for 3 hours, in a 
fume hood and covered with Parafilm. The tubes were cooled slightly 
and to each tube was added 2 drops of 30% H202with a Pasteur 
pipette. Digestion was continued for a further 1,5 hours. The 
digests were cooled and 10% trichloroacetic acid (TeA) was added to 
give a final volume of 2,5 ml. The inorganic phosphate content was 
determined according to the method of Fiske and SubbaRow (1925), 
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using a blank which contained the same amount of EDTA as the LDL 
samples. 
2.2.1.4 Determination of the triglyceride content of LDL samples 
The triglyceride content of LDL samples was determined spectrophoto -
metrically with the use of a Boehringer enzymatic kit. The tri -
glyceride content was subsequently calculated, using the molecular 
weight of trilinolein in the given formula. 
2.2.1.5 Gel exclusion column chromatography 
A Biogel A5m column (19,5 x 1,0 cm) was prepared and equilibrated 
with 0,15 M NaCl - 0,01 % EDTA (pH 7,0). Each lipoprotein (150 - 200 
(1g protein) was layered onto the column and eluted with the same 
solution as above, at a flow rate of 6 ml / hour. The elution was 
monitored at 280 nm (with the ISCO type 6 optical unit) and the 
elution profile was recorded with the aid of the UA - 5 absorbance 
monitor. 
2.2.1.6 Immunodiffusion 
A 1% agarose solution was prepared in 0,9% saline and poured onto 
microscope slides (2,5 x 7,5 cm). When solidified and cooled to 
4°C (30 -- 60 minutes), wells of 2,5 fl capacity were cut into the 
gel. Anti - human ~ - lipoprotein (titer 5,9 mg / ml) was applied 
to the center well and the lipoproteins isolated (Section 2.2.1) were 
applied to the surrounding wells. The slides were incubated in a 
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humid box at 4°C for 18 - 24 hours. The precipitin lines formed 
were either photographed with indirect white light illumination 
or stained to make permanent records (Section 2.2.1.8). 
2.2.1.7 Immunoelectrophoresis 
Agarose gels (1 %) were prepared with .barbital buffer (0,05 M), 
pH 8,0 , and poured onto microscope slides (2,5 x 7,5 cm). Wells 
and troughs were cut prior to electrophoresis. Lipoprotein samples 
were applied to the wells and electrophoresed in the Shandon electro-
phoresis apparatus, using Whatman No. 1 filter paper wicks dipped 
into the above buffer. Electrophoresis was carried out at 150 - 300 
volts (approximately 35 mA) for 2,5 hours. Anti - human antiserum 
(100 fl per trough; titer 5 mg / ml) was applied to each trough and 
allowed to diffuse over a period of 24 hours at room temperature. 
Precipitin lines were recorded before or after staining. 
2.2.1.8 Permanent recording of immunoprecipitation or immunodiffusion 
plates 
The immunodiffusion and immunoelectrophoresis plates were washed in 
0,9% saline for 10 minutes followed by distilled water washes of 
approximately 30 minutes. The washed gels were pressed dry with 
Whatman No. 1 filter paper, after eliminating all air bubbles, then 
oven - dried at 90°C for 5 - 10 minutes. Slides were stained with 
0,5% Coomassie brilliant blue in ethanol - acetic acid - water 
(5 : 1 : 5, by volume) for 10 minutes. The slides were then de -
stained in ethanol - water - acetic acid (5 : 5 : 1, by volume) 
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for 10 minutes, blotted dry and oven - dried. Unstained plates 
were photographed under oblique white light illumination, using a 
high - contrast monochromatic film. 
2.2.1.9 Agarose gel electrophoresis 
Agarose (0,19 g) was dissolved in 13,5 ml distilled water by boiling. 
The agarose was then cooled to 75 °C and to it was added 1,5 ml of a 
10 - fold concentrated electrophoresis buffer (0,36 M Tris HC1, 
pH 7,5 , 0,3 M NaHP04, 0,1 M EOTA). The gel was cast on a UV -
transparent plastic gel plate, of dimensions 60 x 90 mm, when 
cooled to 60 °C. The gel was allowed to set for one hour before 
applying samples (10?g protein per well) to the wells. Electro-
phoresis was carried out in the same buffer as above, in a BioRad 
DNA subcell electrophoresis apparatus, at a constant voltage of 
40 V, for 3,5 hours. A peristaltic pump was used to circulate the 
buffer. The gels were subsequently stained by one of two methods 
after electrophoresi ~ : (a) Gels were stained overnight in 0,25% 
Coomassie brilliant blue in methanol - water - acetic acid 
(5 : 5 : 1, by volume) and destained in methanol - water - acetic 
acid (5 : 5 : 1, by volume) for 48 hours. (b) Gels were stained in 
Coomassie brilliant blue (0,003%) in 10% TCA and did not require 
destaining. The gels were subsequently photographed. Results for 
gels stained by methods (a) and (b) are presented in Figure 2.7 (a) 
and (b) respectively. 
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2.2.1.10 Thin layer chromatography 
LOL samples were subjected to thin layer chromatography to separate 
the lipid components. The following solvent systems were used (all 
ratios are by volume) : solvent A : CHC1 3 - MeOH - 7 N NH3 (65 : 24 4); solvent B : CHC1 3 - MeOH - AcOH - H20 (25 : 15 4: 2 ); 
solvent C hexane - diethylether - acetic acid (70 30: 1); 
solvent 0 CHC1 3 - MeOH (2 : 1); solvent E petroleum ether (60 -
80°C) - diethylether - acetic acid (80 : 20 1); solvent F : CHC1 3 -MeOH - petroleum ether (60 - 80°C) - diethylether - acetic acid -
water (11 : 7 : 16 : 4 : 2 1). Spots were located with iodine 
vapour or with 50% H2S04 and charring. The choline - or ethanolamine-
containing phospholipids were sometimes located with ninhydrin, 
prior to the H2S04 spray and charring. 
2.2.1.11 Separation and solubilization of apoprotein B from the 
lipid components of LOL 
Intact LOL (1,2 mg / ml) was precipitated with heparin (final 
concentration 1 mg / ml) and MnC1 2 (final concentration 92 mM). 
Precipitation was allowed to occur at room temperature for 15 minutes. 
The LOL, pelleted at 9 000 x g (2 minutes, room temperature), was 
redissolved in 0,5 ml of 0,15 M NaCl - 0,05 M Tris - HCl (pH 7,4) -
0,01% EOTA (STE buffer) or 20 mM Tris - HCl (pH 8,2) - 0,1 M SOS 
(sodium dodecyl sulfate) - 1% mercaptoethanol (TSM buffer). The 
precipitation of LOL with ammonium sulfate was also carried out, at 
pH 7,0. Solubilization of the pellicle formed was again attempted 
with STE or TSM. In a third method, LDL was precipitated with Mg++ 
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(final concentration 0,25 M). The pellicles and precipitates formed 
(above) were washed with 0,1 % NaCl and dissolution was attempted 
with STE and TSM. In addition, attempts were made to dissolve 
precipitated LDL in 5% NaCl or 10 % NaHC03. 
In an attempt to obtain the apoprotein in a soluble non - denatured 
form, without the lipid components, the lipids were extracted with 
CHC1 3 - MeOH - AcOH - H20 (25 : 15 : 4 : 2, by volume) from the LDLs 
precipitated by the above methods. Solubilization of the protein 
residues was then attempted in all the solutions described above. 
In addition, lipids were extracted from unprecipitated LDL with 
CHC1 3 - MeOH - AcOH - H20 (25 : 15 : 4 : 2, by volume). This 
resulted in precipitation of the apoproteins. The solubilization 
of the precipitated protein was again attempted by the methods 
described above . The solubilization of LDL with 5% SDS was also 
attempted. 
2.2.2 Preparation of carbodiimide - modified LDL ( ECDl - LDL) 
LDL (1,5 mg, 3,0 nmoles, dialysed against 0,15 M NaCl, pH 6, at 4°C) 
was made up to 1,6 ml with 0,15 M NaCl. To this was added 8,91 mg 
(30 fmoles) of the water""soluble carbodiimide, [3H ] 1-ethyl -3-
[ 3 - (trimethylpropylam moni urn] carbodi imi de (abbrevi ated ECDl), 
dissolved in 140 fl distilled water and adjusted to pH 6. Incubation, 
in the dark, was carried out at room temperature for a duration of 
48 hours. The 13H ] ECDI - LDL was dialysed against 0,15 M NaCl -
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0,01 % EOTA (pH7,0), with several changes of dialysis buffer over 
24 hours, to remove unreacted carbodiimide. The protein content of 
the ECOl - LOL was determined, and the carbodiimide - modified LOL 
was stored at 4°C. The ECOI - LOL was also electrophoresed on a 
1,25% agarose gel (Section 2.2.1.9) to ascertain whether carbodiimide 
modification of LOL had occurred. In addition, the lipid and protein 
components of [3H ] - ECOr - LOL were separated (as described in 
Section 2.2.1.11) and counted in an attempt to locate the components 
of LOL which had been modified by the carbodiimide. 
2.2.2.1 Gel exclusion chromatography of ECOI - LOL 
[3H ] ECOl - LDL (150 f g protein content) was applied to a 19 x 1 cm 
Biogel A5m column and eluted as described in Section 2.2.1.5. The 
elution of ECOl - LOL was monitored at 280 nm. Fractions (0,5 ml) 
were collected and their rad ioactivity was determined on a Beckman 
liquid scintillation counter (Model LS 1305T), using Beckman HP / b 
liquid scintillation fluid. 
2.2.2.2 Reaction of LOL and carbodiimide at different mole ratios 
LOL (1,84 mg protein, 0,37 nmole) in 0,15 M NaCl - 0,01 % EOTA, 
was adjusted to pH 6 with 0,01 M HCl. [3H] ECDI (8,1 mg,27,27 fmoles) 
was dissolved in 135 fl distilled water and adjusted to pH 6 with 
0,01 M HC1. The LDL and carbodiimide were mixed in mole ratios 
of 1 : 500, 1 : 1 000, 1 : 5 000, 1 : 10 000 and 1 : 20 000, and 
incubated at room temperature, in the dark, for 48 hours. Each 
reaction mixture was precipitated with 10% cold (4°C) TCA and 
90 
transferred to a separate GF / C filter. Each filter was washed 
with cold 5% TCA (5 x 5 ml), air - and oven - dried (90°C, 15 minutes) 
and counted (as in Section 2.2.2.1) to determine the acid -
precipitable radioactivity. 
2.2.2.3 Digestion of (3H ] ECDI - LDL with phospholipaseC and 
phospholipase D 
ECOI- LDL (150 pg) was digested with 45 units of phosphol ipase 0 (from 
Streptomyces chromofuscus) in a reaction mixture containing 20 mM 
Tris - HC1, pH 8,2, 0,2 mg Triton X - 100 and 4 mM CaC1 2. For the 
phospholipase C digestion 750 f g of ECOI - LOL was incubated in 
20 mM Tris - HC1, pH 7,5, 0,2 mg Triton X - 100, 4 mM CaC1 2 and 45 
units of phospholipase C (from Bacillus suhtilis) in a total 
volume of 500 ?l. Both reaction mixtures were incubated at 37°C. 
Timed aliquots were withdrawn from each reaction mixture and 
transferred to nitrocellulose filters. The filters were washed twice 
with 500 fl of 0,1 M NaCl - 0,05 M Tris - HC1, pH 7,6 - 0,0025 M EOTA. 
The radioactivity on each dried filter was subsequently determined. 
A parallel digestion of another carbodiimide - modified protein, 
transferrin, was carried out to establish that the [3H ] trimethylpro-
pylammonium residues could be hydrolysed off the carbodiimide-
modified proteins. The reason for carrying out these experiments 
was to establish that the carbodiimide residues are also removed by 
the phospholipase D, which removes choline groups from phosphatidyl-
choline (discussed in Section 2.3.2.2). 
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2.2.2.4 Thin layer chromatography of ECOI - LOLdigested ~ith 
phospholipase 0 
[3H ] ECOI - LOL (750 f g) was digested with phospholipase 0 under 
the same conditions as described in section 2.2.2.3. The reaction 
was stopped and the lipid components extracted with CHC1 3 - MeOH -
AcOH - H20 (25 : 15 : 4 : 2, by volume). The apoprotein B precipi -
tated at the aqueous - organic interface. Both the aqueous and 
and organic phases were reduced in volume under a stream of N2 gas, 
and spotted on a silica gel 60F254 TLC plate. The compound N,N,N, -
trimethyldiaminopropane was spotted as standard. The plate was 
developed in CHC1 3 - MeOH - AcOH - H20 (25 : 15 : 4 : 2, by volume) 
and the spots located by iodine vapour. The radioactivity of the 
spots was subsequently deterniined. 
2.2.2.5 Attempts to conjugate ECOI to phospholipids 
Phosphatidylserine dipalmitoyl (1 mg) was suspended in 0,5 ml 
dimethyl formamide (OMF). To thi s was added 1,55 mg ethyl trimethyl propyl -
ammoniU'~m carbodiimide (ECOI), dissolved in 50 fl OMF. The 
reaction mixture was incubated at room temperature for 48 hours, in 
the dark. The reaction mixture was analysed by thin layer chromato -
graphy. The chromatograms were developed in solvent A (Section 
2.2.1.10). Similar reactions were carried out with other phospho -
lipids, namely, phosphatidylcholine, phosphatidylethanolamine and 
also with sphingomyelin. 
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2.2.3 . Preparation of acetylatedLDL 
LOL (1 mg protein content) was dialysed against 0,15 M NaC1, pH 7,0. 
The LDL was cooled in an ice bath, and to it was added 0,6 ml 
saturated sodium acetate, dropwise, with continuous stirring. To 
this was added 12)-11 (0,13 mmole) acetic anhydride, 2)-11 at a time, 
with continuous stirring. The acetylation reaction was allowed to 
proceed in an ice bath at all times and the additions were made 
over a period of 1 hour. The reaction mixture was stirred for an 
additional 30 minutes. The acetylated LDL was dialysed against 
0,15 M NaCl - 0,27 mM EOTA (pH 7,0), over a period of 24 hours, at 
4°C, with several changes of dialysis buffer~ 
2.2.3.1 Analysis ofacetylated LOL 
Protein, cholesterol, inorganic phosphate and triglyceride content 
of the acetylated LDL were determined as described in Sections 
2.2.1.1,2.2.1.2, 2.2.1.3 and 2.2.1.4 respectively. Acetylated LDL 
was also subjected to immunodiffusion and agarose gel electrophoresis 
(Sections 2.2.1.6 and 2.2.1.9 respectively). 
2.2.4 Preparation of LOL - ethidiumbromideconjugate 
LDL (3,3 mg, 6.6 nmoles), 5,9 mg (14,96 )-1moles) ethidium bromide 
(2,7 diamino - 10 - ethyl - 9 - phenylphenanthridium bromide) and 
9 mg (99.12 )-1moles) of carbodiimide (N - ethyl - N'- (3 dimethyl -
aminopropyl)- carbodiimide hydrochloride) were dissolved separately 
and adjusted to pH 6,0 with 0,1 N HC1, in a total volume of 1,2 ml 
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each. The three solutions were then mixed together and conjugation of 
the ethidium bromide was allowed to proceed at room temperature, in 
the dark, for 48 hours. The ethidium bromide LOL conjugate (EB - LOL) 
was dialysed against 0,15 M NaCl - O,27mM -EOTA (pH 7;0), at 4°C, for 
24 hours, with several changes of dialysis buffer. The preparation was 
analysed by agarose gel electrophoresis as described in Section 
2.2.1.9. 
2.2.4.1 Chemical and spectral analysis of the ethidium bromide -LOL 
conjugate - (EB - LOL) 
The EB - LOL was subjected to spectral analysis (UV and visible) 
and agarose gel electrophoresis (Section 2.2.1.9). The protein 
content was determined as described in Section 2.2.1.1. 
2.2.5 Preparation of (3H ] -cholesteryllinoleoylLOL 
2.2.5.1 - Preparation of [3H ] -cholesteryllinoleate 
The preliminary preparation of cholesteryl linoleate was unlabelled. 
Linoleic anhydride (10 mg, 18,4 mmoles) was placed in a dry pre -
weighed amber round - bottomed flask. Cholesterol (4,373 mg, 12,2 
mmoles) was dissolved in 7,5)l1 pyridine and added to the linoleic 
anhydride. Esterification was allowed to proceed at 37 - 40°C for 
24 hours. The reaction mixture and standard cholesteryl linoleate 
were spotted onto a silica gel 60F254 TLC plate (5 x 20 cm) and 
developed in solvent C (Section 2.2.1.10). Spots were located by 
spraying with 10% perchloric acid and charring. To prepare the 
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labelled cholesteryl linoleate, 250)11 of [3H ] cholesterol 
(specific activity 42,62Ci / m mole; 7,32 n moles) was evaporated 
to dryness. The residue was redissolved in 250 )11 dry pyridine 
and evaporated to dryness again. The residue was redissolved 
in 20)1' dry pyridine, under a stream of N2 gas. To this was 
added 5)11 (100 n moles) linoleic anhydride and mixed by swirling. 
The esterification was carried out at 37°C, over a period of 24 hours. 
2.2.5.2 Preparative thin layer chromatography 
The (3H ] cholesteryl linoleate was isolated by preparative thin 
layer chromatography on a silica gel 60F254 plate (10 x 20 cm). 
Standard, unlabelled cholesteryl linoleate and cholesterol were 
chromatographed on the same plate, as markers. The chromatogram 
was developed in solvent C (Section 2.2.1.10). The labelled 
cholesteryl linoleate was extracted from the plate with 4 x 1 ml 
CHC1 3. A 5)11 aliquot was counted to determine the radioactivity 
of the labelled cholesteryl linoleate. The preparation was 
stored at -15°C, in a teflon - lined, screw - capped vial until 
required. 
2.2.5.3 Preparation of labelled cholesteryl linoleoyl - LDL in 
the presence of DMSO 
[3HJ cholesteryl linoleate (7,11 lCi, 0,167 n moles) in CHC1 3 
was evaporated to dryness under a stream of N2 gas. The residue was 
redissolved in 25)11 of dimethylsulfoxide (DMSO). To this was 
added 1 mg of LDL, in 20 mM Tris HCl (pH 8,2) - 0,15 M NaCl ~ 
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0,01 % EOTA. The reaction mixture was incubated at 37 °C for 2,5 
hours. The final OMSO concentration was 2,5%. A second reaction 
was set up in a separate tube, as described above, except that 
the [3H ] - cholesteryl linoleate residue was not redissolved 
in OMSO, but in the above buffer. Each reaction mixture was 
dialysed separately against 5 x 400 ml buffer (20 mM Tris HC1, 
pH 8,2 - 0,15 M NaCl - 0,01 % EOTA) at 4°C for 24 hours. The 
dialysed [3H ] cholesteryl linoleoyl LOL (CL - LOL) was centri -
fuged at 9 000 x g for 3 minutes, to remove denatured material. A 
10 fl aliquot of each preparation was counted in a liquid scintilla -
tion counter. Protein determination (Section 2.2.1.1), cholesterol 
determination (Section 2.2.1.2) and agarose gel electrophoresis 
(Section 2.2.1.9) of the preparations were carried out. 
2.2.5.4 Preparation of [3H ] cholesteryl linoleoyl LOL by an 
enzymatic cholesteryl ester exchange method 
The experimental procedure was adapted from the method of Roberts et 
3 
aZ., (1985). [H] cholesteryl linoleate (200 fCi, 42,6 Ci / m mole) 
in CHC1 3 was evaporated to dryness under a stream of N2 gas. The 
[3H ] cholesteryl linoleate was redissolved in 100)11 acetone and 
added to 5 ml of lipoprotein - deficient serum. The acetone was 
evaporated with N2 gas applied to the solution for 45 minutes. To 
this was adqed 11 mg of LOL (protein content) in 5,0 ml of 0,15 M 
NaCl - 0,01% EOTA, pH 7,0. The cholesteryl ester exchange was 
allowed to proceed at 4°C for one hour, with gentle swirling every 
10 minutes. The reaction mixture was then adjusted to a density of 
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1,3 g / ml and the labelled LDL was recovered by discontinuous 
density gradient ultracentrifugat i on as described in Section 2.2.1. 
The [3H ] cholesteryl linoleoyl LDL (CL - LDL) was collected by 
density gradient fractionation, with optical minitoring at 280 nm. 
An aliquot was removed from each fraction to determine the radio -
activity. The CL - LDL peak fractions were pooled, dialysed 
against 0,15 M NaCl - 0,01 % EDTA, pH 7,0 and stored at 4°C. 
Chemical and electrophoretic analyses were also carried out on this 
preparation. 
2.3 Results and discussion 
2.3.1 Isolation of LDL 
LDL was isolated between the densities 1,019 - 1,063 g / ml. 
Various methods were attempted for the isolation of low density 
lipoproteins. Sequential multiple ultracentrifugation proved to 
be time - consuming. The method of Rudel et al., (1974) required a 
single ultracentrifugation step to separate the lipoproteins from 
the serum proteins. This was followed by the separation of the 
lipoproteins on a Biogel A5m column (90 x 2,5 cm). The separation 
took 54 hours at a flow rate of 6 ml / hour (Figure 2.1 a). 
However the lipoproteins were very dilute and necessitated concentra -
tion. Concentration of LDL by pressure dialysis with the Amicon 
ultrafiltration apparatus or the Millipore immersible Cx10 ultra -
filter resulted in partial degradation of LDL. Although the 









Figure 2.1 a: Elution profile of lipoproteins separated on a Biogel 
A5m column. Peak 1 = VLOL, peak 2 = LOL and peak 3 = 
HOL. 
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filters and some LDL protein was precipitated. Thin layer 
chromatography of the LDL lipids before and after concentration 
are presented in Figure 2.1 b. LDL isolation was also attempted 
by the method of Zechner et al ., (1984). This also involved 
sequential ultracentrifugation. The LDL preparations showed 
contamination with VLDL (Figure 2.2). The use of a Pasteur pipette 
for the removal of the VLDL, after the first ultracentrifugation 
step, was not efficient. A tube slicer was not available. 
The isolation of LDL by a single spin discontinuous gradient 
ultracentrifugation method (Section 2.2.1) was found to be the 
best with respect to both the time taken for the isolation and the 
purity of the LDL. Initially blood was collected into vessels 
containing EDTA (Hinton et at., 1973; Hatch and Lees, 1968). It 
was subsequently found that better LDL preparations were obtained 
when blood was allowed to coagulate before LDL isolation. The 
density gradient fractionation of the lipoprotein bands resulting 
from the ultracentrifugation yieleed 3 peaks (Figure 2.3). The 
HDL band overlapped with serum proteins (pea~ 3). The density 
of the isolated LDL band, prior to dialysis, was 1,04 9 / ml. 
Dialysis of LDL samples was limited to 24 hours as extensive 
dialysis resulted in loss of cholesterol from the LDL particles. 
The protein cholesterol ratio of dialysed LDL preparations 
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Figure 2.1 b: Thin layer chromatography of LDL samples before 
concentration (1) and after concentration, by pressure 
dialysis (2) and ultrafiltration (3). Chromatograms were 
developed in solvent B (Section 2.2.1.10). Spots were 
located by spraying with 50% H2S04 and charring. Prior 
location of amino group - containing lipids was carried 
out with ninhydrin (N). TG=triglycerides; CE = choles-
teryl esters; PE = phosphatidylethanolamine; PS = 
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Elution of LDL from Biogel A 5m column. The LOL (2) 
was isolated by the method of Zechner et al . (1984) 
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FRACTION NUMBER 
Density gradient fractionation of serum lipoproteins 
separated by discontinuous gradient ultracentrifugation. 
The VLDL (peak 1), LDL (peak 2) and HDL (peak 3) were 
subsequently analysed by column chromatography and 
electrophoresis. 
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2.3.1.1 Gel exclusion chromatography of isolated LDL 
Compared to previous methods of LDL isolation (Figures 2 ~ 1 a and 
2.2) the discontinuous gradient ultracentrifugation method yielded 
purer samples of LDL, which were more concentrated. A 200 fl 
sample (150 - 200 pg protein content) from each lipoprotein band 
was eluted from a Biogel A5m column (Figure 2.4). The VLDL (peak 1) 
and LDL (peak 2) bands yielded single peaks, while the HDL band 
(peak 3) showed slight contamination with albumin (peak 4). 
2.3.1.2 Immunoassays 
Immunoassays to determine the purity of LDL samples isolated by 
different methods, were done on agarose gels. The antiserum used 
was anti - P lipoprotein antiserum. The immunoglobulin 
used here was polyclonal. The LDL and VLDL gave 
positive results, while HDL yielded negative results (Figure 2.5). 
VLDL and LDL have common antigenic determinants which are 
different from HDL (Shore and Shore, 1972). Both LDL and VLDL 
contain apoprotein B (Morrisett et aZ ., 1975; Lees, 1976; Goldstein 
and Brown, 1977), hence a precipitin line was obtained for VLDL also. 
Lipoprotein deficient serum was obtained after ultracentrifugation 
and floatation of the lipoproteins. As expected, it yielded negative 
results in the immunoassays. Immunoelectrophoresis of the lipo -
proteins confirmed that LDL was pure. The antiserum used here was 
anti - whole human antiserum. In some preparations HDL was not 
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Elution of lipoproteins from a Biogel A Srn column. 
VLOL (1) and LOL (2) yielded single peaks while 




Ouchterlony immunodiffusion assay of human serum 
lipoproteins. Center wells contained anti human 
f- lipoprotein antiserum. In A, wells 2, 3, 4, and 
5 contained LDL, HDL, VLDL and LPDS respectively, 
isolated by the discontinuous gradient method. 
Wells 6 and 1 contained LDL samples isolated by the 
methods of Rudel et aZ .(1974) and Zechner et aZ .(1984) 
respectively. In B, the LDL isolated by the 
discontinuous gradient method was serially double 





Immunoelectrophoresis of human LDL (a) and combined 
lipoproteins (b) isolated by the discontinuous 
gradient method. The precipitin lines formed were 
against whole anti - human serum antiserum. 
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2.3.1.3 Agarose gel electrophoresis 
Each lipoprotein sample (VLDL, LDL and HDL) was mixed with 
bromophenol blue tracking solution or stop solution (4 M urea, 
50% (w / v) sucrose, 0,01% bromophenol blue, pH 7,0). 
Electrophoresis was carried out until the tracking dye reached t he 
end of the agarose gels. This took about 3,5 hours and resulted 
in a good separation of the lipoproteins. Staining of the gels 
by method a (Section 2.2.1.9) was long and gave fainter spots 
(Figure 2.7 a). Method b was more rapid. Results were obtained 
within 1 hour and the staining of the spots was enhanced (Figure 
2.7 b) by this method. 
2.3.1.4 Separation and solubilization of apoprotein B 
All methods employed resulted in the precipitation of LDL. Extraction 
of intact LDL with organic solvents (CHC1 3 - MeOH - AcOH - H20, 
25 15: 4 : 2, by volume) also resulted in precipitation of the 
LDL. The amount of heparin utilized for the precipitation of LDL 
varies from 0,1 % to 0,5% (Warnick and A1bers, 1977; Burnstein and 
Scho1nick, 1974; Burnstein et aZ., 1970). LDL was successfully 
precipitated with 0,1% heparin, leading to a drop in pH to 5. 
The precipitated LDL was white and had a homogeneous distribution. 
(NH4)2S04 and Mg++ precipitation methods resulted in pellicle 
formation. The pellets and pellicles were insoluble in low salt 
(0,1% NaCl) and could therefore be washed before attempting 
reso1ubi1ization. The heparin - Mn++ precipitated LDL was 




Agarose gel electrophoresis of human serum lipoproteins 
isolated by the discontinuous gradient ultracentrifuga-
tion method. In (a) lanes 1, 2 and 3 contain VLDL, 
LDL and HDL respectively. Lane 4 contains a human 
serum albumin standard. In (b) lanes 1, 2 and 3 
contain HDL, LDL and VLDL respectively. Staining 
methods for (a) and (b) were as described in Section 
2.2.1.9. 
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10 % NaHC03 (Burnstein et al., 1970). Addition of NaHC03 increased 
the pH to 9. Decreasing the pH to 7, with HC1, did not improve 
the solubility. The (NH4)2504- and Mg++ - precipitated LDL was 
soluble in TSM only. The apoprotein B, separated by extraction of 
lipid did not dissolve in any solution except TSM. Since the 
apoprotein B could not be solubilized without the use of a 
denaturing solution (TSM) it was not suitable for use in the study 
of apo B - DNA interactions. A table of the precipitation and 
solubilization results are presented in Table 2.1. The separa -
tion of apoprotein B in the presence of albumin (Srinivasan et al. , 
1979) or starch (Gustafson, 1965) was undesireable, as this would 
necessitate subsequent removal of such stabilizers. 
2.3.2 Carbodiimide modification of LDL 
The modification of proteins with carbodiimides has been employed 
by many researchers as a tool to study the properties of these 
molecules (Basu et al., 1976; Timkovich, 1977; Dailey and 
Strittmatter, 1978; Geren et al., 1984; Miller et al., 1983; 
Lambeth et al., 1984; Huckett et al., 1986; Gordhan et al., 1986). 
Khorana (1961) was first to use carbodiimides as reagents for 
conjugating proteins and other molecules together. By varying 
the conditions of reaction one can form the N - acylureas of the 
carbodiimides, instead of conjugating them (Figure 1.13). Thus, 
instead of forming peptide bonds, a watersoluble carbodiimide, 
(3H ] ECDl, was utilized to form the N - acylureas. Unlike the 
reaction which brings about peptide bond formation, with subsequent 
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LDL precipitation method 
Solvent 
Solubilization H 
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N N N N 
N N N N 
Y Y Y Y 
Precipitation of intact LDL and subsequent attempts at 
solubilization. LOL samples were precipitated with 
h . M ++ (NH) SO M ++ eparln - n, 4 2 4 or 9 . The precipitated 
LDLs were then subjected to solvent extraction to remove 
the lipids. Extraction of lipids from intact LDL, with 
solvent, also resulted in precipitation of the proteins 
(last column). Solubilization was then attempted as 
indicated. Y = precipitate dissolved; N = precipitate 
did not dissolve. 
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release of the urea, here the carbodiimide moiety underwent internal 
rearrangement and became covalently attached to the glutamic 
and aspartic acid residues of the apoproteins. The modification 
of LDL proteins can yield two types of N - acy1ureas (Figure 2.8 a). 
Gel exclusion chromatography (Bioge1 A5m) confirmed the formation 
of [3H ] ECDI - LDL. The radioactivity peak (due to labelled 
ECDI) followed the optical density peak (the column was first 
standardized with native LDL). Results are presented in Figure 2.8 b. 
Carbodiimide modifications of LDL were also carried out at different 
mole ratios (Figure 2.9). From the results obtained it was 
decided that, for subsequent preparations of ECDI - LDL, a mole 
ratio of 1 : 10 000 would be used. Agarose gel electrophoresis 
has shown that ECDI - LDL is positively charged (Figure 2.10 a) 
and moves in the opposite direction to native LDL. Immunodiffusion 
assays (Figure 2.10 b) show that despite the modification of 
glutamic and aspartic acid residues by the carbodiimide, some 
antibody - binding sites on the apoprotein B were unaffected. 
Hence positive precipitin lines were obtained for the carbodiimide -
modified LDL as well as for native LDL. 
2.32.1 Investigating the possibility of carbodiimide modification 
of lipid components of LDL 
Thin layer chromatography (TLC) of native and carbodiimide - modified 
LDL was carried out to ascertain whether any of the lipid components 
were modified with ECOI. Lipids were extracted with CHC1 3 - MeOH -
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o 
" CH3 - CH2 -NH - C - N - (CH2)3 - N+(CH3)3 1 
Apo B ------- C::-... 
-";:0 
N - acylurea of apoprotein B (I) 
OR 
N - acyl urea of apoprotein B (11) 
Figure 2.8 a: Carbodiimide modification of glutamic and aspartic 
acid residues of LDL yields either N - acyl urea (1) 
or (11), depending on the mode of addition. 
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Figure 2.8 b Elution profile of carbodiimide - modified LDL from 
a Biogel A 5m column, monitored at 280 nm (---). 
The radioactivity of peak fractions was determined 
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Figure 2.9 Mo 1 e ra t i os of [3H 1 ECD I bound per mo 1 e of LDL, 
with increasing carbodiimide concentrations. 
Figure 2.10 a 
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Agarose gel electrophoresis of LDL (lane 1) 
and ECDl - LDL (lane 2). 
Figure 2.10 b 
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Immunodiffusion assay of ECDI - LDL (left) and 
native LDL (right) against anti human f- lipo -
protein (center wells). A serial double dilution 
was done (clockwise); well 1 contained 2,4 f g 




0 (85 : 15 : 10 : 4, by volume). Different solvent 
systems were used in order to resolve different lipid components 
(Section 2.2.1.10). Solvent A (Figure 2.11 a) gave different Rf 
values for the different phospholipids, but did not resolve the 
cholesteryl esters and triglycerides. Solvent B (Figure 2.11 b) 
was also suited to phospholipid separation. Solvent C (Figure 2.11 c) 
was utilized for the separation of neutral lipids. However, the 
resolution was poor (no difference in Rf values of the different 
cholesteryl esters and triglycerides). Solvents 0 and E (Figures 2.11 
d and 2.11 e) did not resolve the neutral lipids either. Solvent F 
(Figure 2.11 f) yielded the same Rf values for the cholesteryl esters 
and the triglycerides. Since there was no difference in the Rf 
values of the separated lipid components of LDL and ECDl - LDL, it 
was assumed that the lipid components of ECDl - LDL had not been 
modified by the carbodiimide. However, to give additional support 
to this assumption, [3H ] ECDl - LDL lipids were separated by TLC 
on silica gel 60F254 plates (Figure 2.12), scraped, extracted with 
CHC1 3 - MeOH - AcOH - H20 (85 : 15 : 10 : 4, by volume) and counted. 
The only radioactivity detected was in the standard, r3H ] ethyl tri -
methylpropylammonium carbodiimide. Since the phospholipids are 
situated peripherally on the LDL particle (Deckelbaum et al. ,1977; 
Brown and Goldstein, 1984), they are more likely to undergo 
carbodiimide modification than the neutral (core) lipids. For this 
reason individual phospholipids were reacted with carbodiimide, to 
modify them under the conditions described in Section 2.2.2.5. 
TLC of reaction mixtures yielded no change in Rf values, hence 
there was no indication of carbodiimide modification of LDL lipids. 
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Figure 2.11 a and b· Thin layer chromatography of LDL (A) and 
ECDI-LDL (8) lipids on silica gel 60 F254 plates. 
Plate a was developed in solvent A and plate b in 
solvent B. Both solvents were suited to the 
separation of phospholipids. Abbreviations are 
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CO CP C A B TO TL TS TP A B 
Figur~ 11 c and d: Thin layer chromatography of LoL (A) and 
ECo! - LoL (B). Plates were developed in solvents 
C (a) ~nd 0 (b). CL = cholesteryl linoleate; CO = 
cholesteryl oleate; CP = cholesteryl palmitate; C = 
cholesterol; TO = triolein; TL = trilinolein; TS = 
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Figure 2.11 e and f: Thin layer chromatography of LDL (A) and 
ECDI - LDL (B) . Plate a was developed in solvent E 
and plate B in solvent F. 1,2, 3 and 4 are 
TL, TO, TS and TP respectively. Lipids are abbreviated 
as per Figures 2.1 b, 2.11 c and 2.11 d. 
Fi gure 2.12 
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A B C 0 
Thin layer chromatography of [3HJ ECOl - LDL 
developed in CHC1 3 - MeOH - AcOH - H20 (85 : 15 : 10 : 4, 
by volume). Spots were located with 12 vapour and 
marked. The plate was then sectioned (dotted lines), 
scraped, extracted as described in Section 2.3.2.1 
and counted. A = [3HJ ECOl - LOL; B = LOL; C = 












Thin layer chromatography of phosphatidylcholine ( 1 ) 
and phosphati dyl seri ne (2 ) reacted with [COl. 
Spots were located with 12 vapour and identified with 
the use of standards. X = [COl. 
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Figure 2.13 shows phosphatidylcholine and phosphatidylserine 
reacted with ECOI and chromatographed on silica gel 60F254 plate 
and developed in solvent B (Section 2.2.1.10). Thin layer chromato -
grams are presented because Rf values of the lipid components vary 
with humidity from day to day (Skipski et al ., 1964; Skipski and 
Barclay, 1969). 
When lipids are extracted from LOL, the protein component precipitates 
out, as the protein cannot exist in solution without the lipid (Lee 
and Alaupovic, 1974). The precipitated proteins of [3H ] ECOI - LOL 
were solubilized in 5% SOS and counted. It was found that 99,5% 
of the total radi6activity was located in the solubilized proteins, 
thus establishing that carbodiimide modification of the protein 
component and not the lipid component had occurred. 
2.3.2.2 Phospholipase C and 0 digestion of ECOI - LOL 
[3H ] ECOI - LOL did not undergo cleavage at the N - acyl urea 
when digested with phospholipase C. However, the trimethylpropylammo-
nium residues were hydrolysed by phospholipase 0 (Figure 2.14a, b). 
The results also show that [3H ] carbodi imide modified transferrin 
also undergoes phospholipase 0 digestion. The phospholipase 0 
enzyme will hydrolyse choline and ethanolamine residues from 
phosphatidylcholine, lysophosphatidylcholine, sphingomyelin and 
phosphatidylethanolamine, respectively. Phospholipase e, on the 
other hand, cleaves phosphorylcholine, phosphorylethanolamine and 







































Figure 2.14 a 
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Figure 2.14 b Digestion of [3H] ECDl - LDL with phosphol ipase 0 (.) 
and phosphol i pase C (fi), and ECDl - transferri n 
with phospholipase 0 (-). The data from Figure 
2.14 a were expressed as percentages. 
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(Lehninger, 1975). The action of phospholipase C and 0, on the 
above lipids, is presented in Figure 2.15 a. Since the trimethylpropyl 
ammo nium group of the carbodiimide has similarities in structure 
and spatial arrangement to that of phosphatidylcholine and 
sphingomyelin (Figure 2.15 b, Figure 2.15 c) it is possibly 
recognized by phospholipase 0 and is therefore hydrolysed as 
shown in Figure 2.15 d. Two confugurations of the N - acylurea 
are possible as indicated in Figure 2.8 a. With structure I, 
phospholipase C cleavage is possible but not phospholipase 0 
cleavage, due to steric hinderance by apoprotein B of LOL. With 
structure 11, phospholipase C cleavage is sterically hindered 
by the apoprotein, whilst the phospholipase 0 cleavage is feasible. 
Since the N - trimethyl group was labelled, the phospholipase C 
and 0 digestions of ECOI - LOL could be monitored. Since the 
phospholipase C digestion of ECOI - LOL was low and phospholipase 0 
cleavage was high, indications are that the N - acylureas formed 
by the reaction of apoprotein B with the carbodiimide, is more 
favourable with the trimethylpropylammonium nitrogen (80%) than with 
the ethyl nitrogen (20%) (Figure 2.14 b). 
The ability of phospholipase 0 to effectively remove choline 
groups from the lipoproteins was confirmed with the use of a 
Boehringer assay kit. The removal of choline groups was determined 
spectrophotometrically, using phosphatidylcholine as standard 
(Takayama et a Z., 1977). For equivalent amounts of LDL and ECDI -
LDL utilized for the assay, ECDI - LDL yeilded a 4% higher value. 
This additional value is attributed to the trimethylpropylammonium group 
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Phospholipase 0 digestion of sphingomyelin (I), 
phosphatidylcholine (11) and the N - acylurea of 
carbodiimide - modified LDL (Ill) indicated by arrows. 
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CPK models of sphingomyelin (I), 
phosphatidylcholine (11) and the trimethylpropyl-
ammonium group of ECDl (I II) showing the same 
spatial arrangement of the quaternary nitrogen 
covalently bound to three methyl groups. 
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Ph, osphol i,.P, ase C~ PI; cleavage by phosphol ipase D, I :terie hinderanee 
CH3 - CH2 - NH J C - ~o- (CH2)3 - N+(CH3)3 
apo B (LDL) 
(1) 
steric hinderance will rPhOSPhOliPase D 
prevent phospholipase C 
cleavage ~ 
.~ ~ + 
CH3 - CH2 - ~ - C - NH - (CH2)3 - N (CH3)3 
CO 1 
I 
apo B (LDL) 
(I 1) 
due to 
Figure 2.15 d Possible mode of action of phospholipase C and 
phospholipase D on the N - acylureas (Figure 2.8 a) 
of carbodiimide - modified LDL apoprotein B. Since 
no phospho 1 i pase C di gesti on of [3H] ECDI - LDL 
was detected 5 11 is the possible N - acyl urea 
hydrolysed by phospholipase D. 
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removed from the carbodiimide - modified LOL proteins. However, the 
possibility of protease activity in the commercial preparation of 
phospholipase 0 (Boehringer Mannheim) cannot be ruled out. 
2.3.2.3 Analysis of phospholipase 0 - digested ECDl- LOL 
Since there was a significant decrease in radioactivity of l3H ] 
ECOl - LOL, following phospholipase 0 digestion, the reaction 
mixture was also subjected to thin layer chromatography to confirm 
that the trimethyl propylammonium group was cleaved. A TLC and 
histogram, presented in Figure 2.16, of the spots scraped off the 
TLC and counted, indicate that the counts may be due to trimethylpro 
pylammonium groups. The action of phospholipase 0 is, therefore, 
the same as on phosphatidylcholine or sphingomyelin. Hence the 
structural similarity to these phospholipids results in its 
cleavage by phospholipase O. Since only the carbodiimide moiety 
was labelled, it suggests that the trimethyl propylammonium res .;due 
was indeed susceptible to phospholipase 0 digestion. 
2.3.3 Acetylation of LDL 
Acetylation of LOL was confirmed by agarose gel electrophoresis 
(Figure 2.17 a). The acetylation method was adapted from published 
procedures (Basu et al ., 1976; Goldstein et aI., 1979; Fraenkel -
Conrat, 1975). The mobility of acetylated LOL was greater than 
that of native LOL and of other modified LOLs. Despite extensive 
acetylation of the protein component, the immunoassay (Figure 2.17 b) 
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Figure 2.16 Thin layer chromatogram and histogram of phospholipase 0 
digested [3HJ ECDI-LDL. The aqueous (A) and organic (8) 
phases were chromatographed separately. Highest 





Figure 2.17: a Agarose gel electrophoresis of native LDL (lane 1) 
and acetylated LDL (lane 2). 
b Immunodiffusion assay of acetylated LDL, serially 
double diluted (clockwise, starting at top well), 
against anti human r - lipoprotein antiserum 
(center well). 
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were unaffected by the acetylation. The anti ~ - lipoprotein 
antiserum has multiple antigenic sites for the LDL apoprotein B. 
2.3.4 Modification of LDL with ethidium bromide 
For the ultraviolet (UV) spectral analysis 8,33 f g / ml of ethidium 
bromide (EB, standard) was used, and gave a ~max value of 386 nm 
while the EB - LDL conjugate had a concentration of 184 f g / ml 
(LDL protein) and yjelded a Amax value of 288 nm (Figure 2.18 a). 
For the visible spectra 100fg / ml EB and 760 f g LDL / ml were 
utilized. The A max values obtained were 482 nm and 465 nm, 
respectively (Figure 2.18 b). The extinction for EB was calculated 
at 482 nm. The mole ratio of LDL : EB was calculated to be 1 : 38 
in the EB LDL conjugate. The conjugation of EB to LDL was 
confirmed by agarose gel electrophoresis (Figure 2.19 a). The 
EB - LDL conjugate was slightly retarded in the electrophoretic 
field because of the positively charged nitrogen of EB. 
Carbodiimide modification of LDL is ruled out here because such 
modification causes ECDl - LDL to move towards the negative 
electrode (as shown in Figure 2.10 a). 
Conjugation of EB to the LDL can occur via the LDL protein side 
chain carboxyl groups of glutamic acid and aspartic acid residues 
(Figure 2.19 b) or via the phosphate functions of the peripherally 
located lipids. Conjugation of EB to the protein is covalent and 
results in the formation of an amide bond. The reaction of 
phospholipid with EB results in the formation of covalent 
phosphoramidate bonds (Figure 2.19 c). 


















UV spectra of LOL - EB conjugate and EB standard 
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Figure 2.18 b: Visible spectra of LDL - EB conjugate and EB 
standard in 0,05 M NaCl - 0,002 M EDTA, pH 7,0. 




Agarose gel electrophoresis of native LDL (A) and 
E8 - LDL (8) stained with 0,5% Coomassie brilliant 
blue. 
Figure 2.19 b 
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C2H5 - NH - C - NH - (CH2)3 - N+(CH3)3I-
ethyl trimethylaminopropylurea 
Conjugation of EB with LOL protein carboxyl groups. 
in the presence of carbodiimide. 
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u + x - 0 - p - a - CH2 - CH2 - N (CH3)3 l-a 






Figure 2.19 c Interaction of ethidium bromide with LDL lipids 
in the presence of carbodiimide. 
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2.3.5Cholesteryl ester exchange in LOL 
2.3.5.1 Preparation of cholesteryl linoleate 
Preliminary preparation of cholesteryl linoleate showed that the 
desired product would be obtained in reasonable yield (Figure 2.20 a). 
Cholesterol and cholesteryl linoleate yielded purple spots when 
sprayed with sulfuric acid and charred. The [3H ] cholesteryl 
linoleate was subsequently prepared as described in section 2.2.5.1 
and purified by preparative TLC (Figure 2.20 b). The (3H ] choles -
teryl linoleate had an activity of 42 fCi / m mole and the 
yield was 36,5%. 
2.3.5.2 Preparation and analysis of cholesteryl linoleoyl LDL 
The purpose of carrying out the cholesteryl ester exchange reaction 
was to devise a method of labelling LOL without altering its 
properties drastically. The labelled LDL would then be utilized 
in studying LDL - DNA interactions. Two methods were employed 
for the preparation of r3H] cholesteryl linoleoyl LOL (CL-LOL). 
The chemical method of preparation necessitated the use of OMSO. 
A final concentration of 2,5% was used. Up to 10% OMSO has been 
used for such reactions (Faust et al., 1975; Goldstein et al., 1975; 
Krieger et al., 1978). The (3H ] CL - LOL prepared by this method 
had an activity of 15 000 cpm / nmole. Thirty pmoles of cholesteryl 
linoleate was incorporated per nmole LDL. The protein: cholesterol 
ratios of these preparations were 1 : 1,4 for the [3H ] CL - LDL 
prepared in OMSO and 1 : 1,6 for [3H ] CL - LDL prepared without DMSO. 
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C CL X 
Figure 2.20 a: Thin layer chromatography of unlabelled Gholesteryl 
linoleate (CL) reaction mixture (X). Cholesterol (C) 
and CL were located in the reaction mixture with the 
use of standards. 
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C and CL react i on mi xture . C and CL 
Figure 2.20 b Preparative thin layer chromatography employed for 
separation of r3HJ cholesteryl linoleate from its 
reactants. The plate was cut (arrows) and the 
standards were located with 10% HC10
4 and charring. 
Areas matching the standards, in the center piece 
of the TLC plate, were scraped, extracted and counted. 




Immunodiffusion assays showed the same reactivity of [3H J CL - LDL 
to anti human r - lipoprotein antiserum, as native LDL, or DMSO -
treated LDL and [3H ] CL - LDL prepared in the absence of DMSO 
(Figure 2.21). Agarose gel electrophoresis of these preparations 
had a different mobility from that of native LDL (Figure 2.22). 
A second method of introducing [3H ] cholesteryl linoleate into 
LDL was by the enzymatic cholesteryl ester exchange method (Roberts 
et al. ,1985; Zilversmit and Johnson, 1975; Glomset, 1959; Zilversmit 
et al., 1975). A cholesteryl ester exchange enzyme is found in the 
p > 1,21 g / ml fraction of plasma (Bachorik, 1979). This transfer 
enzyme exchanges lipids from one lipoprotein type to another and 
was utilized for the exchange of cholesteryl esters of LDL for the 
labelled cholesteryl esters. Figure 2.23 shows the distribution of 
radioactivity of the fractions collected, after ultracentrifugation. 
Dialysed, labelled preparations had an activity of 13 000 cpm / nmole 
LDL. This was slightly lower than the CL - LDL prepared by the DMSO 
method. The protein: cholesterol ratio was 1 : 1,24. 
2.3.6 Chemical analysis of native and modified LDLs 
In addition to determining the protein content (Section 2.2.1.1) of 
all the LDL samples, cholesterol (Section 2.2.1.2), inorganic 
phosphate (Section 2.2.1.3) and triglyceride content (Section 2.2.1.4) 
were also determined. Various methods for the determination of 
protein content have been documented (Lowry et al., 1951; Miller, 
1959; Mokrasch, 1975; Peterson, 1977). The method of Markwell et 
al., (1981), for protein determination, is a modification of the 
Figure 2.21 
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Immunodiffusion assay of native LDL (A), r3HJ CL - LDL 
prepared in DMSO (B), [3HJ CL - LDL prepared in the 
absence of DMSO (C), unlabelled CL - LDL prepared with 
180 ng CL (D), unlabelled CL - LDL prepared with 
1800 ng CL (E) and LDL treated with 2,5% DMSO. 
Figure 2.22 
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1 2 3 4 
Agarose gel electrophoresis of CL LDL prepared in 
DMSO (1), CL - LDL prepared in the absence of DMSO (2), 































































Figure 2.23 Fractionation of [3HJ CL - LDL prepared by the 
enzymatic cholesteryl ester exchange method and 
subsequent ultracentrifugation. Aliquots from each 
fraction were counted. The [3 H1 CL - LDL eluted 
in fractions 5 - 10. Radioactivity in fractions 1 - 4 
was due to the unincorporated [3HJ cholesteryl 
linoleate. 
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Folin- Lowry method and is more specifically designed for the 
determination of protein content in lipoproteins. It gave more 
consistent results and was a more rapid method than the Mokrasch 
method, which is also designed for lipoproteins. 
Cholesterol determination of native and modified LDLs, was determined 
by the method of Zlatkis and Zak (1969). This method was found to 
be superior to other methods (Zak, 1957; Bartlett, 1969; 
Kabara, 1962; Mann, 1961; Rudel and Morris, 1973), in that the 
results were far more consistent and colour development was good. 
The method was also rapid, in contrast to other methods which 
necessitated extraction and quantitative transfer of cholesterol, 
leading to inconsistencies in the results. 
The inorganic phosphate content of the native and modified LDL 
samples was carried out (Section 2.2.1.3) by the method of Fiske 
and SubbaRow (1925). Prior to the determination, the inorganic 
phosphate was released from the phosphol ipids at 150 - 160 °C, in 
the presence of H2S04 and H202 (Bartlett, 1969; Chen et al., 1956). 
The final concentration of H2S04 had to be maintained below 0,5 N. 
Above this concentration the phosphomolybdate colour did not 
develop. Final concentrations of NaCl and EOTA were 3 mM and 6 fM 
respectively, and did not affect the determinations. These were, 
however, corrected for with the blank. Phosphate determination 
without salt was not possible as dialysis against distilled water 
resulted in flocculation of the LDL. Thus all LOL samples subjected 
to the 4,5 hour digestion~ prior to phosphate analysi~ contained 
NaCl (0,15 M) and EOTA (0,27 mM). To convert lipid phosphorus 
to phospholipids, the results obtained (inorganic phosphate) were 
147 
multiplied by a factor of 25 (Lee and Alaupovic, 1974), since 
inorganic phosphates constitute approximately 4% of the phospholipids. 
The spectrophotometric determination of phospholipids, using 
malachite green as the colour reagent (Teichman et al., 1974; 
Itaya and Ui, 1966) gave inconsistent results and was abandoned. 
The enzymatic determination of phospholipids (Boehringer) was not 
attempted because the reagents were not available. 
The triglyceride content of native and modified LDLs was carried 
out by the enzymatic method, using the Boehringer kit. Other 
methods (Witter and Whitner, 1972) were not attempted as they 
required triglyceride extraction and / or saponification. These 
were time - consuming and could lead to erroneous results as they 
entailed quantitative transfers as well. 
The results of the above analyses of native and modified LDLs are 
presented in Table 2.2. The theoretical values were determined, 
using the following parameters: proteins: 22% of total LDL; 
cholesterol : 45%; triglycerides: 7,5 - 10%; inorganic phosphates 
0,9%; carbohydrates : 3 - 5% (Goldstein and Brown, 1977; Shore and 
Shore, 1972). 
The isolation of LDL was always accompanied by a loss in lipids, 
especially cholesterol. Thus a protein: cholesterol ratio of 
1: 1,5 to 1 : 1,6 was a measure of the integrity of the LDL particle 
(Anderson et al., 1981; Brown and Goldstein, 1976;Brown et al., 1976; 










































































































































































































































































































































































































































































































































a considerable loss of cholesterol from the LDL particle, for 
example, Ac - LDL and (3H] CL - LDL prepared by the enzymatic 
cholesteryl ester exchange method (Table 2.2). However, it is 
possible that the peripheral cholesterol, and not the core 
cholesteryl esters, were lost during LDL isolation, modification 
and dialysis. There was little loss of triglycerides, which, 
like the cholesteryl esters, are located in the core of the LDL 
particle (Cardin et aZ., 1982; Brown and Goldstein, 1984). The 
CL - LDL prepared in the presence of DMSO showed a hi gher protei n : 
cholesterol ratio, as expected, since it was prepared in the 
presence of excess cholesteryl esters (namely, cholesteryl linoleate). 
A possible reason for the loss of cholesterol from the enzymically 
prepared [3H] CL - LDL is the second ultracentrifugation step to 
recover the labelled LDL. It is possible that the labelled 
cholesteryl esters adhere to the outer surface of the LDL particles 
and are 'stripped off' when subjected to ultracentrifugation. 
The levels of phospholipids (Table 2.2) were a little highe-r than 
the theoretical values except in the case of (3H J ECDl - LDL and 
[3H] CL - LDL (prepared enzymically). Losses were attributed to 
prolonged dialysis and the second ultracentrifugation step, 
respectively. The phospholipids are situated peripherally on the 
LDL particles and soluble in aqueous medium. 
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2.4 Concluding remarks 
Low density lipoproteins are heterogeneous particles containing 
proteins (apo B, apo A and apo C), lipids (triglycerides, cholesteryl 
esters, cholesterol and phospholipids) and carbohydrates (attached 
to proteins), with molecular weights ranging from 2 x 106 to 3,5 x 106 
daltons. The LDL particles were successfully and rapidly isolated by 
bouyant density gradient ultracentrifugation, at densities 1,019 to 
1,063. LDL was surprisingly easy to modify, notwithstanding its 
complexity, with respect to its protein (carbodiimide modification, 
acetylation, EB modification) and its lipid components (acetylation, 
EB conjugation, CE exchange). Important findings were that 
extensive dialysis and multiple ultracentrifugations resulted in 
decreased protein: cholesterol ratios (Table 2.2). 
Modification of the LDL particles did not affect their immunogenic 
properties. All the modified LDLs gave positive precipitin lines 
The detection of modification in specific regions was not possible 
by Ouchterlony double diffusion assays, using a polyclonal 
antiserull]. 
The modified LDLs showed different electrophoretic mobilities on 
agarose gels. The carbodiimide-modified LDL was retarded whilst 
CL - LDL and EB - LDL were slightly more advanced than native LDL. 
The acetylated LDL showed the highest mobility towards the anode 
because of its high negative charge, after acetylation. Thus, 
despite some losses in cholesterol content during modification 
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the LDL particles maintained biological activity. 
Attempts were made to separate the protein and lipid components of 
LDL. The lipids were successfully extracted in organic solvents 
and separated by thin layer chromatography to determine whether 
lipids had been modified. All attempts to isolate and resolubilize 
the protein component of LDL, without the use of denaturing aqueous 
solutions, failed. This solubility problem arises from the hydro-
phobicity of that part of the protein which is embedded in the 
apolar core of the LDL, which consists of neutral lipids. To date, 
solubilization of the apoprotein B, without the use of stabilizers 
(such as starch or albumin) or denaturing solutions has not been 
documented. However, an aqueous solution of native apoprotein B, 
without stabilizers or denaturants, was required for th~ purpose 
of studying its interaction with DNA, in addition to the interaction 
of the whole LDL particle with DNA (dealt with in Chapter 3). 
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C H APT E R T H R E E 
BINDING AND INTERACTION OF NATIVE AND MODIFIED LDL WITH DNA 
3.1 Introduction 
LDL particles were modified and labelled as described in Chapter 2. 
The native and modified LDLs were then reacted with either calf 
thymus DNA or plasmid pBR322 DNA, which had been labelled by nick 
translation (described in Section 1.14; Maniatis et al. , 1982; 
Rigby et al ., 1977). The interaction of the LDL particles with DNA 
was determined by the nitrocellulose filter - binding assay (Hinkle 
and Chamberl in, 1972; Zubay, 1980; Johnson et al. , 1980). The 
principle behind this assay is that uncomplexed or double - stranded 
DNA is not reta i ned by the fi lters. Hence the double - stranded 
DNA may be retained by nitrocellulose filters if complexed to 
protein, due to protein retention by nitrocellulose filters. 
The retention of protei n - DNA complexes can be detected if the DNA 
is radiolabelled. 
Binding of DNA was suspected to occur through the lipid portion 
of the LDL particle. To investigate this, the bi nding of DNA to 
individual lipids was also studied. In addition, the type of 
interaction between LDL particles and DNA molecules was 
investigated. Such interactions of native and modified LDLs 
with DNA have not been previously investigated. 
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3.2 Methods 
3.2.1 Preparation of labelled DNA by nick translation 
The plasmid pBR322 DNA (99 ng) was nick - translated in a reaction 
volume of 40 fl, containing 40 fCi [3H] dTTP, 0,05 M Tris - HC1, 
pH 7,6, 1 mM mercaptoethanol, 10 mM MgC1 2, 20,5 fM dATP, 
19,5 fM dGTP, 21,5 fM dCTP, 121 pg (2 x 10-4 units) DNase and 
10 units DNA polymerase No. 1. The reaction mixture was incubated 
at room temperature for 40 minutes and nick translation was stopped 
by the additio,n of 10fl 0,1 M EDTA, pH 7,7. The volume of reaction 
mixture was increased to 110 pl by the addition of 60 fl STE buffer 
(100 mM NaCl-l0 m~l Tris-HC1, pH 7,6-1 mM EDTA). The total 
reaction mixture was layered onto a prepared mini - spun column of 
Sephadex G 50 (70mm x 5 mm LD.) equilibrated with STE and 
centrifuged at room temperature in a 15 ml MSE centrifuge tube. The 
eluant containing the nick - translated pBR322 DNA was collected in 
a 1,5 ml Eppendorf tube. Two aliquots (2 fl each) were withdrawn 
to determine the direct count and TCA precipitable count, 
respectively, of the [3HJ pBR322 DNA. The remaining plasmid DNA 
was stored at -20°C until required. 
3.2.2 Binding of plasmid DNA to unmodified LDL 
Native (ll.nmodified) LDL was reacted with nick - translated [3H] 
pBR322 DNA at room temperature for 20 minutes, in STE l buffer 
(0,025 M Tri s - Hel, pH 7,6 - 0,05 M NaCl - 0,27 m M EDTA). The 
concentration of LDL was varied from 0 to 1,0 f g while that of 
/ 
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the plasmid DNA per reaction mixture was kept constant at 18 ng. 
The formation of the LDL - DNA complex was assayed by the nitro-
cellulose filter - binding method. Each reaction mixture was 
transferred to a 25 mm (diameter) nitrocellulose filter (presoaked 
in STE
1
) and washed with 4 x 500 fl of STE 1, to remove DNA that 
had not complexed with LDL. The filtration rate was adjusted to 
approximately 20 fl / second. The filters were air - dried for 30 
minutes and oven - dried at 90°C for 15 minutes. The nitrocellulose 
filters were then placed in counting vials. Beckman HP / b 1 iquid 
scintillation fluid (5 ml) was added to each vial, and the radio-
activity retained on the filters was determined on a Beckman 
(Model LS - 3150T) liquid scintillation counter. 
3.2.3 · Interact i on of ECOI - LDL with P 1 asmi d pBR322 DNA 
The carbodiimide modified LOL (prepared as described in Section 
2.2.2) was reacted wi th (3 H] pBR322 DNA (preparat i on : Section 
3.2.1) under the same conditions as described for native LDL (Section 
3.2.2), except that the ECDI - LDL concentrations util ized were in 
the range of 0 - 0,1 f g and 0,1 - 1 ,0 f g . The amount of [3H] pBR322 
DNA used per reaction mixture was the same as that for native LOL. 
3.2.4 Binding of native LDL and ECDI - LDL to plasmid pBR322 DNA 
at varying salt concentrations 
LDL (0,4 jJg) or ECOI - LOL (0,05 f g) was first reacted with 18 ng 
3 [ HJ pBR322 DNA at room temperature for 20 minutes in a series of 
Eppendorf tubes. Increasing amounts of NaCl were added to the tubes, 
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ranging from 0,05 to 0,5 M. The reaction mixtures were incubated 
for a further 5 minutes and lipoprotein - DNA binding was determined 
by the nitrocellulose filter - binding assay (Section 3.2.2). 
3.2.5 Binding of 13H J pBR322 DNA to LDL and ECDl - LDL treated with 
phospholipase D 
Thirty f g each of LDL and ECDl - LDL were digested with phospholipase 
D (0,45 units) from Streptomyces chromofuscus, in separate reaction 
vessels containing 0,1 mg / ml Triton X - 100, 50 mM Tris - HC1, pH 8,2, 
10 m M CaC1 2• The reaction mixtures were incubated at 37°C for 20 
minutes. DNA - binding studies were then carried out, using 0 - 1,0 f g 
of LOL or ECOl - LDL in STE 1. lncubati on of the phospho 1 i pase 0-
treated lipoproteins with DNA was then carried out at 20°C. 
Lipoprotein - DNA binding was determined by the nitrocellulose 
filter - binding assay (Section 3.2.2). Phosphatidylchol ine di -
palmitoyl and a carbodiimide - modified protein, COl - transferrin, 
were also digested with phospholipase D under the same conditions, 
as a check for phospholipase 0 activity. 
3.2.6 Binding of [3H] pBR322 DNA to acetylated LDL (Ac - LDL) 
The assay was the same as for native LDL (Section 3.2.2), using 
a range of 0-10 f g Ac-LDL (protein content), and a constant 
concentration (18 ng) of the plasmid DNA. Results are presented 
in figure 3.5. 
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3.2.7 Binding of DNA to ethidium bromide - LDL conjugate (EB - LDL) 
The EB - LDL conjugate was prepared as descri bed in Section 2.2.4. 
The EB - LDL (100, jlg) was reacted with 18 ng (3H] pBR322 DNA, which 
was isotope - diluted with 0,3 jl9 of unlabelled pBR322 DNA, at 
room temperature for 20 minutes. The reaction mixture was layered 
onto a 5-20% continuous sucrose gradient containing 0,1M NaCl-
0,05M Tris-HC1, pH 7,5- 0,005M EDTA. Ultracentrifugation was 
carried out at 18°C for 4,5 hours in an SW 50 rotor at 45 000 rpm. 
Fractions were drop - collected by piercing the bottom of the tubes. 
The optical density of each fraction was determined at 280 nm. 
The radioactivity of each fraction was also determined. Complex-
formation between EB-LDL (200?g LDL protein) and DNA (100?g 
calf thymus DNA) was also analysed by glycine - sucrose density 
gradient ultracentrifugation. A 5 - 20% continuous gradient was 
prepared in glyci ne - NaOH, pH 8,8 - 0,005 M EDTA - 0,025 M NaCl. 
Ultracentrifugation was carried out as above, but for a shorter 
time (3 hours). Fractions were collected as before. Since the 
calf thymus DNA was not labelled, the optical density of each 
fracti on was determi ned at 280 n m and at 260 n m . 
3.2.8 Binding of r3HJ pBR322 DNA to cholesteryl linoleoyl LDL 
3 To [ H] CL - LDL prepared by the DMSO method and the cholesteryl 
ester exchange method (Sections 2.2.5.3 and 2.2.5.4, respectively), 
inO,025M Tris-HC1, pH 7,6 -O,05M NaCl -O,27mM EDTA,was 
added a constant amount (18 ng) of [3HJ pBR322 DNA. Incubation 
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was carried out at room temperature for 20 minutes. The binding 
of the DNA was assayed by the nitrocellulose filter - binding 
method (Section 3.2.2). 
3.2.8.1 Binding of r3H] pBR322 DNA to LDL treated with increasing 
amounts of unlabelled cholesteryl linoleate in DMSO 
Cholesteryl linoleate (0 - 180 ng) in CHC1 3 was evaporated to dryness 
in each reaction tube and redissolved in 2,5 fl DMSO by vortexing. 
To the cholesteryl linoleate was added a constant amount (1 fg) 
of LDL in STE 1 buffer (Section 3.2.2). The reaction mixtures 
were incubated at 37°C for 1 hour. [3H1 pBR322 DNA was then added 
to each reaction mixture and incubated at room temperature for 
20 minutes. The binding of the DNA to the cholesteryl linoleate-
treated LDL was assayed by the nitrocellulose filter - binding 
method (Section 3.2.2). 
3.2.9 Binding of [3H] pBR322 DNA to lipid - impregnated filters 
Whatman No.1 filter discs (15 mm diameter) were impregnated with 
different lipids, 100 f g each, dissolved in 10 fl CHC1 3, according 
to Ariatti et al., 1986. The blank consisted of a filter without 
lipids. A chloroform- impregnated filter was used as a control. 
The filters were air - dried for 1 hour at room temperature to 
ensure that all traces of solvent (CHC1 3) had been removed. Each 
filter was placed in a clean glass vial and overlaid with a 100 fl 
solution of [3HJ pBR322 DNA (9 ng each) in STE
1
. The vial lids 
were replaced to ensure that a moist chamber had formed, for the 
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binding of the DNA to the lipids, The reaction vessels were 
incubated for 18 hours at room temperature. Each disc was 
placed on a separate 25 mm nitrocellulose filter, in a Millipore 
filtration apparatus and washed with 5 x 3 ml aliquots of STE 1. The 
Whatman filter discs were air - dried for 30 minutes and oven - dried 
for 15 minutes at 90°C. The radioactivity retained on each lipid -
impregnated Whatman filter disc was then determined. 
3.3 Results and Discussion 
3.3.1 Nick translation of plasmid pBR322 DNA 
The mini - spun column used for the purification of (3H J pBR322 DNA 
was prepared according to the procedure of Maniatis et al. (1982). 
The (3H] dTTP was evaporated to dryness and then redissolved in 
6,5 fl distilled water. The incubation time employed for the nick-
translation was found to be optimum. An increase in time did not 
significantly increase the extent of labelling of the plasmid DNA. 
The direct counts were in the region of 200 000 cpm while the TCA-
precipitable counts were between 140 000 cpm and 180 000 cpm / 36 ng. A 
lower TCA - precipitable count was expected as losses are expected 
to occur during filtration. Also, any [3 HJ dTTP present in the 
nick - translated DNA preparation would be removed when filters 
were washed. 
3.3.2 Binding of native LDL and ECDT - LDL to [3H] pBR322 DNA 
There was a definite increase in binding of r3HJ pBR322 DNA with 
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increasing amounts of LDL (Figure 3.1). Subsequent assays showed 
improved binding and reached saturation at an LDL concentration of 
0,4)1g (Figure 3.2). In contrast, the binding of ECDI - LDL to 
DNA in the same range (i.e. 0,1 - 1,0 f g protein content) showed 
3 b d . . a decrease in the amount of [ Hl pBR322 DNA oun to lncreaslng 
amounts of ECDI - LDL (Fi gure 3.2). However, there was increased 
DNA bi ndi ng when ECDI - LDL was used in the range of ° -0,1 f g LDL 
protein content (Figure 3.3), with saturation at 0,05)1g (50 ng) of 
ECDI - LDL. Thus ECDI - LDL has a 10 - fold higher affinity for the 
DNA than unmodified (native) LDL. 
3.3.3 Studies on the binding and interaction of DNA with LDL and 
carbodiimide - modified LDL particles at varying salt concentrations 
Since LDL and ECDI - LDL bi ndi ng of [3H] pBR322 DNA reached saturation 
at 0,4)1g and 0,05)1g LDL protein content, respectively, these 
amounts of nati ve and carbodi imi de - modified LDL were reacted with 
constant concentrations of [3 HJ pBR322 DNA (18 ng) and subsequently 
treated with increasing amounts of NaCl. Since the LDL-DNA 
complexes bind to the nitrocellulose filters, while uncomplexed, 
double - stranded DNA passes through (Hinkle and Chamberlin, 1972), 
the amount of radioactivity retained on the filters is an indication 
of the lipoprotein - DNA complex formation, as proteins are re-
tained.on the filters. Maximum binding of LDL to 13HJ pBR322 occurred 
between 0,05 - 0,1 M NaCl (Figure 3.4), whilst that of ECDI - LDL 
with the DNA occurred at 0,2 M NaCl. Above these concentrations of 
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Figure 3.4 Binding of native LDL ( .. ) and [COl - LDL (C)) 
to [3HJ pBR322 DNA at increasing salt concentrations. 
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that there was less binding at higher salt concentrations. Binding 
of LDL or ECDI - LDL with [3H] pBR322 DNA is therefore e 1 ectrostat i c 
at low salt concentrations. As the salt concentration was increased, 
the electrostatic attraction between the lipoproteins and the DNA 
vIas disrupted, causing dissociation of the lipoprotein - DNA 
complexes and hence a decreased retention on nitrocellulose filters. 
Since the binding of DNA to LDL and ECDI - LDL has been shown to be 
electrostatic, such attractions must occur between the negative 
phosphate groups of DNA and the positively - charged quaternary nitrogen 
groups of the phospholipids on the lipoproteins (as described in 
Chapter 1, Figure 1.17). Higher affinity of the DNA for ECDI - LDL 
must therefore be due to the additional positively - charged 
quaternary amino groups introduced into the protein moiety, by the 
carbodiimide modification of the LDL (Figure 1.18). 
3.3.3.1 Phospholipase 0 digestion of ECDI - LDL 
The peripheral lipids of native or unmodified LDL probably interact 
with the negatively - charged phosphate groups of DNA as illustrated 
in Figure 1.17. Carbodiimide modification of LDL results in the 
acquisition of additional quaternary amino groups by the protein 
moiety of LOL and hence a higher affinity of the DNA for the 
ECOI - LOL is attained (Figures 3.2 and 3.3). To support the contention 
that increased affinity was indeed due to the carbodiimide modifica -
tion, ECOI - LOL was subjected to digestion with phospholipase 0, 
which removed the N-trimethylpropylammonium groups from the N-acyl-
ureas (Figure 3.5 a). The activity of phospholipase 0 was confirmed 
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as described in Sections 2.3.2.2 and 2.3.2.3. Phospholipase 0-
digested ECDI - LDL showed reduced affinity for DNA (Figure 3.5a) 
at lower concentrations (0 - 0,6 f g). The same was found to be 
true for the unmodified phospholipase 0 - digested LDL. This reduced 
affinity could be attributed to the removal of the positive -
ly charged quaternary nitrogen groups, which reduced the electro-
static attraction between the DNA and the lipoproteins (Figure 3.5b). 
The affinity for both lipoproteins was increased at concentrations 
greater than 0,6 f g protein content. This could be attributed to 
transition to a different type of interaction between the DNA and 
the lipoproteins. This latter interaction was probably non-
electrostatic and due to the exposed fatty acyl groups of the 
phospholipase 0 - digested lipids. This hypothesis was investigated 
further and is discussed in Section 3.3.7. 
3.3.4 Binding assay of r3 HJ pBR322 DNA to acetylated LDL 
The binding of the plasmid DNA to acetylated LDL (Ac - LDL) was 
compared with that of native LDL, and assayed by the nitrocellulose 
filter binding method. Since LDL was extensively acetylated, 
it was expected to have a lower affinity for the DNA. It has been 
reported that acetylation of LDL alters the particles drastically, 
such that the acetylated LDL is no longer recognized by the LDL 
receptors of fibroblasts (Goldstein et al., 1979; Basu et al., 1976). 
However, receptor recognition sites on the LDL occur on the protein 
moiety, therefore non - recognition must be due to N - acetylation 
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In contrast, the reduced affinity of Ac-LDL for DNA (Figure 3.6 a) 
is probably due to quaternary amino - acetyl group interactions 
(Figure 3.6 b). Hence the acetylation of LDL effectively reduces 
the availability of positively - charged quaternary nitrogens 
which can react with the negatively - charged phosphate groups of 
DNA (Figure 3.6 bIll). However, the small amount of Ac - LDL - DNA 
binding could possibly be due to the interaction of hydrophobic 
fatty acyl groups of the phospholipids with DNA. 
3.3.5 Binding of DNA to EB - LDL conjugate 
The Tris - sucrose density gradient analysis of EB - LDL - DNA 
complex formation at pH 7,5 is presented in Figure 3.7. The 00280 
peak indicates the presence of LDL protein (curve 3). However, the 
radioactivity of these fractions (fractions 29 - 31) was negligible. 
Most of the radioactivity (curve 2), matched that of uncomplexed 
[3H1 pBR322 DNA (curve 1). Results appear to indicate that the 
formation of EB-LDL-DNA was negligible. The complex formation 
was subsequently analysed by glycine - sucrose density gradient 
ultracentrifugation at pH 8,8 (Figure 3.8). Curves A (1) and A (2) 
are density gradient fractionation profiles of EB-LDL and ct-DNA, 
respectively. Curves B (1) and B (2) indicate the formation of 
EB-LDL-DNA complex in much higher yield than that of the previous 
experiment (Figure 3.7). A possible reason for this may be the 
higher amount of DNA utilized for complex formation, or the 
difference in pH. High 00260 readings obtained from the bottom 
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Acetylation of LDL modifies lysine residues of apo -
protein B as shown (I). Since the major peripheral 
lipid components of LDL are phospholipids, these can 
possibly react with acetate ions as illustrated in (11). 
* 
This would eliminate the interaction of the phospholipid 
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Figure 3.8 : Glycine-sucrose density gradient analysis of EB-LDL and 
EB-LDL-ct DNA reaction mixtures. A1: EB-LDL (00280 ); 
A2: ct DNA (00260 ); B1: EB-LOL-ct DNA (00280 ); B2: 
EB-LOL-ctONA (00280 ), 
173 
readings of bottom fractions (Curve A 1) is likely to be denatured 
protein components of the LDL particles. 
Conjugation of the EB - LDL to the DNA occurs by the intercalation 
of the EB phenanthridium moiety to DNA (Le Pecq, 1971; Berman and 
Neidle, 1979; Alden and Kim, 1979; Ariatti et al. ,1986; Hawtreyet 
al., 1986). This intercalation occurs at hydrophobic sites (Le Pecq, 
1979) at the low ionic strengths employed in the experiments. 
A possible mechanism for the intercalation of ethidium bromide -
LDL complex to DNA is presented in Figure 3.9. 
3.3.6 Binding of [3HJ CL - LDL to pBR322 DNA 
There was no bind i ng of 13H] pBR322 DNA to [3H] CL - LDL prepa red 
in the presence of DMSO (Section 2.2.5.3). This was probably due 
to the use of DMSO (final concentration 2,5%) in the preparation of 
the modified LDL. DMSO is known to make lipid bilayers of cell 
membranes more permeable. DMSO probably disrupts the LDL structure, 
thus allowing an exchange of cholesteryl esters, but also allowing 
a substantial loss of core lipids. 
DNA has been shown to react with the intact, unmodified LDL by an 
ionic interaction (Section 3.3.3), probably between the negatively~ 
charged phosphate groups of DNA and positively - charged quaternary 
nitrogens of peripheral lipids, namely phosphatidylcholine and 
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Figure 3.9 : Possible model for the intercalation ef EB (in EB - LDL) to 
double - stranded DNA. A part of the DNA is presented as a 
'ball and stick model' to differentiate it from the EB 
(solid lines). The sequence of the double stranded DNA is 
5' 3' - GpCpGpCp The phenanthridium moiety is perpendicular 
. to the phenyl ring and intercalates with the DNA as if it 
were a base - pair. The attachment of the EB to the LDL (~) 
occurs via one of its reactive amino groups (*), as 
described in Section 2.3.4. The DNA unwinds partially at 
the intercalation site (arrow) to accomodate the EB. 
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sphingomyelin. However, if the quaternary amino groups become 
involved in interaction with the electronegative oxygen atoms of 
DMSO, as shown below, the interaction of the modified LDL with 
DNA might possibly be eliminated. 
LDL 1 ipid ---
+ 
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The bi nding of [3H] pBR322 DNA to 13H 1 CL - LDL prepared by the 
cholesteryl ester exchange method (Section 2.2.5.4) was successful. 
Results are presented in Figure 3.10, after correcting for the 
radioactivity due to the [3HJ cholesteryl linoleate in the 
modified LDL. Maximum binding occurred at 7 19 LDL protein content. 
The binding from 0 - 21g was linear, followed by a sharp increase in 
affinity at higher concentrations. 
A further DNA binding study was carried out with native LDL treated 
with increasing amounts of cholesteryl linoleate in DMSO (Section 
3.2.6.1). There was increased binding of [3HJ pBR322 DNA with 
i ncreas i ~g amounts of [3H] cho 1 esteryl 1 i no 1 ea te added (Fi gure 3. 11) • 
reaching a maximum at 130 ng cholesteryl linoleate. Thus the effects 
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Figure 3.10 Binding of native LDL (0) and [3HJ CL - LDL (e) 
to [3HJ pBR322 DNA. Results presented here have 
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Figure 3.11 Binding of r3H] pBR322 DNA to LDL treated with 
increasing amounts of cholesteryl linoleate in 
DMSO. 
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Modifying the LDL particle with cholesteryl linoleate does 
enhance its affinity for DNA to a small extent, but it also provides 
a method of labelling the LDL particle. Such a modification does 
not alter the immunological properties of LDL (Figure 2.21), nor 
does it affect the receptor binding properties of the LDL (Faust et 
al., 1977; Brown et al., 1975; Roberts et al., 1985) but it has 
been found to enhance its affinity for DNA to a small extent 
(Figures 3.10 and 3.11). This increased affinity may be attributed 
to the adsorption of the cholesteryl linoleate to the exterior of 
the LDL particle, and has been investigated further (Section 3.3.7). 
3.3.7 Interaction of r3H] pBR322 DNA with individual lipids 
To study further the interaction between pBR322 DNA and lipid 
components of LDL, the binding of [3 H1 pBR322 DNA to individual 
lipids on Whatman filters was carried out (Section 3.2.9). Results 
presented in Table 3.1 showed that the DNA binds to phospholipids. 
(The LDL particle consists of peripheral phospholipids, which 
interact with DNA.) It was also found that cholesteryl esters 
interacted with DNA. The triglycerides, however, showed a far 
greater affinity for the DNA than did the other lipids. Since 
the peripherally situated lipids present polar head groups to 
the aqueous exterior, in the intact LDL, DNA interaction will 
occur with the hydrophilic portions of these peripheral lipids 
(as discussed in Section 1.16). Although cholesteryl esters and 
triglycerides have shown a far greater affinity than the phospho-




























Table 3.1 The binding of [3H1 pBR322 DNA tQ filters impregnated 
with lipid. Results are averages of duplicate studies. 
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the LDL. Thus, due to their hydrophobicity and interior location 
in LDL, these lipids cannot participate in interactions with the 
DNA. 
Of considerable interest is the finding that the cholesteryl 
esters showed a greater affinity for DNA than the phospholipids. 
This lends support to the proposal that modification of LDL with 
cholesteryl linoleate results in peripheral or surface adsorption 
of the cholesteryl esters, subsequently enhancing the affinity of 
the LDL particles for the DNA (Section 3.3.6). 
Since cholesterol bound DNA very poorly, the affinity of DNA for 
cholesteryl esters must be due to hydrophobic interactions between 
the DNA and the fatty acid chains of cholesteryl esters. To 
support this hypothesis, further DNA- lipid binding experiments 
were carried out, using increasing amounts of cholesteryl esters or 
triglycerides (both lipids contain fatty acid chains). Results in 
Figure 3.12 show that binding to DNA was highest with triglycerides 
(tristearin), which contain three fatty acid chains, compared to 
phospholipids, which contain two fatty acid chains per molecule. 
Even the straight chain hydrocarbons, hexadecane and octadecane, 
showed an affinity for DNA. This indicates that DNA participates 
in hydrophobic interactions with fatty acids and straight chain 
paraffins. Results appear to indicate that the degree of binding 
of lipids to DNA could possibly be related to the degree of 
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3.4 Concluding remarks 
The carbodiimide - modified LDL showed a 10 - fold greater affinity 
for r3HJ pBR322 DNA than native LDL. However, both lipoproteins 
showed a similar electrostatic interaction with DNA. This 
interaction, in the case of native LDL, is presumed to be between 
the positively - charged quaternary nitrogen groups of the peripheral 
phospholipids of LDL and the plasmid DNA. 
Carbodiimide modification of LDL confers additional positive 
charges in the form of trimethylpropylammonium groups, which also 
contain quaternary nitrogens. The interaction between ECDl - LDL 
and DNA is also electrostatic, but additional affinity for the 
DNA is attributed to the trimethylpropylammonium groups. The 
electrostatic attraction between the lipoproteins and DNA is 
greater at low salt concentrations (Figure 3.4), that is, between 
0,1 and 0,25 M NaCl; and is destroyed at higher salt concentrations. 
The removal of trimethylpropylammonium residues with phospholipase D 
suggests that the higher affinity of ECDl - LDL for DNA was due 
to its carbodiimide modification, since removal of this group 
yielded ECDl - LDL - DNA binding curves which were almost equivalent 
to those of native LDL - DNA. 
Acetylated LDL showed little affinity for DNA as it was extensively 
modified, with respect to its protein and lipid components (discussed 
in Chapter 2). Acetylation is likely to remove the positive charges 
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on the LDL and thus reduce the electrostatic attraction between 
LDL and DNA. 
Of the two methods of modification of LDL with cholesteryl 
linoleate, the chemically modified LDL (Section 2.2.5.3) showed 
negligible affinity for the DNA (pBR322). The DMSO possibly 
interacts with positively charged phospholipid groups thus 
preventing their association with DNA. However, the [3H] cholesteryl 
linoleoyl LDL prepared by the enzymatic cholesteryl ester exchange 
method (Section 2.2.5.4) showed significant binding of pBR322 DNA, 
as assayed by the nitrocellulose filter binding method (Figure 3.10). 
LDL was also modified by conjugation with ethidium bromide. Its 
affinity for DNA was assayed by Tris - sucrose and glycine - sucrose 
density gradient ultracentrifugation. The latter assay, carried 
out at pH 8,8 , showed binding of EB -' LDL conjugate to DNA. Le Pecq 
(1971) proposed that the interaction between ethidium bromide and 
DNA was by intercalation of the dye to the DNA at hydrophobic sites. 
A model for the interaction of EB - LDL conjugate, with plasmid 
pBR322 DNA is presented in Figure 3.9. 
As confirmation of the interaction of lipid components with DNA, 
individual lipids were reacted with plasmid DNA (Section 3.3.7). 
A surprising finding was that triglycerides showed the greatest 
affinity for the DNA, followed by cholesteryl esters and phospho-
lipids. Cholesterol did not react with the DNA. The interaction 
between the neutral lipids and DNA are most likely to be hydrophobic 
184 
and will not occur in the intact LDL as neutral lipids are 
embedded in the core of the LDL particle. The phospholipids, 
however, are located on the periphery of the LDL particle (Goldstein 
and Brown, 1984) and can participate in electrostatic interactions 
with the DNA phosphate backbone. 
Perebityuk and Bronin (1984) reported the association of plasmid 
NR1 DNA with membranes at high salt concentrations of 0,5 M, at 
initiation and termination of replication. However, the membrane-
DNA complex was susceptible to disruption by high salt concentrations 
in the elongation stage of replication. It is possible that the 
former associations with the membrane lipid bilayers were hydro-
phobic, or with membrane proteins. The latter interactions were 
possibly electrostatic and similar to the associations of LDL 
peripheral phospholipids with plasmid pBR322 DNA. 
x - ray' diffraction data has suggested that the interaction between 
phosphatidylcholine and fatty acid occurs in the vicinity of their 
carboxyl groups, that is, the carboxyl group of the fatty acid 
chain is located in the region between the carbonyl at C2 and the 
glycerol moiety of phosphatidylcholine. This suggests a possible 
hydrophobic interaction. A similar hydrophobic interaction (Figure 3.6b) 
may be .postulated for the interaction of neutral lipids with DNA. 
Such interactions may be investigated by NMR and PMR spectroscopy, 
ESR, circular dichroism and X - ray diffraction techniques, which 
have thus far been utilized in the study of lipid- lipid and 
lipid - protein interactions (Lee, 1977; Papahadjopoulus,1973; 
Chapman, 1973). 
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C H APT E R F 0 U R 
RECEPTOR -BINDING ACTIVITIES OF NATIVE AND CARBODIIMIDE - MODIFIED 
LDL AND OF NATIVE AND CARBODIIMIDE - MODIFIED LDL - DNA COMPLEXES 
IN EUKARYOTIC SYSTEMS 
4.1 Introduction 
Mammalian cells contain, on their plasma membrane surfaces, receptors 
for low density lipoproteins (Goldstein et al .J979a; Young et al ., 
1986; Aulinskas et al . ,1983; st. Clair et al., 1986; Brown et al., 
1975 a, b, c; Brown and Goldstein, 1974; Bradley et al ., 1984). 
Thus, as long as the receptor site on the LDL is not modified, the 
LDL should bind to the cell surface receptor and be internalized 
as described in Chapter 1 (Figure 1.2). Of all the modifications 
of LDL attempted (Chapter 3) only acetylated LDL and cholesteryl 
linoleoyl LDL prepared in the presence of DMSO, did not bind to 
the DNA. Although the immunological properties of these modified 
LDL particles were not altered (Figures 2.17 band 2.21) the 
, 
receptor - bi ndi ng properti es of acetyl ated LDL were altered 
(Goldstein et al., 1979 b). For these reasons the acetylated LDL 
and cholesteryl linoleoyl LDL (prepared in DMSO) could not be 
utlilzed for studying LDL - DNA interactions with eukaryotic 
systems . . 
The ethidium bromide - conjugated LDL - DNA complex was also not 
used for eukaryotic studies for several reasons. The formation of 
EB - LDL DNA complexes necessitated the use of high pH. A deviation 
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from physiological pH for studying receptor binding activities 
would not be conducive to in vitro studies. The EB - LDL conjugate 
reacts with DNA by intercalation of the phenanthhdium moiety 
with the DNA (Figure 3.9; Le Pecq, 1971). This intercalation 
results in partial unwinding of the DNA, which is undesireable 
as supercoiled plasmid constructs carrying specific genes are to 
be introduced into cells in culture (Chapter 5). In addition, the 
ethidium bromide is a known carcinogen, which can cause cellular 
mutation and possibly mask the expression of the internalized DNA. 
Thus, of all the modified LDLs, the cholesteryl linoleoyl LDL 
(CL - LDL)prepared by the cholesteryl ester exchange rpethod (Section 
2.2.5.4) and ECDI-LDL (Section 2.2.2), which enhanced LDL-DNA 
binding could be utilized for receptor - binding studies in 
eukaryotic cells. Of these, the latter was chosen for the studies 
because it showed a higher affinity for DNA. 
Native LDL and ECDl - LDL were labelled with [1251 ] I in order to 2 
follow the receptor - binding activity of LDL and ECDI - LDL and 
LDL - DNA and ECDl - LDL - DNA in eukaryotic systems. In parallel 
experiments the DNA was labelled. The purpose of these experiments 
was to establish that DNA, complexed with LDL or ECDl - LDL was 
i nterna 1 i zed by LDL receptor - med i ated endocytos is. 
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4.2 Methods 
4.2.1 Preparation of culture medium 
Eagl e' s mi nimum essenti a 1 medi urn (MEM) was prepared in 20 m M Hepes 
buffer, pH 7,2 , and supplemented with 10% fetal calf serum, 
penicillin (10 mg / ml), streptomycin (10 mg / ml), fungi zone (2,5 
mg / ml) and sodium bicarbonate (25 mM). Eagle's MEM without 
fetal calf serum was also prepared for use with lipoprotein deficient 
serum. MEM was fi 1 ter - steri 1 i zed and stored at 4°C. 
4.2.2 Preparation cif 1 ipoprotein - deficient serum 
Lipoproteins from freshly collected human serum were isolated at 
densities below 1,21, as described in Section 2.2.1. The lipopro-
tein - deficient serum was collected at densities greater than 1,21 
g / ml, dialysed against 0,15 M NaCl - 0,01% EDTA at 4°C, over a 
period of 24 hours, with several changes of buffer and stored at 
-20°C after filter sterilization (Millipore Millex GS filter). 
The protein content of the lipoprotein deficient serum was 
determined by the method of Markwell et al. (1981). 
4.2.3 Culture of normal skin fibroblasts 
Fibroblasts were obtained from a skin biopsy of a clinically 
normal adult male donor. Fibroblasts were used between the fifth 
and fifteenth passage. Culturing techniques were adopted from the 
methods of Brown and Goldstein (1976). Cells were grown in 75 cm2 
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stock flasks at 37°C. To subculture, the fibroblast monolayers 
were treated with 0.25% trypsin (1 ml) in Hank's balanced salt 
solution (Freshney, 1986), without Ca++ and Mg++, for 2 - 5 
minutes at 37°C. The action of trypsin was stopped with 2 ml 
growth medium containing 10% fetal calf serum (FCS). The 
dissociated cells were pelleted at 900 x g, washed once with 
phosphate buffered saline (PBS) and resuspended in medium containing 
10% FCS. Cells were plated in 25 cm2 flasks containing 3,0 ml MEM 
supplemented with FCS. The cells attached to the flasks within 
24 hours. On the third day after seeding, the medium was replaced 
with fresh medium. On the sixth day ce l ls were washed with PBS 
and 3,0 ml of fresh medium containing 5% lipoprotein - deficient 
serum was added. Experiments were initiated 24 hours after the 
cells had been incubated with lipoprotein - deficient serum (LPDS). 
4.2.4 Iodination of native LDL and carbodiimide - modified LDL 
N - chlorobenzene sulfonamide derivatized non - porous polystyrene 
beads (Pierce), of diameter 3,175 mm, were used in the preparation 
of [125 r ] LDL and ECDr - [ 125r ] LDL. Two beads were washed twice 
with 5 ml 0,05 M sodi urn phosphate buffer, pH 7,4, and dri ed on 
Whatman No. 1 filter paper. The beads were added to a solution 
of [1251 ] NaI (5 )11, specific activity 10 mCi / ml) and 0,05 M 
sodium phosphate buffer (400 )11; pH 7,4) and allowed to stand for 
5 minutes at room temperature. To this solution was added 5 - 10 f g 
of native LDL or ECDl - LDL in 0,05 M phosphate buffer, pH 7,4. 
The reaction mixture was incubated at room temperature for 7,5 
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minutes and the iodinqted compound was purified on a Sephadex G 25 
(medium) column (19 x 1 cm). The radioactivity of 5 fl aliquots 
of alternate fractions (0,5 ml fractions) was determined on a 
gamma counter (Model ANSR - 7040) in addition to monitoring 
optical density at 280 nm. Peak fractions, containing the 
highest activity were pooled and the protein content was determined 
according to the method of Markwell et al . (1981; Section 2.2.1.1). 
4.2.5 Preparation of LDL - DNA complexes and carbodiimide - modified 
LDL - DNA complexes 
[125r ] _ labelled native and carbodiimide - modified LDL were 
complexed with six - time sheared calf thymus DNA (ct DNA). 
Unlabelled native and carbodiimide - modified LDL were complexed 
with nick - translated [3H] pBR322 DNA. The preparation of [125 r ] 
LDL - ct DNA and ECDr - [125 r ] LDL - ctDNA were carried out in a 
similar manner: To 3,75 f g [125 r ] -labelled lipoprotein was 
added 0,25 f g DNA. Each reaction was incubated at room temperature 
for 20 minutes, in 0,05 M Tris - HC1, pH 7,5 - 0,025 M NaCl - 0,27 mM 
EOTA in a total volume of 200 fl. Each preparation was utilized 
without further treatment, for receptor - binding studies in normal 
skin fibroblasts. For the preparation of LDL - [3H] pBR322 and 
ECDr - LDL - [3H] pBR322, 1,0 f g LOL or ECDr - LDL was reacted with 
18 ng [3H] pBR322 at room temperature for 20 minutes, in the same 
buffer as above. The complexes were subsequently added to skin 
fibroblast monolayers and assayed for receptor recognition and 
internalization by receptor - mediated endocytosis. 
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4.2.6 Total binding of r 1251 ] LOL and ECOI - [1251 ] LOL 
Monolayets of skin fibroblasts (about 70 - 80% confluent) were 
pre - chilled at 4°C for 30 minutes. The growth medium was 
removed and 3,0 ml MEM containing 5% lipoprotein deficient serum 
(LPOS) and varying amounts of [1251 ] LOL or ECOI_[1251 ] LOL 
(0 - 80 fg) was added to the culture flasks. The monolayers were 
incubated at 4°C for 1 hour without shaking. The medium from 
each flask was removed and retained for assay of degradation 
products (Section 4.2.7). The monolayers were washed according to 
the method of Go 1 dstei n et al. (1976) and Brown et al. (1976), 
using buffer containing bovine serum albumin. Cells were finally 
washed with 50 mM Tris - HCl (pH 7,4) - 0,15 M NaCl and solubilized 
in 1 ml 0,1 N NaOH. A 500 fl aliquot of the cell suspension was 
withdrawn to determine total cell associated radioactivity, while 
a 50 fl aliquot was utilized to determine cellular protein 
content. 
4.2.7 Assays for [1251 ] - labelled degradation products 
The assay method was adapted from the method of Goldstein and 
Brown (1974). Following incubation of monolayers at 4°C for 
1 hour, the medium was removed and precipitated with an equal 
-
volume 9f cold 20% TCA. After standing at 4°C for 30 minutes 
the TCA precipitated material was pelleted by centrifugation at 
3 000 rpm and discarded. To a 1 ml aliquot of the supernatant 
was added 100 fl K1 (1 %) and 30 fl 30% H202• Free iodine was 
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extracted with 2 ml CHC1 3. A 500 fl aliquot of the aqueous 
phase was counted to determi ne the amount of TCA - sol ub 1 e [125 r ] -
labelled degradation product released into the medium by the 
fibroblasts. 
4.2.8 Determination of specific binding of iodine - labelled LDL 
and ECDr - LDL 
Binding assays were carried out as described in Section 4.2.6. 
. 125 125 Increas 1 ng amounts of [ I ] LDL and ECDI - [ I ] LDL (0 - 600 ng) 
were added to normal skin fibroblast monolayers in the presence 
or absence of a 200 - fold excess of unlabelled native LDL. The 
specific binding was then determined as described in Section 4.3.5. 
4.2.9 Binding of [1251 ] LoL and ECoI [125 r ] LOL by normal skin 
fibroblasts in the presence of heparin 
Monolayers were chilled for 30 minutes. To the cells were added 
0- 600 ng of [1251 ] LDL or ECOI_(125 I ] LOL. Flasks were incubated 
at 4°C for 1 hour. After incubation the medium was removed and 
the monolayers were washed as described in Section 4.2.6. To 
each flask was added 1 ml of fresh medium containing 1 mg heparin, 
and the cells were incubated at 37°C for 1 hour. The medium was 
then removed and an aliqout was counted to determine the heparin-
released or receptor - bound lipoprotein. The cells were solubilized 
in 0,1 N NaOH and an aliquot of the cell suspension was counted 
to determine the heparin - resistant counts. The total cellular 
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protein content for each flask was also determined. 
4.2.10 Binding studies at 4°C and 37 °C 
One set of flasks containing normal skin fibroblast monolayers 
were incubated at 4°C and a second set at 37 °C, after addition 
of [1251 ] LDL or ECDl - [ 1251 ] LDL. Both sets were processed in an 
identical manner. The medium from each flask was assayed for 
TCA - soluble degradation products as described in Section 4.2.7. 
The monolayers were washed (Section 4.2.6), solubilized in 
0,1 N NaOH and the radioactivity determined. The binding and 
degradation were thus compared at 4°C and 37 °C. 
4.2.11 Binding, internalization and degradation of LDL - DNA and 
carbodiimide - modified LDL - DNA complexes 
Binding " internal ization and degradation assays of [1251 ] LDL - ctDNA, 
ECDl - [ 1251 ] LDL - ct DNA, LDL -r3H] pBR322 and ECDl - LDL - [3H] pBR322 
(prepared as described in Section 4.2.5) in normal skin fibroblasts, 
in vitro,at 4°C were carried out as outlined in Section 4.2.6 
and 4.2.7 except for one variation: All monolayers were pre -
treated with 10 f g of six - times sheared calf thymus DNA for 
10 minutes prior to the addition of the above complexes to the 
cell cultures. Heparin - release experiments were carried out as 
described in Section 4.2.9. 
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4.3 Results and Discussion 
4.3.1 Iodination of native and carbodiimide - modified LDL 
Both LDL and ECDI - LDL were successfully iodinated by using the 
N - chlorobenzene sulfonamide derivatized polystyrene beads. A 
scheme for the synthesis is presented in Figure 4.1. The iodine 
monochloride method of McFarlane (1958), used by Bilheimer et al . 
(1972) and other researchers (Trezzi, 1984; Brown and Goldstein, 
1974a; Bradley et al ., 1984; Anderson et al ., 1981; Goldstein 
e t a l ., 1976; Brown and Goldstein, 1975), for the iodination of 
LDL was not employed as the method of preparation required 
conditions of high pH, which must affect the integrity and solubility 
of the LDL. The iodination of the LDL apoprotein occurs at tyrosine 
residues (Brown and Goldstein, 1976) without drastically altering 
the receptor binding properties of the particles. The iodinated 
LOL and ECOl - LDL were purified by gel filtration on a Sephadex G 25 
column . Peak fractions were counted on a '>! - counter in addition 
to being monitored at 00280 . The elution profiles presented in 
Figure 4.2 shows that the radioactivity peak followed the 
optical density peak closely. [125 r ] LDL had a specific activity 
of 4 500 cpm / ng, whilst that of ECDl - [125 r ] LDL was 5 000 cpm / ng. 
The number of moles of I per LDL calculated was < 1~0. Similar 
rates of iodination of native LDL have been reported for iodination 
by the iodine monochloride method (Brown and Goldstein, 1974a). 
The iodination procedure proved to be satisfactory since recoveries 
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Gel filtration profiles of native LDL (a), [1251] LDL, 
(b), ECDl - LDL (c) and ECDl - [1251] LDL (d) recorded 
on an lSCO monitor, at OD280 (---). The radioactivity 
(e e) of peak fractions (1fl aliquots) was determined 
on a ¥ - counter. Both the standard and labelled 
components eluted between fractions R ~nrl 11 
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4.3.2 Preparation of [1251 ] LDL - DNA and ECDl - [125 r ] LDL - DNA 
complexes 
The initial activities of [125 r ] LDL - DNA and ECDr - [1251 ] LDL - DNA 
were 1 500 cpm / ng and 2 500 cpm / ng respectively. The activities 
of LDL - [ 3H ] pBR322 and ECD r - LDL - [ 3H] pBR322 were 4 000 cpm / ng 
and 6 000 cpm / ng respectively. The activity of the iodine labelled 
complexes were determined for each experiment. [3H] - labelled 
LDL - DNA and ECDr - LDL - DNA complexes were utilized to monitor 
the metabolism of the DNA in the above complexes. 
4.3.3 Receptor - binding activities of [125 r ] LDL and ECDl - [125 r ] LDL 
in cell cultures of normal skin fibroblasts 
[ 125 r ] LDL and ECDr - [ 125 r ] LDL bound to receptors of normal ski n 
fibroblasts in culture to different extents. The binding of 
ECDr - [ 125 r ] LDL at 80 ng was 100 - fo 1 d greater than that of.r 125 r ] 
LDL (Figure 4.3). Results presented here constitute both bound 
and internalized [125 r ] - labelled LDL and ECDr -LDL (i.e., total 
binding assays). 
4.3.4 Degradation of [125 r ] LDL and ECDl - [125 r ] LDL 
Degradation products were obtained within 1 hour of addition of 
[125 r ] LDL and ECDr - [125 r ] LDL to normal skin fibroblast monolayers 
in culture. Compared to the [125 r ] LDL, the ECDI - [ 125 r ] LDL 
was degraded to a far greater extent, as shown in Figure 4.4. 
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Figure 4.3 Binding of [1251 ] LDL (e) and ECD1- [125 1 ] LDL (0) in 
normal skin fibroblasts at 4°C. [1251 ] LDL had a specific 
activity of 179 cpm / ng while ECDl - [125 1 ] LDL had a 
specific activity of 75 cpm / ng. The average cellular 
























LDL protein, ng 
Figure 4.4: Degradation of [1251] LDL (e) and ECDl - [1251] LDL (0) 
by normal skin fibroblasts at 4°(. The specific activity 
and protein content were the same as for Figure 4.3. 
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Section 4.4.3) was 1 100, whilst the ratio of EC01-r
1251] LOL 
bound: degraded was : 1,4. This indicates that although a 
, 
greater amount of ECOI-[125 I ] LOL was bound (and internalized), 
and a larger amount was degraded, the turnover of native LOL was 
greater than that of carbodi imi de - modi fied LOL (i.e., 1 : 100 as 
opposed to 1 : 1,4). This suggests that in addition to binding 
specifically to the LOL receptors on the cell surfaces, the 
carbodiimide - modified LOL binds non - specifically to the plasma 
membrane. If these non - specifically bound ECOl - LOL are subsequent-
ly internalized, they would escape lysosomal degradation, whereas 
the native LOL, internalized by receptor mediated endocytosis, 
duly undergoes lysosomal degradation, yielding a 67 - fold greater 
turnover. 
4.3.5 Specific binding of [1251 ] LOL and ECOl - [1251 ] LOL 
Binding studies were carried out as described in Section 4.2.8. 
The specific binding was subsequently calculated by subtracting 
the binding of [125 11 LOL or ECOI-[125Il LOL, obtained in the 
presence of 200 - fo 1 d excess of un 1 abe 11 ed nati ve LOL, from that 
obtained in the absence of unlabelled native LOL (total binding). 
The binding data was processed as described by Brisette and 
No~l (1986). Results presented in Figures 4.5 and 4.6 show that 
there was reduced binding of both [1251 ] LOL and ECOI - [125 1 ] LOL 
in the presence of excess LOL. This illustrates that unlabelled 
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LDL PROTEIN, (x 10-2) ng 
Binding of [125 1 ] LDL to normal skin fibroblasts in the 
presence (0) and absence (.) of 200 - fold excess 
unlabelled LDL. The specific activity of [125 r ] LDL 
was 250 cpm / ng and the total cellular protein per 
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Binding of ECDI - [1251 ] LDL to normal skin fibroblasts 
in the presence ()) and absence (tt) of 200 - fold 
excess unlabelled LDL. 
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The specific binding data obtained from Figures 4.5 and 4.6 
were transformed into plots of the ratio of receptor - bound to 
free lipoprotein versus the receptor- bound lipoprotein. Results 
on the Scatchard plot (Figure 4.7) showed that the [1251 ] LDL 
bound specifically to the cell surface receptors as reported by 
Brown and Goldstein (1974). The ECDI_[1251 ] LDL, on the other 
hand, bound both specifically to the LDL receptors, and by a second 
type of binding. This additional binding possibly occurs at 
'residual· receptor sites (Brown and Goldstein, 1975). Nevertheless, 
the experimental results (Figures 4.5, 4.6 and 4.7) illustrate 
that the carbodiimide - modified LDL does enjoy receptor recognition 
and is internalized by adsorptive endocytosis. 
4.3.6 Competitive binding of ECDI - [1251] LDL to normal skin 
fibroblasts in the presence of native LDL 
In order to confirm that carbodiimide - modified LDL was subject 
to receptor recognition, a competitive binding experiment was carried 
out (as described in Section 4.2.6) in the presence of increasing 
amounts of native, unlabelled LDL. There was a progressive decrease 
in the binding of ECOI_[1251 ] LOL to the normal skin fibroblasts 
(Figure 4.8) with increasing amounts of native LDL, up to 10 f g 
(LDL protein). Additional amounts of native LDL (exceeding 
10 f g ) did not displace any more ECDI - [1251 ] LDL, hence the 
ECOI - (1251 ] LDL remaining bound to the cell s was probably non-
specifically bound. This experiment illustrates that carbodiimide-
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Scatchard transformations for the binding of [1251 ] LDL 
(e) and ECD1-[1251JLDL (O)from Figures 4.5 and 
4.6. 'Bound / free- on the ordinate of the Scatchard 
plot represents the amount of specifically bound 
[ 1251 ] LDL and ECD1 - r 1251 ] LDL (ng / mg protein) 
divided by the concentration of unbound [125 1 ] LDL or 
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NATIVE LOL, f g 
Competitive binding of ECOr - [125 r ] LOL to normal skin 
fibroblasts Four hundred ng of ECOl - [125 r ] LOL was 
applied to each flask. The specific activity of the 
ECOl - [125 r ] LOL was 432 cpm / ng. The total protein 
content per flask averaged 398 ?g. Native LDL was 
added as indicated. 
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and is therefore subject to receptor - recognition for binding, 
internalization by receptor - mediated endocytosis and lysosomal 
degradation. Faust et al.(1977) have shown similar competitive 
reductions in the binding of labelled LDL in cultured mouse 
adrenal cells. The addition of ACTH, however, enhanced receptor-
binding of the labelled LOL in the presence of unlabelled LOL. 
4.3.7 Heparin chase experiments as a means of monitoring receptor-
binding activities of [1251 ] LDL and ECDl - [1251 ] LDL 
Surface - bound [125 1 ] LDL and ECOl - [1251 ] LOL were released with 
heparin. Results (Figure 4.9) show that 3-fold more ECDl _[1251 ]_ 
LOL was released with heparin than (125 1 1 LDL at 600ng (protein 
content). The binding of native LOL reached saturation at 
approximately 300 ng, while the carbodi imide - modified LOL binding 
increased with increasing amounts of ECOl - [125 1 ] LOL. This 
indicates that the native LOL bound specifically to the cell 
surface receptors while ECDl - [125 1 ] LDL bound non - specifically 
to the plasma membrane in addition to binding to the LDL receptors, 
hence the heparin-released EC01_[125 1 ] LDL did not reach 
saturation (Figure 4.9). 
The heparin resistant counts represent the [125 1 ] LDL and ECDl -
[1251 ] LDL internal ized by LDL receptor mediated endocytosis 
(Brown and Goldstein, 1976b). Similar amounts of [1251 ] LDL and 
ECDl - (1251 J LDL were internal ized (Figure 4.10). This indicates 
s:: 
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LDL PROTEIN, -2 (x 10 ) ng 
Heparin - release of surface - bound [125 r ] LDL (.) and 
ECDI - [1251 ] LDL (0) from skin fibroblasts. Specific 
activities were 1481 cpm / ng and 75 cpm / ng, and 
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LDL PROTEIN, (x 10-2) ng 
Figure 4.10 Internal ization of [125 1 ] LOL (.) and ECOI _ [125 1 ] 
LDL (0), in normal skin fibroblasts, which were 
heparin - resistant. 
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that only the receptor - bound LDL and carbodi imide - modified LDL 
was i nterna 1 i zed, by LDL receptor - med i a ted endocytos is, since 
the degradation of both lipoproteins (Figure 4.11) was also almost 
equivalent. 
4.3.8 Temperature dependence of binding and degradation 
of LDL and ECD I - LDL 
Binding studies were carried out at both 4°C and 37 °C. Results 
presented in Table 4.1 indicate that binding and degradation of 
[1251 ] LDL and ECDl - [125 1 ] LDL were greater at 37 °C than at 4°C. 
A repeat of the experiments at higher concentrations of LDL protein 
also yielded greater binding and degradation at 37 °C. Enhanced 
binding of native LDL to the receptors at 4°C and greater 
internalization at 37°C has been reported (Brown and Goldstein, 
1976 a). However, the purpose of the experiment was to establish 
that both binding and internalization were feasible at 4°C. 
Results in Sections 4.3.3, 4.3.4 and 4.3.9 show that binding, 
internalization and degradation were successfully carried out 
at 4°C. 
4.3.9 Binding and degradation of [1251 ] LDL-ct DNA and ECDl - r 1251 ] -
LDL - ct DNA in vitro 
The binding of native and carbodi imide - modified lDL - DNA complexes 
to normal skin fibroblasts in culture was studied at 4°C. At 
2 ?9 of LDL or ECDl - LDL protein content approximately 500 ng of 
[1251 ] lDL-ct DNA was bound and internalized while at the same 
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LDL PROTEIN, (x 10-2) ng 
Degradation of [1251 ] LDL (e) and ECD1-[125 I1 - LDL 
()) by normal skin fibroblasts. 
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Binding, ng I mg protei n Degradation, ng I mg prate in 
4°C 37 °C 4°C 3rC 
r 125r ] LDL 
40 ng 0,06 0,77 3,39 73,2 
80 ng 0,10 2,33 9,08 241 ,7 












Binding and degradation of [125 1 ] LDL and ECDl _ [125 r ] -
LDL at 4°C and 37 °C. The activities of [125 r ] LDL and 
ECDl - [ 125r ] LDL were 1250 cpm I ng and 575 cpm I ng 
respectively. The average cellular protein values 
were 278 ji9 for the former and 458 jig for the 1 atter. 
Total biriding included both surface-bound and 
i nterna 1 i zed LDL and ECDl - LDL. 
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concentration approximately 100 ng of ECDr - [125 r ] LDL - ct DNA 
was bound and internal ized, that is, 5 - fold less binding occurred 
with the carbodiimide - modified LDL - DNA complexes (Figure 4.12). 
However, ECDl - LDL has a 10 - fold greater affinity for DNA (Section 
3.3.2) than native LDL, hence these particles carry twice the 
DNA carried by native LDL because they bind far more DNA. 
The degradation of native LDL (complexed with DNA) was 10 - fold 
greater than for carbodiimide - modified LDL (complexed to DNA) 
(Figure 4.13). Although this experiment indicated that ten times 
more [1251 ] LDL was degraded than ECDl - [125 1 ] LDL, one could 
not estimate the extent of binding, internalization and degradation 
of the DNA complexed to these lipoproteins. For this reason, 
a further experiment was carried out, using the same lipoprotein-
DNA complexes, but this time with labelled DNA (Section 4.3.10). 
4.3.10 Assay for surface - bound and i nterna 1 i zed LDL - DNA and 
ECDl - LDL - DNA complexes using heparin 
To determine whether the LDL and ECDl - LDL complexed to DNA did 
carry the DNA to the LDL receptors and were subsequently internal -
ized, binding assays were carried out with lipoprotein - DNA 
complexes which contained labelled DNA (i.e, [3H1 pBR322 DNA). 
Surface - bound LDL - [3H] pBR322 and ECD1- LDL _[3 H] pBR322 \,yere released 
with heparin (as described in Section 4.2.9). Results show that 
3 far more ECDl - LDL - [ H J pBR322 complexes were surface - bound 



































LOL PROTEIN concentration, )19 
Binding of [125r ] LOL-ct DNA (e) and EC01-[125 r ]_ 
LOL - ct DNA (0) to normal skin fibroblasts. The specific 
activities of the [125 r ] - labelled lipoproteins 
were 960 cpm / ng and 65 cpm / ng respectively. The 
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Dedradation of [125 1 ] LDL - et DNA (e) and ECDl _[125 1 ]_ 




















































Fi gure 4. 14: Surface - bound LDL [3H] pBR322 (e) and [CD I -
LDL - [3H] pBR322 (0) re 1 ea sed from no rma 1 ski n 
fjbroblastswith heparin. The average cellular 
protein value per flask was 2501'g. The ratio of 
1 ipoprotein to DNA in the lipoprotein - DNA complexes 
was 100 : 1. 
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specific binding of the modified LDL to the surface of the skin 
fibroblasts (as described in Section 4.3.7). The amounts of 
LDL - [3H] pBR322 and ECDl - LDL - [3H J pBR322 internal ized (heparin 
resistant counts) were equivalent (Figure 4.15). Thus, although 
more of the modified LDL (complexed to DNA or uncomplexed) bound 
to the cell surface, only those that were bound to LDL receptors 
were internal ized (Figure 4.6). Non - specifically bound ECDl - LDL-
r3HJ pBR322 was, therefore, not internalized. There was a slight 
difference (Figure 4.16) in the degradation of LDL - [3H] pBR322 
and ECDl - LDL - [ 3H ] pBR322, the former bei ng a 1 i ttl e hi gher. 
Thus both lipoprotein-DNA complexes were internalized by LDL 
receptor-mediation and degraded in the cell lysosomes. However, 
the amount of degradation was more than 50% lower than the 
internalization. Compared with the iodine -labelled lipoprotein-
DNA complexes internalized and degraded (Figures 4.12 and 4.13), 
far less DNA was degraded than the lipoproteins in these complexes. 
4.3.11 Competitive binding of ECDl - LDL - [.3H ] pBR322 complex to 
normal skin fibroblast LDL receptors in the presence of native LDL 
The reaction was analogous to that described in Section 4.3.6. 
Results in Figure 4.17 show that there was decreased binding of 
ECDl - LDL - [3H] pBR322 to normal skin fibroblast monolayers when 
increasing amounts of unlabelled LDL were added. This experiment 
a 1 so shows that, 1 i ke the ECDl - [ 1251 J LDL, the ECOl - LOL - [3H ] pBR322 
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Figure 4.15 Internalization of LDL - [3H] pBR322 (e) and ECDI - LDL 





































Degradation of LDL - [3H] pBR322 (e) and ECDl - LDL -
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LDL protein, f g 
Competitive binding of LDL and ECDl-LDL - [3HJ pBR322 
complex to normal skin fibroblasts. A 100 ng of 
ECDl - LDL - [3H ] pBR322 (LDL protein content) was 
added to each flask. Native LDL was added as 
indicated. 
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carbodiimide - modified LDL - DNA complex is also subject to recogni-
tion by the LDL receptors for binding and internalization. 
4.4 Concluding remarks 
The total binding of ECDl - [125 1 ] LDL (LDL bound to receptors 
and internalized) was 100 - fold greater than that of native LDL. 
However, a study of the turnover (binding versus degradation) of 
the two lipoproteins showed that the ratio of bound: degraded 
[1251 ] LDL was 1 : 100. This was 67 - fold greater than that of 
ECDl - [1?51 ] LDL, suggesting that some carbodiimide - modified LDL 
bound non - specifically to the fibroblast membranes. This was 
confirmed by results of the specific binding of [1251 ] LDL and 
ECDl - [125 1 ] LDL (Section 4.3.5, Figures 4.5 and 4.6) and the 
Scatchard transformation (Figure 4.7) data. The additional 
type of binding by ECDl - [1251 ] LDL may be analogous to the 
binding to 'residual receptor sites' described by Brown and 
Goldstein (1975 a). Nevertheless, a competitive binding of 
ECDl - [125 1 ] LDL to the same receptors as native lDL ( i.e., 
their displacement by native LDL) was shown to occur (Figure 4.8). 
This confirmed that ECDl - [125 1 ] LDL enjoyed recognition by 
the same receptors as native LDL. 
Hepari n - chase experiments also served to i 11 ustrate that both 
125 125. r r ] LDL and ECDl - [ 1 ] LDL enJoyed LDL - receptor 
recognition and were internalized and degraded to the same extent. 
ECDr - [125 r ] LDL bound to non - receptor sites on the plasma membrane 
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were not internalized by LDL receptor mediation or degraded in 
the lysosomes. 
For receptor - binding studies involving lipoprotein - DNA complexes, 
either the lipoprotein or the DNA component was radiolabelled. 
The lipoprotein to DNA ratios varied from 15: 1 to 55: 1. Binding 
assays showed an overall 2 - fold greater binding of [1251 ] LDL - DNA 
than ECDl - [1251 ] LDL - DNA (figures 4.12 and 4.13). However, 
heparin - chase experiments showed that although more of the 
carbodiimide - modified LDL - DNA complex was surface - bound, there 
was not a significant difference in the internalization and 
degradation of the DNA component of the two 1 ipoprotein - DNA 
complexes (Figures 4.14 - 4.16). A decrease in the binding of 
ECDl - LDL - [3H] pBR322, to normal skin fibroblasts, in the presence 
of native LDL showed that the internalization of the carbodiimide-
modified LDL - DNA complex was LDL receptor - mediated. 
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C H APT E R F I V E 
TRANSFECTION OF CELLS IN CULTURE BY RECEPTOR - MEDIATED 
ENDOCYTOSIS 
5.1 Introduction 
The classical and most frequently used method for the introduction 
of foreign DNA into cultured cells is by the calcium - precipitated 
DNA technique (Graham and van der Eb , 1973; Pellicer et al. ,1980; 
Colbere-Garapin et al., 1981; Scangos and Ruddle, 1981; Gorman et 
al., 1982 a, b; Laimins et al., 1982; Kruckzek and Doerfler, 1983; 
Gorman et al., 1983; Mc Lauchlan et al., 1985; Burke and Mogg,1985; 
Darnell and Boime, 1985; Gorman, 1986). Several other methods for 
the introduction of foreign DNA intoeukaryotic cells have also been 
employed (Section 1.13). Few of these techniques, however, can be 
applied in vivo, especially to larger organisms, including 
mammals. 
A method of transfecting eukaryotic cells with a view to its 
applicability in vitro and in vivo was sought. The use of serum 
and serum carriers for drug targeting has been employed. However, 
the use of ligands such as LDL, insulin,<:x 1 -
acid glycoprotein, 
growth hormone and transferrin, for the transfer of genetic 
material into eukaryotic cells is a novel idea which has not been 
tested previously. Since these ligands contain receptors on most 
cell surfaces of mammalian organisms, such ligands complexed with 
foreign DNA should be able to transfer the DNA into the cells by 
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their normal internalization process of receptor - mediated 
endocytosis. 
The ligand utilized for this study was human serum low density 
lipoprotein (LDL) which contains receptors on all normal somatic 
cell types throughout , the body. The foreign DNA utilized for the 
study was the recombinant pSV2cat DNA. This is an expression 
vector which contains the beta - lactamase gene and origin of 
replication from plasmid pBR322, coupled to the SV40 early 
transcription region. The SV 40 early region contains the 72 base-
pair (bp) repeated sequences which function as activators or 
enhancers of early viral gene expression in eukaryotic systems 
(Bernoist and Chambon, 1981; Gruss et al ., 1981). The pSV2cat 
recombinant DNA also contains the chloramphenicol acetyl transferase 
(CAT) gene (Gorman et al., 1982, a, b; Gorman et al . ,1983; 
Gorman, 1986). The construction of the pSV2cat recombinant vector 
is presented in Figure 5.1. 
Chloramphenicol acetyltransferase (CAT) activity is not an 
endogenous characteristic of mammalian cells (Gorman et al., 1982b), 
thus the successful expression of CAT activity in mammalian cells 
i s indicative of successful transfection of the cells. The CAT 
gene is transiently expressed in mammalian cells in culture, 
thus the pSV2cat recombinant DNA should provide a convenient 
method for assaying the expression of the vector, introduced into 
mammalian cells, in vitro, by LDL receptor-mediated endocytosis. 




The pSV2cat expression vector. The recombinant DNA 
contains the SV 40 early region promoter (~) 
sequences and the polyadenylation site and small 
t intron from SV 40 (EB). It also contains the 
prokaryotic ori region and the ampR gene from 
pBR322. The cat gene is indicated by (11). The 
pSV2cat plasmid contains 5 003 base pairs. 
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In order to carry out the transfection of mammalian cells by LDL 
receptor - mediated endocytosis, LDL was first prepared as described 
in Section 2.2.1. A portion of the LDL was also modified with 
carbodiimide as described in Section 2.2.2. The expression vector 
pSV2cat was amplified i n E. coli HB 101 according to published 
methods (Mani at is et al. , 1982; Gorman, 1986). L i poprotei n - DNA 
complexes were applied to sub - confluent monolayers of several 
mammalian cell lines. Successful transfection of these cells by 
LDL receptor - mediated endocytosis was detectable as the 
expression of chloramphenicol acetyl transferase activity. 
5.2 Methods 
5.2.1 Preparation of pSV2cat plasmid DNA (Method 1) 
5.2.1.1 Growth of pSV2cat plasmid in E. coli 
A tryptose agar base (TAB) streak - plate was prepared using E. coli 
HB 101 containing pSV2cat plasmid grown on an agar slope. The TAB 
agar plate was incubated overnight at 37°C. A single colony from 
the streaked plate was used to inoculate a 15 ml liquid culture of 
Penassay broth, prepared according to the manufacturer's instructions . 
This constituted the first inoculum. The inoculum was then added 
to a 75 ml aliquot of Penassay broth to allow further growth of 
the plasmid - containing bacteria, overnight, at 37°C, without 
shaking. The overnight culture was used to inoculate 750 ml of 
Penassay broth, which was subsequently incubated at 37°C, with 
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vigorous shaking, for 6 hours or until the turbidity had increased 
(00600 
= 0,6). To the plasmid- E. coli culture was added 170)19 
chloramphenicol I ml broth and amplification was allowed to proceed 
overnight, with vigorous shaking, at 37°C. All culture media 
contained 50 )1g ampicillin per ml of medium. 
5.2.1.2 Harvesting of E. coli containing the pSV2cat plasmid DNA 
E. coli cells containing the pSV2cat plasmid DNA were harvested 
by centrifugation at 4 000 x g for 30 minutes, at 4°C. The pelleted 
bacterial cells were washed by suspension in buffer (0,1 M NaCl -
0,01 M Tris - HC1, pH 7,8 - 1 mM EDTA) and centrifugation. The 
bacterial cells were resuspended in 10 ml STET (0,1 M NaCl - 10 mM 
Tris - HC1, pH 8,0 - 0, 1 m~1 EDTA - 0,5% Triton X 100). 
5.2.1.3 Lysozyme treatment of pSV2cat DNA - containing E. coli 
Lysozyme (20 mg) was dissolved in 1 ml 10 mM Tris - Hel (pH 8,0) 
and added to the pSV2cat plasmid - containing E. coli cells in 
STET. The bacterial cells were incubated with lysozyme for 10 
minutes at room temperature. The resultant viscous solution was 
boiled rapidly over a flame, plunged into boiling water for 40 
seconds and then into an ice - ba th for 5 mi nutes . The bacteri a 1 
cell debris was pelleted at 80 000 x g, in an SW 50 rotor, for 
30 minutes, at 4°C and discarded. The supernatant constituted 
the crude plasmid preparation. 
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5.2.1.4 Purification of plasmid DNA bycestumchloridedensity 
gradient ultracentrifugation 
The crude plasmid DNA preparation was mixed with CsCl to give a 
refractive index of 1,3862. Ethidium bromide (10 mg / m1) was 
added to the preparation, and dispensed into 3,5 ml nitrocellulose 
tubes. Each tube was over1ayed with paraffin oil and placed 
in an SW 50 rotor. Ultracentrifugation was carried out at 
10 000 x g at 20 °C for 35 hours. The upper and lower plasmid 
bands were located under UV illumination and collected with a 
finely drawn out Pasteur pipette. The ethidium bromide was 
extracted twice with water - saturated butanol. The top and 
bottom plasmid bands were dialysed against 0,01 M Tris-HC1, pH 8,0-
1 mM EDTA at 4°C, with six changes of buffer over a period of 
36 hours. The plasmid preparation was analysed by agarose gel 
electrophoresis and UV spectroscopy. The plasmid DNA was also 
subjected to restriction analysis (Section 5.2.3). The pSV2cat 
DNA was stored at -20°C. 
5.2.2 Alternate method for the preparation ofpSV2cat plasmid 
DNA (Method 2) 
Plasmid - containing E. coli were grown in IIsuperbroth" (Gorman, 1986), 
prepared as follows: 24 g tryptone, 48 g yeast extract, 10 ml 
glycerol and 1 800 m1 distilled water were mixed together; to this 
mixture was added 25 g K2HP04 and 7,6 g 
KH2P04 
dissolved in 200 m1 
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distilled water. A 5 ml inoculum in "superbroth" was prepared 
from a single colony picked off a streaked TAB plate by incubation 
at 37°C for six hours, and added to 2 1 of "superbroth". The 
bacterial growth and amplification was then carried out as described 
in Section 5.2.1.1. The plasmid - containing bacterial cells were 
harvested as described in Section 5.2.1.2. The E. coli HB 101 
r 
cells were either stored at -20 °C at this stage of plasmid 
preparation or resuspended in TES (40 mM Tris - HC1, pH 7,5 - 40 mM 
EDTA - 25 % sucrose) and subjected to lysozyme treatment. For 
the lysozyme treatment, the bacteri a 1 cell s were resuspended in 
8,0 ml TES and placed on ice. To the cell suspension was added 
0,6 ml lysozyme solution (20 mg dissolved in TES), and incubated 
on ice for 5 minutes. EDTA (2,4 ml, 0,25 M, pH 8,0) was added 
and incubation on ice was continued for a further 5 minutes. To 
the resultant viscous solution was added 9,7 ml Triton solution 
(0,1% Triton X-100 - 8 mMEDTA - 50 mMTris-HC1, pH 7,9) and 
incubation was continued on ice for an additional 10 minutes. 
Bacterial cell debris was pelleted at 75 000 x g, in an SW 28 
rotor, for 30 minutes, at 4°C. The plasmid and cellular DNA -
containing supernatant was subjected to CsCl density gradient 
ultracentrifugation as described in Section 5.2.1.4. The ethidium 
bromide was extracted with isopropanol saturated with CsCl solution 
at a density of 1,574 g / ml. The plasmid DNA was dialysed against 
several changes of 0,01 M Tris-HC1, pH 8,0 - 0,001 M EOTA at 4°C, 
analysed by restriction endonuclease digestion, and stored at 
- 20°C. 
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5.2.3 Restriction endonuclease digestion of pSV2cat ONA 
Plasmid DNA prepared by methods 1 and 2 was subjected to digestion 
with Eco R1 and Ps t1 restriction enzymes, according to the 
manufacturers' recommendations, at medium salt strengths. In a 
total volume of 42 fl, pSV2cat DNA (1,725 fg) was incubated at 3JOC 
for 1 hour, in a reaction mixture containing 50 mM NaCl, 10 mM 
Tri s - HCl (pH 7,6), 10 m M MgC1 2 and 1 m M mercaptoethano 1, wi th 
3,7 units of Eco R1 restriction enzyme. For the Pst 1 digestion, 5 
units of enzyme was used to digest 2 f g pSV2cat DNA, in a reaction 
mixture containing, 55 mM NaCl, 10mM Tris-HCl (pH 7,2), 10mM 
MgC1 2 and 0,5 mg / ml albumin. 
5.2.4 Ethanol precipitation of plasmid DNA 
To the plasmid DNA dialysed in 10 mM Tris-HC1, pH 8,0 - 0.001 M 
EOTA was added 0,1 volume 4 M NaCl and 2,5 volumes redistilled 
ethanol. The DNA was precipitated at -20 °C for 1 hour and then 
centrifuged at 9 000 x g, at 4°C, to pellet the DNA. The DNA was 
dissolved overnight in 10 mM NaCl for use in the transfection 
of cells in culture. 
5.2.5 Transfection of cells in culture with pSV2cat DNA 
5.2.5.1 Transfection of cells in culture by the calcium phosphate -
DNA coprecipitation technique 
Cells in culture were trypsinized and plated in 25 cm2 flasks, to 
a density of 5 x 105 cells, 24 hours prior to transfection. 
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Three hours prior to transfection fresh complete medium was 
added to each flask. The calcium phosphate - DNA complex 
preparation for each flask was as follows: To the pSV2cat DNA 
(1 - 10 fg) was added CaC1 2 to give a final concentration of 250 mM 
in a volume of 250 fl. In experiments where low concentrations of 
DNA were added, 10 f g calf thymus DNA was added as carrier. The 
Ca++- DNA solution was then added dropwise with agitation (sterile 
N2 gas or air bubbled through) to 250 fl Hepes buffered saline 
which consisted of 1,64% (w / v) NaCl, 1,2% (w / v) 2-[4- (2-
hydroxyethyl) - 1 - piperazinyl J - ethane-sulfonic acid and 
0,04% (w / v) Na2HP04 adjusted to pH 7,1. The calcium phosphate -
DNA coprecipitation was allowed to occur at room temperature for 
30 minutes and then added to the cells. Monolayers were incubated 
at 3JOC for 4 - 18 hours post - transfection before being washed 
and fed with complete medium. Incubation was continued until 
48 hours post-transfection. The cell lines utilized for 
transfection studies were normal skin fibroblasts, HeLa cells, 
fetal fibroblasts, CV - 1 cells and human lung fibroblasts. 
5.2.5.2 Transfection of cells in culture by LDL receptor mediation 
Cells in culture were trypsinized and plated in 25 cm2 flasks 24 
hours prior to transfection, to a density of 5 x 105 cells. 
About 10 minutes prior to transfection the complete medium was 
removed and replaced with 3 ml Eagle's MEM containing 10% 
lipoprotein - deficient serum. Ten f g calf thymus DNA was also 
added to each flask prior to transfection. Each flask received 
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1 ipoprotein - DNA solutions prepared as follows: To 50 - 100 jlg 
LDL or ECDI-LDL (protein) in STE1 (25 mM Tris - HC1, pH 7,6-
50 mMNaCl - 2,7 mMEDTA) was added 1 - 25jlg DNA (in 10 mM NaCl), 
in a total volume of 500 jll. The solution was mi xed and incubated 
at room temperature for 20 minutes before being added to each 
fl ask. Ce 11 s were incubated for 24 hours post - transfect ion 
before complete medium was added. Incubation was continued for 
up to 48 hours post - transfect ion. The ce 11 1 i nes used in the 
experiments were human skin fibroblasts, HeLa cells, fetal 
fibroblasts~ CV - 1 cells and human lung fibroblasts. 
5.2.5.2.1 Preparation of cell - free extract 
Transfected cells (in 25 cm2 flasks) were washed with phosphate -
buffered saline (PBS) pH 7,5 (2 washes, 3 ml each). Cells 
from individual flasks were incubated on ice for 5 minutes ~ith 
1 ml each of TEN (40 mM Tris-HC1, pH 7,5 - 1,0 mM EDTA - 0,15 M 
NaCl). Monolayers were dislodged with a cell scraper and 
transferred to Eppendorf tubes and placed on ice. Cells were 
pelleted at 9 000 x 9 for 1 - 2 minutes and resuspended in 100 jll 0,25M 
Tris - HC1, pH 7,9 and then disrupted by freeze - thawing. 
Cell debris was pelleted at 9 000 x g a~d discarded. The cell -
free supernatant was assayed for chloramphenicol acetyl transferase 
(CAT) activity. 
5.2.5.2.2 Assay for the expression of the CAT gene 
The cell - free extracts (prepared as described in Section 5.2.5.2.1) 
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were assayed for chloramphenicol acetyl transferase activity. 
Fifty fl of ~ell extract in a final Tris - HCl (pH 7,9) buffer 
concentration of 0,25 M was incubated with 0,2 fCi [ 14CJ chloram -
phenicol (0 - threo - [ dichloroacetyl - 1 - 1\ 1 chloramphenicol, 
54 mCi / m mole) and 0,8 mM acetyl coenzyme A in a total volume of 
100 fl~ The reaction mixtures were incubated at 37 °C for exactly 
one hour. Cell extracts from flasks to which either only DNA or 
lipoprotein were added were used as controls. An enzyme control 
was also included with each set of assays. CAT enzyme activity was 
stopped by the addition of 1 ml ethyl acetate to each reaction 
mixture. Thorough mixing ensured that the chloramphenicol (CM) 
and its acetylated derivatives were extracted into the ethyl acetate. 
The organic layer was retained and evaporated to dryness under a 
stream of N2 gas. The residue was redissolved in 30 fl ethyl acetate 
and spotted onto silica gel 60 F254 plastic - backed thin layer 
plates. Each plate was developed in freshly prepared CHC1 3 - MeOH 
(95 : 5, v / v). The acetylated products were located by auto -
radiography. 
5.2.5.2.3 Autoradiography 
Thin layer chromatograms were placed in contact with Hyperfilm p max 
X - ray film for 48 - 72 hours. The X - ray film was developed in 
Phenisol X 
", 
- ray film develqper (Ilford), for 2 - 3 minutes, with 
agitation, . d . \ 1 . lmmerse ln stop s6 utlon for 30 seconds and fixed 
in rapid fixer for 3 minutes. Solutions were prepared according to 
manufacturers' instructions. 
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5.3 Results and Discussion 
5.3.1 Preparation of pSV2cat DNA 
The plasmid - containing E. coli were grown from an agar slope 
onto agar plates. Single colonies from the streaked plates were 
used to amplify the plasmid in suspension cultures by methods 
and 2. The difference in the methods lay in the preparation of 
growth media and lysozyme digestion of the bacteria l cell walls 
(Sections 5.2.1 .3 and 5.2.1.5). Method 1 entailed boiling and 
rapid cooling, following lysozyme treatment under alkaline 
conditions. Bacterial DNA remains denatured under these conditions 
(Maniatis et a l ., 1982) while closed circular plasmid DNA 
molecules regain their native configuration upon cooling. Method 2 
made use of alkaline conditions and Triton X - 100 for bacterial 
cell lysis. A return to neutral pH results in renaturation of plasmid 
DNA while E. coli DNA remains denatured. Nevertheless, both 
preparation methods involved the differential sedimentation step 
for the removal of larger E. col i DNA strands, together with the 
lysed cell debris, to yield the crude plasmid preparation. 
Plasmid DNA was purified by CsCl density gradient ultracentrifugation 
in the presence of ethidium bromide. Since the covalently closed 
circular plasmid DNA binds much less of the intercalating dye 
than the linear bacterial DNA, it bands at a higher density than 
the linear or nicked DNA (Radloff et al ., 1967). Thus, highly 
purified bands were obtained (Figure 5.2 a) . The ethidium bromide 
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Figure 5.2a Cesium chloride density gradient ultracentrifugation 
of pSV2cat plasmid; 1 = nicked circular DNA; 2 = 
supercoiled circular DNA. Bands were visualized 
under UV illumination. 
b Agarose gel electrophoresis of pSV2cat plasmid DNA 
prepared by method 1. Lanes 1 and 2 contain top 
and bottom bands respectively~ lanes 3 and 4 contain 
pSV2cat plasmid crude preparation and pBR322 DNA 
respectively. 
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was removed from the plasmid preparations by either water -
saturated butanol (method 1) or isopropanol saturated with CsCl 
of density 1,574 g / ml (method 2). 
The concentration of pSV2cat DNA was determined using the formula 
00
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= 1 = 40 f g DNA (Humphreys et al ., 1975). Plasmid yield 
by method 1 was 2 mg / 1 of culture medium while the yield with 
method 2 was 5 mg / 1 culture medium. Higher yield by method 2 
was probably due to the use of a highly enriched medium which 
allowed a denser growth of the plasmid - carrying bacteria. 
Another reason could be the gentler bacterial lysis procedure used 
in method 2, which would reduce losses of plasmid DNA through 
nicking or linearization. UV spectral analysis yielded an 
00280 / 00260 ratio of 0,7 , indicating slight contamination with 
protein. 
5.3.2 Electrophoretic analysis of pSV2cat DNA 
The purity of the top and bottom bands after ultracentrifugation 
was assessed by agarose gel electrophoresis (Figure 5.2 b). The 
crude preparation showed linear, nicked circular and circular 
supercoiled DNA. The top band (Figure 5.2 a) contained nicked 
circular DNA and was collected fairly pure (lane 1, Figure 5.2 b). 
The bottom band contained supercoiled DNA, but was contaminated 
with nicked circular DNA (lane 2). Contamination possibly occurred 
during collection of the plasmid bands after CsCl density gradient 
ultracentrifugation. 
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5.3.3 Restriction analysis of pSV2cat DNA 
Eco R1 and Pst1 restriction of pSV2cat were carried out as described 
in Section 5.2.3. Restriction fragments were separated on 1,25% 
agarose mini gels (Figure 5.3). The size of each fragment was 
determined from a plot of log of marker fragment molecular weight 
versus its mobility in the electrophoretic field. The fragment 
sizes c~rresponded closely with published values (Gorman, 1986). 
Since separation of restricted fragments was done on mini gels, 
errors in determination of fragment lengths were expected. 
5.3.4 Transfection of cells in culture with pSV2cat recombinant 
DNA by LDL receptor mediation 
5.3.4.1 Chloramphenicol acetyl transferase (CAT) activity 
Some bacterial strains of Escher ichia coli , Streptococcus aur eus, 
Diplococcus pneumoniae and Agrobact er i um tumefaciens are resistant 
to the antibiotic chloramphenicol (Shaw, 1967; Shaw and Brodsky, 
1968; Shaw, 1975). This resistance phenotyp~ is due to the 
inactivation of the antibiotic by the enzyme chloramphenicol 
acetyl transferase (CAT) which is induced by episomal resistance 
factors (Shaw, 1967). The plasmid - borne CAT gene codes for the 
CAT enzyme which inactivates chloramphenicol by acetylating the 
3 1 - hydroxy position (Shaw, 1975). The 1 - acetylated derivative 
is produced by intramolecular conversion of chloramphenicol 3 -
acetate to chloramphenicol 1 - acetate. Subsequent enzymatic 
acetylation of chloramphenicol 1 - acetate yields the 1,3 - di -
Figure 5.3 
236 
EcoR1 and Pst1 digestion of pSV2cat DNA. Lanes 1 and 8 : 
DNA molecular weight marker; lanes 2 and 3 : EcoR1 
digestion of pSV2cat DNA; lanes 4 and 5 Pst1 
digestion of pSV2cat DNA; lanes 6 and 7 pSV2cat DNA. 
Components in lanes 2, 4 and 6 were from pSV2cat DNA 
prepared by method 1 (Section 5.2.1) and those in 
lanes 3, 5 and 7 were from the plasmid prepared by 
method 2 (Section 5.2.2). 
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acetylated chloramphenicol (Figure 5.4). 
Use has been made of purified CAT enzyme to acetylate ( 14CJ chloram-
phenicol at 37°C, for 1 hour, in the presence of Acetylcoenzyme A 
(i.e., under ideal conditions). Chloramphenicol and its acetylated 
derivatives were extracted into ethyl acetate and separated by thin 
layer chromatography as described in Section 5.2.5.2.2. Spots were 
located by UV illumination (Figure 5.5 a) and autoradiography 
(Figure 5.5 b). Quantitation of acetylated products in a liquid 
scintillation counter showed that 58,8% of the chloramphenicol 
had been converted to chloramphenicol 3 - acetate, 7,6% to chloram -
phenicol 1 - acetate and 28,5% to chloramphenicol 1,3 - diacetate. 
Only 5,1 % of the [ 14CJ chloramphenicol remained un reacted and 
was detectable by autoradiography (Figure 5.5b) and not by UV 
illumination. The [ 14CJ chloramphenicol standard appeared as a 
single UV absorbing spot but con~istently showed contamination 
on the autoradiograms. 
5.3.4.2 Control experiments 
The prime aim of the experimental work in this chapter was to 
transfect cells in culture with the recombinant pSV2cat expression 
vector by LDL receptor mediation. In order to confirm that 
transfection could be carried out with some degree of success by 
this method, several control experiments had to be carried out. 
Since LDL or ECDI - LDL was complexed to pSV2cat DNA (supercoiled, 
Figure 5.4 
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Figure 5.5a Thin laye~ chromatography of [ 14CJ chloramphenicol (1), 
enzymatically acetylated products of [ 14C] chloram -
phenicol (2) and chemically prepared derivatives of 
chloramphenicol (3). Spots were located by UV illimination. 
b Autoradiogram of thin layer chromatogram (a). 
A = chloramphenicol, B = chloramphenicol 1 - acetate, 
C = chloramphenicol 3 - acetate, 0 = chloramphenicol 1,3-
diacetate. 
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Section 5.3.1) for the transfections, control experiments were 
carried out by applying (i) LDL only, (ii) ECDl - LDL only, or 
(iii) pSV2cat alone, to monolayers in control flasks. Cells in 
control flasks were incubated at 37 °C for 48 hours and harvested. 
The cell-free extracts were assayed for chloramphenicol acetyl -
transferase (CAT) activity as described in Section 5.2.5.2.2. 
Results showed no CAT activity in any of the controls (Figure 5.6). 
A single spot obtained on the autoradiograms, between the 
. monoacetylated derivatives, Band C, was also found in the 
chloramphenicol standard and was probably a contaminant. The 
acetylated derivatives are indicated by arrows (Figure 5.6) and 
constitute products of the purified enzyme (enzyme control). 
Enzyme controls were used with most CAT assays of transfected 
cell extracts, as reference for locating the acetylated chloram -
phenicol products. The results in Figure 5.6 are those obtained 
with human lung fibroblasts and are representative of controls 
in all cell lines used for transfection with LDL - pSV2cat or 
ECDl - LDL - pSV2cat complexes. 
5.3.4.3 Transfection of eukaryotic cells by LDL receptor - mediation 
Transfection by LDL receptor - mediation was attempted on human 
skin fibroblasts, He La cells, CV - 1 cells, human fetal fibroblasts 
and human lung fibroblasts grown in culture. Cells were incubated 
for up to 48 hours with LDL - pSV2cat complex or ECDl - LDL - pSV2cat 
complex (Section 5.2.5.2). The cells were harvested and lysed 
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Autoradiogram of typical control experiments carried 
out on all cell lines used for transfection by LOL 
receptor - mediated endocytosis. Results presented here 
are chloramphenicol acetyl transferase enzyme assays 
carried out on cell extracts of human lung fibroblasts 
to which either LOL (2 and 3), ECOl - LOL (4 and 5) or 
pSV2cat DNA (6, 7,6 and 9 - containing 2,5 f g, 5 f g, 
10 f g and 15 )1g DNA respectively) were added and 
incubated at 37°C for 48 hours. [ 14C] chloramphenicol 
standard = 1; 10 represents [ 14C] chloramphenicol 
subjected to acetylation by purified chloramphenicol 
acetyl transferase enzyme. A,8,C and 0 are defined 
in the legend of Figure 5.5b. 
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activity (Section 5.2.5.2.2). [ 14CJ Chloramphenicol was used 
for the assays,(all assays were for one hour) and acetylated 
products were separated by thin layer chromatography, located by 
autoradiography (Section 5.2.5.2.3) and quantitated by liquid 
scintillation counting. With each cell type used to carry out 
transfection by LDL receptor-mediated endocytosis (Section 5.2.5.2) 
the calcium phosphate - DNA coprecipitation method of transfection was 
also carried out (Section 5.2.5.1). Untransfected cell extracts were 
used as controls for the Ca 3(P04)2 - DNA transfected methods. 
Normal skin fibroblasts could not be transfected efficiently by LDL 
receptor mediation. Both LDL - pSV2cat and ECDl - LDL - pSV2cat 
transfected cells exhibited low efficiencies of transfection in these 
cells (Figure 5.7). Up to 10 f g of plasmid DNA was used in the 
studies. The efficiency of transfection by LDL receptor - mediation 
was assessed by assaying for CAT activity for exactly one hour and 
quantitating the conversion of r 14C] chloramphenicol to acetylated 
, 
products. About 0,1% of the chloramphenicol was converted to 
acetylated products in the skin fibroblasts transfected with both 
LDL - pSV2cat and ECD! - LDL - pSV2cat complexes and \'/ere barely 
detecteble by autoradiography. 
He La cells also showed a very low efficiency of transfection by LDL 
receptor - mediated endocytosis (Figure 5.8). CAT assays yielded up 
to 0,4% acetylation. CV- 1 cells showed lower efficiencies of trans -
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Autoradiogram of cell extracts from normal skin 
fibroblasts transfected by Ca3(P04)2 - pS
V2cat and 
lipoprotein - pSV2cat techniques. 1 [
14CJ chloram-
phenicol standard; 2, 3 and 4 : calcium phosphate - DNA 
transfections using 2,5 , 5 and 7,5 f9 DNA respectively; 
5, 6 : transfection with LDL - pSV2cat and ECDl - LDL -
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HeLa cells transfected by LDL receptor - mediated 
endocytosis and calcium - precipitated DNA technique. 
1 : [ 14C] chloramphenicol standard; 2, 3 : calcium 
phosphate - pSV2cat - transfected cell extracts (2,5 f g 
and 5 f g DNA respectively); 4, 5 : LDL - pSV2cat -
transfected cell extracts; 6, 7 : ECDl - LDL - pSV2cat 
transfected cell extracts; 8 : pSV2cat DNA control; 
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Autoradiograms of CV - 1 cell extracts assayed for 
CAT activity following transfection with calcium 
phosphate - pSV2cat (1 and 2), LDL - pSV2cat (5 and 6), 
and ECDl - LDL - pSV2cat complexes (8 and g).Controls were 
as follows: 3 enzyme control; 4 : LDL; 7: ECDl - LDL; 
10 : pSV2cat DNA control. 
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Fetal fibroblasts showed slightly higher transfection efficiencies 
than the above celi lines. The CAT assays yielded up to 1,05% 
acetylation with cell extracts from LDL - pSV2cat transfected cells 
and 1,2% in ECDI - LDL - pSV2cat transfected cell s. The amount of 
DNA in each case varied between 2,5 and 25?9 (Figure 5.10). The 
lipoprotein was kept constant at 100lg (protein content). 
The hi ghest efficiency of transfecti on by LDL receptor - medi ated 
endocytosis occurred in ~uman lung fibrob~asts in culture. Using 
LDL - pSV2cat complex in a ratio of 100lg LDL to 25 jUg DNA per flask, 
a tim2 study for the transf2ction wus curried out over a period of 
48 hours (Figure 5.11). Cell Extracts assayed for CAT activity 
showed that maximum acetylation (4,4%) occurred in cells harvested 
at 32 hours post - transfection. Nevertheless, activity was 
detectable 1,5 hours post - transfection. 
When ,ECDI - LDL : DNA were used in a ratio of 100fg : 251g, 
precipitation of the complexes occurred upon incubation at room 
temperature, prior to application to monolayers. This resulted in 
lower efficiencies of transfection of the lung fibroblasts. Lower 
concentrations of ECDI - LDL or pSV2cat or higher dilution were 
employed to overcome this problem. This resulted in higher CAT 
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Figure 5.10 CAT activities expressed in fetal fibroblasts. 
1 : untransfected control; 2 - 4 calcium phosphate-
pSV2cat transfected cell extracts; 5 and 14 : enzyme 
controls; 6: chloramphenicol; 7: pSV2cat DNA control; 
8, 9 and 10 : LDL - pSV2cat - transfected cell extracts 
(5, 15 and 25 f9 DNA respectively); 11, 12 and 13 : 
ECDl - LDL - pSV2cat - transfected cell extracts (5, 
15 and 25 f9 DNA respectively). 
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Figure 5.11 Transfection of human lung fibroblasts by LDL receptor-
mediated endocytosis. The cells were transfected with 
LDL - pSV2cat complexes and harvested between 1,5 and 
48 hours, as indicated. CM = chloramphenicol; E = 
enzyme control. The ratio of LDL to DNA per flask 
was 100 )1g to 25 jJg. A - 0 are defined in the legend 
of Figure 5.Sb. 
Figure 5.12 
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1 2 34567 8 9 10 
~c 
· +-8 
CAT activity in human lung fibroblasts in culture, 
transfected by LDL receptor - mediation. 1 : chloram -
phenicol; 2,3,4,5: ECoI - LDL transfected extracts 
(10 )-Ig, 2,5 )-Ig, 5)-19 and 10 )-Ig, DNA respectively); 7 : 
ECDI - LDL - pSV2cat transfected cell extracts 
(complex prepared at high dilution with 25)-1g DNA); 
8, 9 : calcium phosphate - pSV2cat - transfected cell 
extracts; 6, 10: enzyme controls. ECDI - LDL was 
decreased to 50 )-Ig in 3, 4 and 5, and mai~tained at 100 )-Ig 
in 2 and 7. A - 0 are defined in the legend of 
Figure 5.5b. 
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5.4 Concluding remarks 
The recombinant expression vector pSV2cat was amplified in E. coli 
HB10l by two methods (Maniatis et al., 1982; Gorman, 1986). The 
second method gave a higher yield of plasmid because a richer 
medium was used for bacterial growth and a gentler method was 
used for bacterial cell lysis. 
The purified plasmid vector was complexed to either native LDL or 
ECDI - LDL. The LDL - pSV2cat and ECDl - LDL - pSV2cat complexes 
were subsequently applied to cells in culture to carry out transfec -
tions by LDL receptor - mediated endocytosis. Of all the cell 
lines used, human skin fibroblasts and CV - 1 cells showed the 
lowest efficiency of transfection and were barely detectable by 
autoradiography. Fetal fibroblasts and HeLa cell extracts of 
the low density lipoprotein - pSV2cat transfected cells assayed 
for CAT activity showed a greater amount of acetylated (chlorampheni-
col) products. The highest amount of acetylation occurred in 
human lung fibroblasts transfected with LDL - pSV2cat and ECDl - LDL-
pSV2cat complexes. In all experiments, 10 f g ct DNA was added 
to all 25 cm2 flasks prior to transfections, to guard against 
entry of pSV2cat DNA by processes other than LDL receptor -
mediated endocytosis. 
Since DNA controls showed no acetylated products, the lipoprotein -
DNA complexes were assumed to bind to LDL receptors on the plasma 
membrane and internalize by LDL receptor - mediated endocytosis. 
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Lipoprotein - DNA complexes were shown to be successfully internalized 
by LDL receptor - mediated endocytosis in Chapter 3. Degradation 
products of both LDL and DNA were indicative of internalization by 
LDL receptor mediation and subsequent lysosomal degradation. The 
internalization of LDL - pSV2cat and ECDI - LDL - pSV2cat complexes 
by LDL receptor mediation is also subject to a similar fate. However, 
some DNA probably escapes lysosomal degradation and is subsequently 
expressed. Since the pSV2cat recombinant contains a eukaryotic 
SV 40 promoter (Gorman et al ., 1982 ), it can induce eukaryotic 
cellular mechanisms to express the foreign gene, albeit transiently. 
Thus successful transfection of pSV2cat could be assayed by the 
expression of the CAT enzyme. However, when compared with the 
calcium phosphate - DNA coprecipitation method, the efficiency of 
transfection was low in the cell lines used. Human lung fibroblasts 
showed the highest efficiency of transfection from all cell lines 
used to study transfections by LDL receptor - mediated endocytosis. 
Differences in efficiencies of transfection thus could be a function 
of cell selectivity. Nevertheless, the pSV2cat DNA was able to 
escape lysosomal degradation to some extent and induce expression 
in normal human cell lines. 
The CAT gene has been utilized also in expression vectors containing the 
a - gonadotropin gene (Darnell and Boime, 1985). Transfection of 
the a~ gonadotropin gene was thus monitored in placental and tumour 
cells by the expression of the linked CAT gene. In the placental cells 
transfection efficiency was 10 - fold higher than in tumour cells. 
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However, in these and other cell lines transcript i on was enhanced or 
induced by either cAMP or butyrate, and the method of transfection 
was the calcium phosphate - DNA technique (Darnell and Boime, 1985; 
Gorman .'et aI. , 1983; Gorman,1986). In addition to using the 
SV 40 tandem repeat sequences as eukaryotic enhancers of transcription,
 
other plasmid constructs expressing the CAT gene have made use of 
the Malony murine sarcoma virus (MSV) enhancers (Laimins et al ., 1982),
 
Rous sarcoma virus (RSV) long terminal repeats (Burke and Mogg, 1985; 
Gorman et al .,1982), Adenovirus type 12 (Ad 12) promoters (Kruckzek 
and Doerfler, 1983), or HSV promoters (McLaughlan et al ., 1985) for 
expression of CAT activity in eukaryotic cells. Transfection by 
the above plasmid constructs has been carried out in CV - 1 monkey 
kidney cells, HeLa cells, placental cells, LMTK mouse cells, NIH 
3T3 mouse cells, CHO cells and MEFC mouse cells, and expression 
has been detected by assays for CAT activity. 
McLauchlan and coworkers (1985) have used plasmid constructs with 
the CAT gene linked to an HSV terminator fragment to study the 
effects of deletions on CAT activity, in HeLa cells and to 
identify consensus sequences in the eukaryotic mRNA. The authors 
have been able to show that the -YGTGTTYY- (Y = pyrimidine) 
sequence is essential for efficient formation of mRNA 3' - termini. 
amb38 
The pRSVcat vector has been used to quantitate amber expression 
in various mammalian cells (Burke and Mogg, 1985). Suppressor tRNA 
does not occur naturally in mammalian cells and its successful 
introduction into mammalian cells was monitored by assaying for 
254 
REFERENCES 
ARKIGG, A., GARDNER, S. D. and GREENAWA~ P. J. (1981), J. Gen. 
Virol., 55,247. 
ALADJEM, F. (1966), Nature, 209, 1003. 
ALAUPOVIC, P. (1981), Advances in Physiological Sciences, 35, 3. 
ALAUPOVIC, P., LEE, D. M. and Mc CONATHY, W. J. (1972), Biochim. 
Biophys. Acta, 260, 689. 
ALBERS, J. J. and CHEUNG, M. C. (1979), In Report of the high density 
lipoprotein methodology workshop. Ed. K. Lippel. NIH publ., no. 82 -
1661, pp. 252 - 265. U. S. Dept. of Human Services, Bethesda. 
ALDEN, C. J. and KIM, S- H. (1979), in Stereodynamics of Molecular 
Systems. Ed. R. H. Sarma , pp. 331 - 350. Pergamon press, New York. 
ALWINE, J. C., KEMP, D. J. and STARK, G. R. (1977), Proc. Natl. Acad. 
Sci. U.S.A., 74, 5350. 
ANDERSON, R. G. W., BROWN, M. S. and GOLDSTEIN, J. L.(1981), J. Cell. 
B i 0 1 ., 88, 441. 
ANDERSON, M. L. M. and YOUNG, B. D. (1985), in Nucleic Acid 
Hybridization, a practical approach. Ed. B. D. Hames and S. J. 
Higgins , pp. 73 - 111. IRL Press, Oxford. 
ANDERSON, W. F., KILLOS, L., SANDERS - HAIGH, L.,KRETSCHMER, P. J. 
and DIACUMAKOS, E. G. (1980), Proc. Natl. Acad. Sci. U.S.A., 77, 
5399. 
ARIATTI, M., HAWTREY, R., KHAN, Z. and HAWTREY, A. O. (1986), IRCS 
Med. Sc i., ..!i, 382. 
254 
REFERENCES 
ARKIGG, A., GARDNER, S. D. and GREENAWA~ P. J. (1981), J. Gen. 
V i ro 1 ., 55, 247. 
ALADJEM, F. (1966), Nature, 209, 1003. 
ALAUPOVIC, P. (1981), Advances in Physiological Sciences, 35, 3. 
ALAUPOVIC, P., LEE, D. M. and Mc CONATHY, W. J. (1972), Biochim. 
Biophys. Acta, 260, 689. 
ALBERS, J. J. and CHEUNG, M. C. (1979), In Report of the high density 
lipoprotein methodology workshop. Ed. K. Lippel. NIH publ., no. 82 -
1661, pp. 252 - 265. U. S. Dept. of Human Services, Bethesda. 
ALDEN, C. J. and KIM, S- H. (1979), in Stereodynamics of Molecular 
Systems. Ed. R. H. Sarma , pp. 331 - 350. Pergamon press, New York. 
ALWINE, J. C., KEMP, D. J. and STARK, G. R. (1977), Proc. Natl. Acad. 
Sci. U.S.A., 74, 5350. 
ANDERSON, R. G. W., BROWN, M. S. and GOLDSTEIN, J. L.(1981), J. Cell. 
B i 0 1 ., 88, 441. 
ANDERSON, M. L. M. and YOUNG, B. D. (1985), in Nucleic Acid 
Hybridization, a practical approach. Ed. B. D. Hames and S. J. 
Higgins , pp. 73 - 111. IRL Press, Oxford. 
ANDERSON, W. F., KILLOS, L., SANDERS - HAIGH, L.,KRETSCHMER, P. J. 
and DIACUMAKOS, E. G. (1980), Proc. Natl. Acad. Sci. U.S.A., 77, 
5399. 
ARIATTI, M., HAWTREY, R., KHAN, Z. and HAWTREY, A. O. (1986), IRCS 
Med. Sc i ., 14, 382. 
255 
ARRAND, J. E. (1985), in Nucleic Acid Hybridization, a practical 
approach. Ed. B.O. Hames and S.J. Higgins, pp. 17 - 45. IRL Press, 
Oxford. 
ASSMANN, G. and JABS, H-U. (1985), Biochem. Soc. Trans., 1i, 19. 
AULINSKAS, T. H., van der WESTHUYZEN, D. and COETZEE, G. A. (1983), 
Artherosclerosis, 47, 159. 
BACHORIK, P. S. (1979), in Report of the high density lipoprotein 
Methodology Workshop. Ed. K. Lippel. NIH Publication no. 82 - 1661, 
pp. 164 - 166. U.S. Dept. of Human Services, Bethesda. 
BARRETT, A. J. (1984), Biochem. Soc. Trans., 12,899. 
BARTLETT, G. R. (1959), J. Biol. Chem., 234, 466. 
BASU, S. K., GOLDSTEIN, J. L., ANDERSON, R. G. W. and BROWN, ~1. S. 
(1976), Proc. Natl. Acad. Sci. U.S.A., 73, 3178. 
BEATTIE, D. S., CLEJAN, L. and BOSCH, C. G. (1984), J. Bio1. Chem., 
259, 10526. 
BEISIEGEL, U., SCHNEIDER, W. J. S., BROWN, M. S. and GOLDSTEIN, J. l. 
(1982), J. Bio1. Chem., 257, 13150. 
BEISIEGEL, U., SCHNEIDER, W. J., GOLDSTEIN, J. -L., ANDERSON, R. G. W. 
and BROWN, M. S. (1981), J. 8io1. Chem., 256,11923. 
BELL, F. P. (197~), in Low Density Lipoproteins. Ed. C.E. Day and 
R.S. Levy. pp. 111 - 133. Plenum Press, New York. 
BENOIST, C. and CHAMBON, P. (1981), Nature, 290, 304. 
BERMAN H. M. and NEIOLE, S. (1979), in Stereodynamics of 
Molecular Systems. Ed. R.H. Sarma, pp. 376 - 382. Pergamon Press, N.Y . .. 
256 
BERNFELD, P. (1958), in The Lipopro
teins: Methods and Clinical 
Significance. Ed. F. Homburger and 
P. Bernfeld, pp. 24 - 36. S. 
Karger, Basle. 
BERNFELD, P., DONAHUE, V. M. and BERK
OWITZ, M. E.(1957), J. Biol. 
Chem., 22, 51. 
BESTERMANN, J. M. and LOW, R. B. (19
83), Biochem. J., 210, 1. 
BIERMAN, E. L., STEIN, O. and YECHE
ZKIEL, S. (1974), Circ. Res., 35, 
136. 
BILHEIMER, D. W., EISENBERG, S. and 
LEVY, R. I. (1972), Biochimica et 
Biophysica Acta, 260, 212. 
BLIGHT, E. G. and DYER, W. J. (1959
), Can. J. Biochem. Physio., E, 
911. 
BOLIVAR, F., RODRIGUEZ, R. L., GREEN
E, P. J., BETLACH, M. C., 
HEYNEKER, H. L., BOYER, H. W., CROSA
, J. H. and FALKOW, S. (1977), 
Gene, 2, 95. 
BRADLEY, W. A., HWANG, S-L. C., KAR
LIN, J. B., LIN A. H. Y., PRASAD, 
S. C., 6OTTO Jr., A. M. and GIANTURC
O, S. H. (1984), J. Biol. Chem., 
259, 14728. 
BRAGDON, J. H., HAVEL, R. J. and BOY
LE, E. (1956), J. Lab. Clin. Med., 
48, 36. 
BRISETTE, L. and NOEL, S-P. (1986), 
J. Biol. Chem., 261,6847. 
BROWN, M. S., ANDERSON, R. G. W. and
 GOLDSTEIN, J. L. (1983), Cell, 
32, 663. 
BROWN, M. S., DANA, S. E. and GOLDS
TEIN, J. L. (1974), J. Biol. 
Chem., 249, 789. 
257 
BROWN, M. S., DANA, S. E. and GOLDSTEIN, J. L. (1973), Proc. Natl. 
Acad. Sci., U.S.A., 70, 2162. 
BROWN M. S., DANA, S. E. and GOLDSTEIN, J. L. (1975a), J. Biol. 
Chem., 250, 4025. 
BROWN, M. S., DANA, S. E. and GOLDSTEIN, J. L. (1975b), Proc. Natl. 
Acad. Sci., 72, 2925. 
BROWN, M. S., FAUST, J. R. and GOLDSTEIN, J. L. (1975c), J. Clin. 
Invest., 55, 783. 
BROWN, M. S. and GOLDSTEIN, J. L. (1974a), Proc. Natl. Acad. Sci., USA 
71, 788. 
BROWN, M. S. and GOLDSTEIN, J. L. (1974b), J. Bio1. Chem., 249, 7306. 
BROWN, M. S. and GOLDSTEIN, J. L. (1975), Cell, 6, 307. 
BROWN, M. S. and GOLDSTEIN, J. L. ( 1976a ) , Science, 191, 150. 
BROWN, M. S. and GOLDSTEIN, J. L. (1976b), Ce11,9,663. 
BROWN, M. S. and GOLDSTEIN, J. L (1979), Proc. Natl. Acad. Sci., 76, 
3330. 
BROWN, M. S. and GOLDSTEIN, J. L. (1984), Scientific Amer., 
251,52. 
BROWN, M. S., SOBHANI, M. K., BRUNSCHEDE, G. Y. and GOLDSTEIN, J. L. 
(1976), J. Bio1. Chem., 251, 3277. 
BROWN, D. D. and STERN, R. (1974), Ann. Rev. Biochem., 43, 667. 
BURKE, J. F. and MOGG, A. E. (1985), Nucl. Acids Res., 13, 1317. 
BURNSTEIN, M. and SCHOLNICK, H. R. (1974), Nouv. Rev. Franc. 
d'H~matol., 14, 131. 
258 
BURNSTEIN, M., SCHOLNICK, H. R. and MORFIN, R. (1970), J. Lipid 
Res., 11, 583. 
CAPECCHI, M. R. (1980), Cell, 22, 479. 
CARDIN, A. D., l~ITT, K. R., BARNHART, C. L. and JACKSON, R. L. (1982), 
Biochemistry, ~, 4503. 
CARDIN, A. D., WITT, K. R., CHAO, J., MARGOLIUS, H. S., DONALDSON, 
V. H. and JACKSON, R. L. (1984), J. Bio1. Chem., 259, 8522. 
CARROLL, R. M. and RUDEL, L. L. (1983), J. Lipid Res., 24, 200. 
CAWLEY, L. P. and MINARD, B. (1969), Lab. Synopsis (Behring),~, 56. 
CELIS, J. E. (1984), Biochem. J., 223, 281. 
CELlS, J. E., KALTOFT, K. and BRAVO, R. (1980), in Introduction of 
Macromolecules into viable mammalian cells. Ed. Baserga, R.,Croce, C. 
and Rovera, G., pp . 99 - 123. Alan R. Liss, New York. 
CHAIT, A., BIERMAN, E. L. and ALBERS, J . J. (1979), Diabetes, 28, 914. 
CHAt~, L., WEI, C-F., LI, W-H., YANG, C-Y., RATNER, P., POWNALL, H., 
GOTTO, A. M. Jr. and SMITH, L.C. (1985), J. Biol. Chem., 260, 2629. 
CHAPMAN, D. (1973), in Form and Function of Phospholipids. Ed. 
Ansell, G.B., Dawson, R.M.C. and Hawthorne, J.N., pp. 117 - 142. 
Elsevier Scientific Publishing Co., Amsterdam. 
CHEN, H. W., HEINIGER, H. and KANDUTSCH, A. A. (1975), Proc. Natl. 
Acad . Sci., U.S.A., 72, 1950. 
) 
CHEN, P. 5., TORIBARA, T. Y. Jr. and WARNER, H. (1956), Anal. Chem., 
28, 1756. 
259 
CHU, G. and SHARPE, P. A. (1981), Gene, 13, 197. 
CHUNG, B. H., WILKINSON, T., GEER, J. C. and SEGREST, J. P. (1980), 
J. Lipid Res., ~, 284. 
COHEN, S., CHANG, A., BOYER, H. and HELLIG, R. (1973), Prac. Natl. 
Acad. Sci., U.S.A., 70, 3240. 
COLBERE - GARAPIN, F., HORODNICEANU, F., KOURILSKY, P. and GARAPIN, 
A - C. (1 981 ) , J. Mo 1. B i 01 ., 1 50, 1. 
COLEMAN, R. (1973), in Form and Function of Phospholipids. Ed. Ansell, 
G. B., Dawsan, R.M.C. and Hawthorne, J.N., pp. 345 - 375. Elsevier 
Scientific Publishing Co., Amsterdam. 
CORNWELL, D. G. and KRUGER F. A .. (1961), J. Lipid Res.,~, 110. 
CRYER, A. (1985), Biachem. Soc. Trans., 13,27. 
CUATRECASAS, P. (1974), Ann. Rev. Biachem., 43, 169. 
DAILEY, H. A. and STRITTMATTER, P. (1979), J. Biol. Chem., 254, 5388. 
DANA, S. F., BROWN, M. S. and GOLDSTEIN. J. L. (1977), Biochem. 
Biaphys. Res. Comm., 74, 1369. 
DARNELL, R. B. and BOIME, I. (1985), Mol. Cell Bia1., ~, 3157. 
DAVIS, R. A. and MALONE - MC NEAL, M. (1985), Biachem. J., 227, 29. 
DAWSON, G., KRUSKI, A. W. and SCANU, A. M. (1976), J. Lipid Res., 
17,125.' 
DEAN, R. T. (1984), Biachem. Soc. Trans., 12,911. 
DEAN, R. T., JESSUP, W. and ROBERTS, C. R. (1984), Biachem. J., 
217, 27. 
260 
DECKELBAUM, R. J., SHIPLEY, G.G. and SMALL, D. M. (1977), J. Biol. 
Chem., 252, 744. 
DEMPSEY, M. E. (1974), Ann. Rev. Biochem., 43, 967. 
De PAMPHILIS, M. L. and WASSARMAN, P.M. (1980), Ann. Rev. Biochem., 
49, 627. 
DEVOS, R., VAN EMMELO, J., CONTRERAS, R. and FIERS, W. (1979), J. 
Mol. Biol., 128,595. 
DIACUMAKOS, E. G. (1980), in Introduction of Macromolecules into 
Viable Mammalian cells. Ed. Baserga, R., Croce, C. and Rovera, G., 
pp. 85 - 98. Alan Liss Inc., New York. 
DICKSON, R., ABELSON, J., BARNES, W. and REZNIKOFF, W. (1975), 
Science, 187,27. 
DOBROTA, M. and HINTON, R. H. (1984), Biochem. Soc. Trans., 12, 1021. 
DONOVAN, J. J., SIMON, M. I., DRAPER, R. K. and MONTAL, M. (1981), 
Proc. Natl. Acad. Sci., U.S.A., 78, 172. 
DRlKAMER, K. (1981), J. Biol. Chem., 256,5827. 
DRlKAMER, K. and MAMON, J. F. (1982), J. Biol. Chem., 257,15156. 
DUBENSKY, T. W., CAMPBELL, B. A. and VILLARREAL, L. P. (1984), Proc. 
Natl. Acad. Sc;., U.S.A., 81 , 7529. 
DUGIACZYK, A., BOYER, H. W. and GOODMAN, H. M. (1975), J. Mol. 
B; 01., 96, 1 71. 
DUNCAN, R., KOPECEK. J. and LLOYD, J. B. (1984), Biochem. Soc. Trans., 
.1.£, 913. 
261 
DUNN, W. A., HUBBARD, A. L. and ARONSON, N. N. Jr. (1980), J. Biol. 
Chem., 255,5971. 
'. 
EDELSTEIN, c. (1979), in Report of the High density Lipoprotein 
Methodology Workshop. Ed. K. Lippel. NIH pulication, no. 82 - 1661, 
pp. 325 - 327. U.S. Dept. of Human Services, Bethesda. 
EFSTRADIADIS, A., KAFATOS, F. C., MAXAM, A. M. and MANIATIS, T. (1976), 
Cell, 7, 278. 
ENQUIST, L. W., VAN DE WOUDE, G. F., WAGNER, M., SMILEY, J. R. and 
SUMMERS, W. C. (1979), Gene, 7,335. 
FAUST, J. R., GOLDSTEIN, J. L. and BROWN, M. S. (1977), J. Biol. Chem., 
252,4861. 
FEINBERG~ A. P. and VOGELSTEIN, B. (1983), Anal. Biochem., 132,6. 
FELLIN, R., AGNOSTINI, B., ROST, W. and SEIDEL, D. (1974), Clin. 
Chim. Acta., 54, 325. 
FIERS, W., CONTRERAS, R., DUERINCK, F., HAEGEMAN, G., ISERENTANT, D., 
MERREGAERT, J., MINJOU, W., MOLEMANS, F., RAEYMAEKERS, A., BERGHE, V., 
VOLCKAERT, G. and YSEBAERT, B. (1976), Nature, 260,500. 
FINEAN, J. B. (1973), in Form and Function of Phospholipids. 
Ed. Ansell, G.B., Dawson, R.M.C. and Hawthorne, J.N., pp. 171 - 203. 
Elsevier Publishing Co., Amsterdam. 
FISKE, C. H. and Subbarow, Y. (1925), J. Bio1. Chem., 66, 375. 
FLESS, G. M., ROLIH, C. A. and SCANU, A. M. (1984), J. Bio1. Chem., 
259, 11470. 
FONG, B. S., RODRIGUES, P. O. and ANGEL, A. (1984), J. Bio1. Chem., 
259, 10168. 
262 
FOREMAN, J. R., KARLIN, J. B., EDELSTEIN, C., JUHN, D. J., RUBENSTEIN, 
A. H. and SCANU, A. M. (1977), J. Lipid Res., ~, 759. 
FRAENKEL - CONRAT, H. (1957), Methods in Enzymology, ±, 247. 
FREDRICKSON, D. S., LEVY, R. I. and LEES, R. S. (1967a), New 
England J. ~1ed., 276, 34. 
FREDRICKSON, D. S., LEVY, R. I. and LEES, R. S. (1967b), New 
England J. ~led., 276, 94. 
FREDRICKSON, D. S., LEVY, R. I. and LEES, R. S. (1967c), New 
England J. Med., 276, 148. 
FREDRICKSON, D. S., LEVY, R. I. and LEES, R. S. (1967d), New 
England J. Med., 276, 215. 
FREDRICKSON, 0.5., LEVY, R. I. and LEES, R. S. (1967e), New 
England J. Med., 276, 273. 
FRESHNEY, R. I. (Ed.). (1986), Animal Cell Culture - A Practical 
Approach. IRL Press, Oxford. 
FRIEFELDER, D. (1982), Physical Biochemistry: Application to 
Biocher.1istry and Molecular Biology. W. H. Freeman and Co., San 
Franscicso. 
GALTON, D. J., STOCKS, J. and REES, A. (1985), Biochem. Soc. Trans., 
13, 31. 
GASSER, C. S. and SCHIMKE, R. T. (1986), J. Bio1. Chem., 261, 6938. 
GEFTER, M. L. (1975), Ann. Rev. Biochem., 44, 45. 
GEREN, L. M., O~BRIEN, P., STONEHUERNER, J. and MILLET, F. (1984), 
J. Biol. Chem. ,259, 2155. 
263 
GHOSH, S. (1976), in Low density Lipoproteins. Ed. Day, C.E. and 
Levy, R.S., pp. 371 - 419. Plenum Press, New York. 
GIDEZ, ~. 1., MILLER, G. J., BURNSTEIN, M. and EDER, H. A. (1979), 
in Report of the High Density Lipoprotein Methodology Workshop, ed. 
Lippel, K. NIH Publication, no. 82 - 1661, p 328. U.S. Oert. of 
Health and Human Services, Bethesda. 
GLASS, E. (1982), Gene Function.: E. coli and its Heritable Elements. 
Croom Helm Ltd., London. 
GLOMSET, J. (1969), Meth. Enzymol., E' 543. 
GOOFREY, W., DOE. B. and WOFSY. L. (1983), Proc. Natl. Acad. Sci., 
, U. S. A., 80, 2267. 
GOEDDEL, D. V., HEYNEKER, H. L., HOZUMI, T., ARENTZEN, R., ITAKURA, K., 
YANSURA, O. G., ROSS, M. J., MIOZZARI, G., CREA, R. and SEEBURG, P. H. 
(1979), Nature, 281, 544. 
GOFMAN, J. W. (1958), in The Lipoproteins : Methods and Clinical 
Significance. Ed. Homburger, F. and Bernfeld, P., pp. 47 - 70. 
S. Karger, Basle. 
GOLDSTEIN, J. L., BASU, S. K., BRUNSCHEDE, G. Y. and BROWN, M. S. 
( 1976) , Ce 11, 7, 85. 
GOLOSTEIN, J. L. and BROWN, M. S. (1974), J. Biol. Chem., 249, 5153. 
GOLOSTEIN, J. L. and BROWN, M. S. (1977), Ann. Rev. Biochem., 46, 897. 
GOLOSTEIN, J. L., OANA, S. E., FAUST, J. R., BEAUOET, A. L. and 
BROWN, M. S. (1975), J. Bio1. Chem., 250,8487. 
GOLDSTEIN, J. L., HELGESON, J. A. S. and BROWN, M~ S. (1979a), Ann. 
Rev. Biochem., 254, 5403. 
264 
GOLDSTEIN, J. L., HO, Y. K., BASU, S. K. and BROWN, M. S. (1979b), 
Proe. Natl. Aead. Sci., U.S.A, 76, 333. 
GOLOFARB, D. S., RODRIGUEZ, R. L. and oor, R. H. (1982), Proc. Natl. 
Acad. Sei., U.S.A . , 79, 5886. 
GORDHAN, H., ARIATTI, M. and HAWTREY, A. O. (1986), IRCS Med. Sci., 
14, 1118. 
GORMAN, C. (1986), in DNA cloning, a practical approach, vol 11. Ed. 
Glover, D.M., pp. 143 - 190. IRL Press, Oxford. 
GORMAN, C. M., HOWARD, B. H. and REEVES, R. (1983), / Nucl. Acids Res., 
11,7631. 
GORMAN, C. M., MERLINO, G. T., WILLINGHAM, M. C., PASfAN, I. and 
HOWARD, B. H. (1982a), Proc. Natl. Acad. Sci . , U.S.A, 79,6777. 
GORMAN, C. M., MOFFAT, L. F. and HOWARD, B. H. (1982b}, Mol. Cell 
Bio1., 2; 1044. 
GOT TO , A. M., LEVY, R. I., LINGRED, F. T. and FREDERICKSON, O. S. (1969), 
Biochim. Biophys. Acta, 176,667. 
GRAESSMANN, A., GRAESSMANN, M. and MUELLER, C. (1980), Methods 
Enzymol., 65, 816. · 
GRAESSMANN, M. and GRAESSMANN, A. (1976), Proc. Natl. Aead. Sci., 73, 
366. 
GRAESSMANN, M. and GRAESSMANN, A. (1983), Methods Enzymol., lQl. 484. 
GRAHAM, F. L., BACHETTI, S., Mc KINNON, R., STANNERS, C., CORDELL, B. 
and GOODMAN, H. M. (1980), in Introduction of Macromolecules into 
Viable Mammalian Cells. Ed. Baserga, R., Croce, C. and Rovera, G., 
pp. 3 - 25. Alan R. Liss Inc., New York. 
265 
GRAHAM, F. L. and van der EB, A. J. (1973), Virology, 52, 456. 
GRUSS, P., DHAR, R. and KHOURY, G. (1981), Proc. Natl. Acad. Sci., 
U.S.A., 78, 943. 
GUSTAFSON, A. (1965), J. Lipid Res.,~, 512. 
HABERLAND, M. E., OLCH, C. L. and FQLGELMAN, A. M. (1984), J. Biol. 
Chem., 259,11305. 
HANIG, M. (1958), in The Lipoproteins : Methods and Clinical 
Significance. Ed. Homburger, F. and Bernfeld, P., pp. 71- 74. 
S. Karger, Basle. 
HARDY, E. (1981), Bacterial Plasmids. Thomas Nelson and Sons, 
Hong Kong. 
HARDY, K. G. (1986), in DNA Cloning Vol. 11. Ed. Glover, D.M., pp. 
1 - 17. IRL Press, Oxford. 
HARIKUMAR, P. and REEVES, J. P. (1984), Biochem. Soc. Trans., 12, 906. 
HARLEY, E. H., OLLIVER, C. L., RHODES-HARRISON, L., MEW, R. T., 
LECATSAS, G. and NAUDE, W. duT. (1982), S.A.J. Sci., 78, 112. 
HATCH, F. T. and LEES, R.S. (1968), Adv. Lipid Res.,~, 1. 
HAVEL, R. J., EDER, H. A. and BRAGDON, J. H. (1955), J. Clin. Invest., 
34, 1345. 
HAWTREY, R., ARIATTI, M. and HA\OJTREY A. O. (1986), IRCS Med. Sci., 
14, 380. 
HELENIUS, A. and SIMONS, K. (1971), Biochemistry, lQ, 2542. 
HINKLE, D. C. and tHAMBERLIN, M. J. (1972), J. Mol. Biol., 70, 157. 
266 
HINTON, O. M., BAEZ, J. A. and GUMPORT, R. I. (1978), Biochem., 
17, 5091. 
HINTON, O. M., BRENNAN, C. A. and GUMPORT, R. I. (1982), Nucleic 
Acids Res., 10, 1877. 
HINTON, R. H., KOWALSKI, A. J. and MALLINSON, A. (1973), Clin. Chim. 
Acta., 44, 267. 
HOLLEY, R. W. (1966), Sci. Amer., 214, 30. 
HOMBERGER, F. and BERNFELO, P. (Ed.) (1958), T~e Lipoproteins : 
Methods and Clinical Significance. Buchdruckerei Ludin A.G., Basle. 
HUCKETT, B., GOROHAN, H., HAWTREY, R., MOOOLEY, N, ARIATTI, M. and 
HAWTREY, A. O. (1986), Biochem. Pharmacol., 35, 1249. 
HUT, O. Y., INNERARITY, T. L., MILNE, R. W., MARCEL, Y. L. and 
MAHLEY, R. W. (1984), J. Bio1. Chem., 259,15060. 
HUMPHREYS, G. 0., WILLSHAW, G. A. and ANOERSON, E. S. (1975), Biochim. 
Biophys. Acta., 383, 457. 
HUTCHISON, N. J., LANGER-SAFER, P. R., WARD, D. C. and HAMKALO, B. A. 
(1982), J. Cell Bio1., 95,609. 
ITAYA, K. and UI, M. (1966), Clin. Chim. Acta., 14,361. 
JANSEN, H. and HULSMANN, W. c. (1985), Biochem. Soc. Trans., 
13, 24. 
JAY, E., SETH, A. K., ROMMENS, J., SO~O, A. and JAY, G. (1982), 
Nucleic Acids Res., iQ, 6319. 
JOHNSON, A. D., PABO, C. O. and SAHER, R. T. (1980), Methods 
Enzymol., 65, 839. 
267 
KABARA, J. J. (1962), Methods Biochem. Anal.,.1.Q., 263. 
KANE, J. P. (1973), Anal. Bioehem., g, 350. 
KARLSSON, S., HUMPHRIES, R. K., GLUZMAN, Y. and NIEHUIS, A. W. 
(1985), Proc. Natl. Aead. Sei., U.S.A., 82,158. 
KASUGA, M., ZICK, Y., BLITH, D. L., KARLSSON, F. A., HARING, H. U. 
and KAHN, C. R. (1982), J. Biol. Chem., 257, 9891. 
KELLY, T. J. Jr. and SMITH, H. O. (1970), J. Mo1. Bio1., 51, 393. 
KESSLER, C., NEUMAIER, P. S. and WOLF, W. (1985), Gene, 33, 1. 
KHORANA, H. G. (1961), Some Recent Developments in the Chemistry of 
Phosphate esters of Biological interest. John Wiley and Sons, Inc, 
New York. 
KHORANA, H. G. (1978), Bioorganic Chemistry, I, 351. 
KINGSLEY, D. M. and KRIEGER, M. (1984), Proc. Natl. Aead. Sei., 
81, 5454. 
KIRSTEN, E. S. and WATSON, J. A. (1974), J. Biol. Chem., 249, 6104. 
KOLATA, G. (1984) ', Science, 223, 1376. ' 
KORN, E. D. (1955), J. Biol. Chem., 215, 1. 
KOSTNER, G. M. and LAGGNER, P. (1979), in Report of the High Density 
" 
Lipoprotein Methodology Workshop. Ed. Lippel, K. NIH Publication, 
pp. 343 - 355. U. S. Dept. of HUman Serv ices, Bethesda. 
KOVANEN, P. T., BROWN, M. S. and GOLDSTEIN, J. L. (1979), J. Biol. 
Chem., 254, 11367. 
KRIEGER, M., BROWN, M. S., FAUST, J. R. and GOLDSTEIN, J. L. (1978a), 
J. Biol. Chem., 253, 4093. 
268 
KRIEGER, M., GOLDSTEIN, J. L. and BROWN, M. s. (1978b), Proc. Natl. 
Acad. Sci., U.S.A., ~, 5052. 
KREIGER, M., SMITH, L.C., ANDERSON, R. G. W., GOLDSTEIN, J. L., 
KAO, Y. J., POWNALL, H. J., GOTTO, A. M. Jr. and BROWN, M. S. (1979), 
J. Supramol. Structure, lQ, 467. 
KRUCZEK, I. and DOERFLER, W. (1983), Proc. Natl. Acad. Sci., 80, 7586. 
LAGGNER, P. (1976), in Low Density Lipoproteins. Ed. Day, C.E. and 
Levy, R.S. Plenum Press, New York, pp 49 - 69. 
LAIMINS, L. A., KHOURY, G., GORMAN, C., HOWARD, B. and GRUSS, P. 
(1982), Proc. Natl. Acad. Sc;', U.S.A., 79, 6453. 
LAMBETH, J. D., GEREN, L. M. and MILLETT, F. (1984), J. Biol. Chem., 
259, 10025. 
LEE, A. G. (1977), Biochim. Biophys. Acta., 472,285. 
LEE, D. M. (1976), in Low Density Lipoproteins. Ed. Day, C.E. and 
Levy, R.S., pp. 3 - 47. Plenum Press, New York. 
LEE, D. M. and ALAUPOVIC, P. (1974a), Biochem. J., 137, 155. 
LEE, D. M. and ALAUPOVIC, P. (1974b), Atherosclerosis, 19, 501. 
LEES, R. S. and HATCH, F. T. (1963), J. Lab. Clin. Med., 61, 518. 
LEHNINGER, A. L. (1975), Biochemistry: the Molecular Basis of Cell 
Structure and Function, pp. 290 - 291. Worth Publishers Inc., New York. 
Le PECQ, J-B. (1971), Methods of Biochem. Analysis, pp. 41 - 86. 
Ed. Glick, D. John Wiley and Sons Inc., New York. 
lICHTENSTEIN, C. and DRAPER, J. (1986), in DNA Cloning, Vol 11, ed. 
Glover, D.M., pp 67 - 119. IRl Press, Oxford. 
269 
LINDGREN, F. T., JENSEN, L. C. and HATCH, F. T. (1972), in Blood 
Lipids and Lipoproteins : Quantitation, Composition and Metabolism~ 
ed. Nelson, G.J., pp. 181 - 274. John Wiley and Sons, New York. 
LITTLEFIELD, J. (1974), Science, 145, 709. 
LOBBAN, P. and KAISER, A. D. (1973), J. Mol. Biol., 79, 453. 
LOWY, I . , PELLICER, A., JACKSON, J. F., SIM, G-K, SILVERSTEIN, S. and 
AXEL, R. (1980), Cell, 22, 817. 
LOWRY, o. H., ROSEBROUGH, N. J., FARR, L. A. and RANDALL,R. J. (1951), 
J. Biol. Chem., 193, 265. 
LOYTER, A., VAINSTAIN, A., GRAESSMANN, M. and GRAESSMANN,A. (1983), 
Exp . Cell Res . , 143, 415. 
LOYTER, A., ZAKAI, N. and KULKA, R. G. (1975), J. Cell Biol., 66, 292. 
MACKETT, M., SMITH, G. L. and MOSS, B. (1986), in DNA Cloning: Vol. II, 
ed. Glover, D.M., pp. 191 - 211. IRL Press, Oxford. 
MAHLEY, R. W. and WEISGRABER, K. H. (1979), in Report of the 
High Density Lipoprotein Methodology Workshop, ed. Lippel, K.,NIH 
Publication no. 82 - 1661, pp. 356 - 367. U.5. Dept. of Human 
Services, Bethesda. 
MAIZELS, N. M. (1973), Proc. Natl. Acad. Sci., 70, 3585. 
MANIATIS, T., FRITSCH, E. F. and SAMBROOK, J. (1982), in Molecular 
Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, 
Cold Spring, New York. 
MANIATIS, T., PTASHNE w M., BARRELL, B. G., and DONELSON, J. (1974), 
Nature, 250, 394. 
( 
270 
MANN, G. V. (1958), in The Lipoproteins : Methods and Clinical 
Significance, ed. Homburger, F. and Bernfeld, P., pp. 7 - 13. 
S. Karger, Basle. 
MANN, G. V. (1961), Clin. Chem., 7, 275. 
MANUELIDIS, L., LANGER - SAFER, P. R. and WARD, D. C. (1982), J. Cell 
Biol., 95, 619. 
MARGOLIS, S. and CAPUZZI, D. (1972), in Blood Lipids and Lipoproteins: 
Quantitation, Composition and Metabolism, ed. Nelson, G.J., pp. 825-880. 
John Wiley and Sons Inc., New York. 
MARKWELL, M. A. K., HAAS, S. M., TOLBERT, N. E. and BIEBER, L. L. 
(1981), Methods Enzymol., Z£, 296. 
MASON, P. J. and WILLIAMS, J. G. (1985), in Nucleic Acid Hybridization, 
a Practical Approach. Ed. Hames, B.O. and Higgins, S.J., pp. 113 - 117. 
IRL Press, Oxford. 
MAXAM, A. M. and GILBERT, W. (1977), Proc. Natl. Acad. Sci., 74, 560. 
MAZZONE, T. and CHAIT, A. (1982), Arteriosclerosis, 2, 487. 
Mc FARLANE, A. S. (1958), Nature, 158, 53. 
M~ LAUCHLAN, J., GAFFNEY, D., WHITTON, J. L. and CLEMENTS, J. B. 
(1985), Nucl. Acids Res., 13, 1347. 
MERTZ, J. E. and DAVIS, R. W. (1972), Proc. Natl. Acad. Sci.,U.S.A., 
69, 3370. 
MILLER, A. D., ECKNER, R. J., JOLLY, D. J., FRIEDMANN, T. and 
VERMA, I. M. (1984), Science, 223, 630. 
271 
MILLET, F., de JONG, C., PAULSON, L. and CAPALDI, R. A. (1983), 
Biochemistry, 22, 546. 
MILLET, F., DARLEY-USMAR, V. and CAPALDI, R. A. (1982), Biochemistry, 
21, 3857. 
MOKRASCH, L. C. (1975) , Methods Enzymo 1 ., ~, 334. 
MONAHAN, J. J., Mc REYNOLDS, L. A. and O' MALLEY, B. W. (1976), 
J. Biol. Chem. , 251, 7355. 
MORRISETT, J. D., JACKSON, R. L. and GOTTO, A. M. Jr. (1975), Ann. 
Rev. Biochem., 44,183. 
MUNYON, W., KRAISELBURD, E., DAVIS, D. and MANN, J. (1971), J. Virol., 
7,813. 
MULLIGAN, R. and BERG, P. (1981), Proc. Natl. Acad. Sci., U.S.A., 
78, 2072. 
NAKANISHI, S., ADHYA, S., GOTTESMAN, M. and PASTAN, I. (1973), 
J. Biol. Chem., 248, 5937. 
NEUFELD, E. F, LIM, T. W. and SHAPIRO, L. J. (1975), Ann. Rev. 
Biochem., 44, 357. 
NOBLE, R. P. (1968), J. Lipid Res., ~, 693. 
NYSTROM, E. and SJOVALL, J. (1975), Methods Enzymol., 35, 378. 
OMARY, M: B. and TROWBRIDGE, I. S. (1981), J. Biol. Chem., 256, 12888. 
ONCLEY, J. L. (1958), in The Lipoproteins : Methods and Clinical 
Significance. Ed. Homburger, F. and Bernfeld, P., pp. 14 - 23. 
S. Karger, Basle. 
272 
ONCLEY, J. L., WALTON, K. W. and CORNWELL, D. G. (1957), J. Amer. 
Chem. Soc., 79, 4666. 
OWEN, J. S., CHAVES, M. E. C. and CHITRANUKROH, A. (1985), Biochem. 
Soc. Trans., 13 , 20. 
PAPADOPOULOS, N. M. (1978), Clin. Chem., 24, 227. 
PAPAHADJOPOULOS, D. (1973), in Form and Function of Phospholipids, 
ed. Ansell, G.B., Dawson, R.M.C. and Hawthorne, J.N., pp. 143 - 169. 
Elsevier Scientific Publishing Co., Amsterdam. 
PEARSE, B. M. F. (1975), J. Mol. Biol. ,~, 93. 
PELLICER, A., ROBINS, B., WOLD, R., SWEET, J., JACKSON, I., LOWY, J. M., 
ROBERTS, G. K., SIMS, S., SILVERSTEIN, S. and AXEL, R. (1980), 
Science, 209, 1414. 
PELLICER, A., WIGLER, M., AXEL, R. and SILVERSTEIN, S. (1978), Cell, 
14, 133. 
PEREBITYUK, A. N. and BORONIN, A. M. (1984), Mol. Biol.(Moscow), 
18, 136. 
PERUCHO, M., HANAHAN, D. and WIGLER, M. (1980), Cell, 22, 309. 
PETERMANN, M. L., BARCLAY, M., ESCHER, G.and KAUFMAN, R. (1958), 
in The Lipoproteins : Methods and Clinical Significance, ed. 
Homburger, F. and Bernfeld, P.,pp. 75 - 86. 
S. Karger, Basle. 
PETERSON, G. L. (1977), Analytical Biochem., 83, 346. 
PHILIPPSEN, P., KRAMER, R. A. and DAVIS, R. W. (1978), J. Mol. 
Bio1., 123, 371. 
273 
PITAS, R. E., INNERARITY, T. L. and MAHLEY, R. W. (1983), Arterio-
sclerosis, 3, 2. 
POTTER, H. and DRESSLER, D. (1979), DNA Recombination: In vivo and 
i n vitro studies. Cold Spring Harbor Symp . Quant. Bio1., 43, 969. 
POTTER, H., WEIR, L. and LEDER, P. (1984), Proc. Natl. Acad, Sci., 
U.S.A., 81,7161. 
RADLOFF, R., BAUER, W. and VINOGRAD, J. (1967), Proc. Natl. Acad. 
Sci., U.S.A., ~, 1514. 
REDGRAVE, T. G., ROBERTS, D. C. K. and WEST, C. E. (1975), Anal. 
Biochem., 65, 42. 
R~IJNGOUD, D-J. and TAGER, J. M. (1977), Biochim. Biophys. Acta., 
472, 419. 
RIGBY, P. W. J., DIECKMANN, M., RHODES, C. and BERG, P. (1977), 
J. Mol. Biol., lli, 237. 
ROBERTS, D. C. K., MILLER, N. E., PRICE, S. G. L., CROOK, D, 
CORTESE, C., LaVlLLE, A., MASANA, L. and LEWIS, B. (1985), Biochem. J., 
226, 319. 
ROBERTS, R. J. (1983), Nucl. Acids Res., 11, 135. 
ROENSCH, L. F. and BLOHM, T. R. (1976), in Low Density Lipoproteins, 
ed.Day, C.E. and Levy, R.S., pp. 93 - 110. Plenum Press, New York. 
RONINSON, I. B. (1983), Nucl. Acids Res., 11,5413. 
RUDEL, L. L. and MORRIS, M. D. (1973), J. Lipid Res., 14,364. 
RUDEL, L. L, LEE, J. A., MORRIS, M. D. and FELTS, J. M. (1974), 
Biochem. J., 139,89. 
274 
RUSSELL, D. W., YAMAMOTO, T., SCHNEIDER, W. J., SLAUGHTER, C. J., 
BROWN, M. S. and GOLDSTEIN, J. L. (1983), Proc. Natl. Acad. Sci., 
U.S.A. ,80, 7501. 
SALSER, W. A. (1974), Ann. Rev. Biochem., 43, 923. 
SANGER, F., NICKLEN, S. and COULSON, A. R. (1977), Proc. Natl. Acad. 
Sci., U.S.A., 74,5463. 
SANGER, F. and COULSON, A. R. (1978), FEBS Letters, 87, 107. 
SCAGNOS, G. and RUDDLE, F. H. (1981), Gene, 14, 1. 
SCHAFFNER, W. (1980), Proc. Natl. Acad. Sci., U.S.A., 77, 2163. 
SCHLEGEL, R. A. and MERCER, W. E. (1980), in Introduction of 
Macromolecules into Viable Mammalian Cells, ed. Baserga, R, Croce, C. 
and Rovera, G., pp. 145 - 155. Alan R. Liss, New York. 
SCHNEIDER, D. L. (1981), J. Bio1. Chem., 256, 3858. 
SCHNEIDER, J. A., JONAS, A. J., SMITH, M. L. and GREENE, A.A. (1984), 
Biochem. Soc. Trans., 12,908. 
SCHNEIDER, W. J., BASU, S. K., McPHAUL, M. J., GOLDSTEIN, J. L. and 
BROWN, M. S. (1979), Proe. Natl. Acad, Sei., U.S.A., 76, 5577. 
SCHNEIDER, W. J., BEISIEGEL, U., GOLDSTEIN, J. L. and BROWN, M. S. 
(1982), J. Bio1. Chem., 257, 2664. 
SCHROEPFER, G. J. Jr., SHERRIL, B. C., WANG, K-S., WILSON, W. K., 
KISIC, A. and CLARKSON, T. B. (1984), Proc. Natl. Acad. Sci., U.S.A., 
81, 6861. 
SEIDEL, D. (1979), in Report on the High Density Lipoprotein 
Methodology Workshop, ed. Lippel, K., pp. 84 - 96. NIH Publication 
no. 82 - 1661. U.S. Dept. Human Services, Bethesda. 
275 
SEIF, 1., KHOURY, G. and DHAR, R. (1979), Cell, 18,963. 
SHARP, P. A., SUGDEN, B. and SAMBROOK, J. (1973), Biochemistry, 
12, 3055. 
SHAW, \11. V. (1967), J. Bio1. Chem., 242, 687. 
SHA1~, W. V. (1975), Methods Enzymo 1 ., 43, 737. 
SHAW, W. V. and BRODSKY, R. F. (1968), J. Bacteriol., 95, 28. 
SHM1, J. E., HUANG, E-S. and PAGANO, J. S. (1975), J. Virol., 
16, 132. 
SHORE, B. and SHORE. V. (1969), Biochemistry,~, 4510. 
SHORE, V. G. and SHORE, B. (1972), in Blood Lipids and Lipoproteins 
Quantitation, Composition and Metabolism, ed. Nelson, G. J., pp. 789 -
824. John Wiley and Sons Inc., New York. 
SILVERSTEIN, S. C., STEINMAN, R. M. and COHN, Z. A. (1977), Ann. Rev. 
Biochem., 46, 669. 
SINSHEIMER, R. L. (1977), Ann. Rev. Biochem., 46, 415. 
SKIPSKI. V. P. (1972), in Blood Lipids and Lipoproteins 
Quantitation, Composition and Metabolism, ed. Nelson, G.J., pp. 471 -
583. John Wiley and Sons Inc., New York. 
SKIPSKI, V. P. and BARCLAY, M. (1969), Methods in Enzymology, 
14, 530. 
SKIPSKI, V. P., PETERSON, R. F. and BARCLAY, M. (1964), Biochem. J., 
90, 374. 
SMITH, H. O. and WILCOX, K. W. (1970), J. Mol. Biol., 51, 379. 
276 
SOUTHERN, E. M. (1975), J. Mol. Bio1., 98,503. 
SPEAKE, B. K., PARKIN, S. M. and ROBINSON, D. S. (1985), Biochem. Soc. 
Trans., 13, 29. 
SRINIVASAN, S. R., RADHAKRISHNAMURTHY, B. and BERENSON, G. S. (1979), 
in Report of the High Density Lipoprotein Methodology Workshop, ed 
Lippel, K., pp. 70 - 83. U.S. Dept. of Human Services, Bethesda. 
STACEY, D. W. (1980), in Introduction of Macromolecules into 
Viable Mammalian Cells, ed. Baserga, R., Croce, C. and Rovera, G., 
pp. 100 - 125. Alan R. Liss Inc., New York. 
St. CLAIR, R. W., LEIGHT, M. A. and BARAKAT, H. A. (1986), 
Arteriosclerosis, 6, 170. 
STEER, C. J., KEMPNER, E. S. and ASHWELL, G. (1981), J. Biol. Chem., 
256, 5851. 
STRAIN, A. J. and WYLLIE, A. H. (1984), Biochem. J., 218, 475. 
STRAUBINGER, R. M., HONG, K., FRIEND, D. S. and PAPAHADJOPOULOS, D. 
( 1983) , Ce 11, 32, 1069. 
SUTCLIFFE, J. G. (1978), Nucleic Acids Res., 5, 2721. 
SZYBALSKI, W., SZYBALSKA, E. H. and RAGNI, G. (1962), National 
Cancer Institute Monograph, i, 75 - 89. 
TAGER, J. M., JONSSON, L. V. M., AERTS, J. M. F., ELFERINK, R.P.J., 
SCHRAM, A. W., ERIKSON, A. H. and BARRANGER, J. A. (1984), Biochem. 
Soc. Trans., ~, 902. 
TAKAYAMA, M., ITOH, S., NAGASAKI, T. and TANIMIZU, 1. (1977), Cl in. 
Chim. Acta, 79, 93. 
277 
TEICHMAN, R. J., TAKE!, G. H. and CUMMINS, J. t~. (1974), J. 
Chromatography, 88, 425. 
TIMKOVICH, R. (1977), Anal. Biochem., 79, 135. 
UNGEWICKELL, E. (1984), Biochem. Soc. Trans., ~, 978. 
UNGEWICKELL, E. and BRANDON, D. (1981), Nature, 239, 420. 
USHIRO, H. and COHEN, S. (1980)~ J. Biol. Chem., 255,8363. 
VAHERI, A. and PAGANO, J. S. (1965), Virology,~, 435. 
VAINSTEIN, A., RAZIN, A., GRAESSMANN, A. and LOYTER, A. (1983), 
Methods Enzymol., lQi, 492. 
Van BERKEL, T. J. C., KRUIJT, J. K., SPANJER, H. H., NAGELKERKE, J. F., 
HARKES, L. and KEMPEN, H. J. M. (1985), J. Biol. Chem., 260, 2694. 
Van der WESTHUYZEN, D. R., COETZEE, G. A., DEMASIUS, I. P. C., HARLEY, 
E. H., GEVERS, W., BAKER, S. G. and SEFTEL, H. C. (1984), Arterio-
sclerosis, 4, 238. 
VOGEL, T., WEISGRABER, K. H., ZEEVI, M. I., BEN-ARTZI, H., LEVANON, A. 
Z., RALL, S. C. J. Jr., INNERARITY, T. L., HUI, D. Y., TAYLOR, J. M., 
KANNER, D., YAVIN, l., AMIT, B., AVID, H., GORECKI, M.and MAHLEY, R. W. 
(1985), Proc. Natl. Acad. Sci., U.S.A., 82, 8696. 
WARNICK, G. R. and ALBERS, J. J. (1979), in Report of the High 
Density Lipoprotein Methodology Workshop, ed. Lippel, K., pp. 53 - 68. 
NIH publication No. 82 - 1661, U.S. Dept. Health and Human Services, 
Bethesda. 
WATSON, J. D., TOOlE, J. and KURTl, D. T. (1983), Recombinant DNA 
A Short Course. W.H. Freeman and Co., New York. 
278 
WIBERG, F. C., SUNNERHAGAN, P., KALTOFT, K., ZEUTHEN, J. and BJURSELL, 
G. (1983), Nucl. Acids Res., 11,7287. 
WEILAND, H. and SEIDEL, D. (1973), Clin. Chem., 19, 1139. 
WIGLER, M .• SILVERSTEIN, S., LEE, L-S .• PELLICER, A., CHENG, Y-C. and 
AXEL, R. (1977), Cell, ll. 223. 
WIKLUND, 0., DYER, C. A., TSAO, B. P.and CURTISS, L.K. (1985), J. 
Biol. Chem., 260, 10956. 
WILCOX, G., MEURIS, P .• BASS, R. and ENGLESBERG, E. (1974), J. Biol. 
Chem., 249, 2946. 
WILSON, K. and GOULDING, K. H. (Ed.). (1986), A Biologists' Guide 
to Principles and Techniques of Practical Biochemistry. Pp. 153 - 197. 
WINTER, G. and BROWNLEE, G. G. (1978), Nucl. Acids Res., 5, 3129. 
WITTER, R. F. and WHITNER, Y. S. (1972), in Blood Lipids and 
Lipoproteins : Quantitation, Composition and Metabolism, ed. Nelson, 
G.J., pp. 75 - 111. John Wiley and Sons Inc., New York. 
YAMAMOTO, K. R. and ALBERTS, B. M. (1976), Ann. Rev. Biochem .• 
45,721. 
YOUNG, B. D. and ANDERSON, M. L. M. (1985), Quantitative Analysis of 
Solution Hybridization in Nucleic Acids Hybridization, a Practical 
Approach, ed. Hames, B.O. and Higgins, S.J., pp. 47 - 71. IRL Press, 
New York. 
YOUNG, S. G., WITZTUM, J. L., CASAL, O. C., CURTISS, L. K. and 
BERNSTEIN, S. (1986), Arteriosclerosis, 6, 178. 
279 
ZAK, B. (1957), Amer. J. Clin. Pathology, ~, 583. 
ZECHNER, R., DIEPLINGER, H., ROSCHER, A. and KOSTNER, G. M. (1984), 
Biochem. J., 224, 569. 
ZILVERSMIT, D. B., HUGHES, L. B. and BALMER, J. (1975), Biochim. 
Biophys. Acta, 409, 393. 
ZILVERSMIT, D. B. and JOHNSON, L. W. (1975), Methods Enzymol., 35,262. 
ZLATKIS, A. and ZAK, B. (1969), Anal. Biochem., 29, 143. 
ZUBAY, G. (1980), Methods Enzymol., 65,856. 
280 
APPENDIX 
All lipid standards were purchased from Sigma Chemical Co., St. 
Louis, U.S.A. 
Restriction endonucleases and phospholipase C and 0 were purchased 
from Boehringer Mannheim, Germany. 
Sephagex G25 was obtained from Pharmacia fine chemicals, Upsala, 
Sweden. 
Human lung fibroblasts were obtained from Highveld Biologicals. 
All radiochemicals were purchased from the Radiochemical Center, 
Amersham, England. 
The plasmid pSV2cat was a gift from Professor E. Harley, Dept, of 
Chemical pathology, University of Cape Town. 
Feta 1 fi brob 1 asts and CV - 1 ce 11 s were a gift from Professor E. 
Harley and Or R. Rubenstein, Dept. of Chemical Pathology, University 
of Cape Town. 
Normal skin fibroblasts were a gift from Professor I. Jaylal and 
Mrs R. Hanif, Dept. of Chemical Pathology, University of Natal. 
A 11 other chemical s used were purchased from E .Merck ,Damstadt, Germany. 
